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ABSTRACT 
Background: Numbers of older people are increasing rapidly in most low and middle-
income countries and there is a pressing need for adequate information on dementia and 
cognitive disorders in these regions. Mild cognitive impairment is increasingly recognized 
as an important ‘transition’ prior to dementia onset, but is poorly understood outside 
Western settings, as are key constructs underlying this concept: namely, subjective memory 
complaints, informant-reported memory deficits and the relationship between cognition and 
disability.  
Methods: Data were analysed in relation to these questions from a series of catchment area 
surveys of older people carried out following identical methodologies in Cuba, Mexico, 
Dominican Republic, Peru, Venezuela, India and China, involving over 15,000 
participating residents aged 65 years and over. Measurements had been rigorously assessed 
for cross-cultural applicability and were identically administered.  
Results: Normative data for cognitive function are described and compared, followed by 
the prevalence of amnestic mild cognitive impairment. Substantial variations were found 
between sites in the prevalence of subjective memory complaints and informant-reported 
memory deficits, and in their associations with dementia, and with cognitive function in 
participants without dementia. Variation was also found in the association between 
cognitive function and informant-reported disability in participants. For example, 
subjective memory complaints in China were relatively rare but much more strongly 
associated with dementia and/or cognitive function than in other sites.  
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Conclusions: The high level of between-site variability in the associations in question 
suggests that mild cognitive impairment as a construct is strongly influenced by cultural 
factors which need to be taken into account when interpreting it or applying it in healthcare. 
252 words 
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I.1 Worldwide demographical aging 
Population ageing has been one of the most important demographic events of the twentieth 
century and is likely to persist in the twenty first, with profound impacts on a broad range 
of economic, political and social outcomes. Although this demographic change began in 
developed countries, many low and middle-income countries face dramatic and rapid 
population ageing. 
 
From the 1950´s to the year 2000, the global population aged 60 years or over increased 
about three-fold, from 205 million to 606 million, and for the first half of the current 
century it is projected that this will expand again more than three-fold to reach nearly 2 
billion in 2050. By the year 2000, 1 person in every 10 was age 60 years or older and by the 
year 2050 it is projected that a 1 in 5 proportion will be attained. Currently, the average 
annual growth rate of persons aged 80 or over is 3.8 per cent: twice as high as the growth 
rate of 60-79 year olds (1.9 per cent). At the moment, women comprise a significant 
majority of the ageing population because their life expectancy is greater than men’s, and in 
the year 2000 the world’s population aged 60 or over comprised 81 males per hundred 
females. However, the expected trend for the next half-century is an equalizing of this sex 
ratio because of a faster growth in life expectancy among men than women, particularly in 
more developed regions. In 2050, the global number of men per hundred women is 
projected to rise to 85 at ages 60 over, to 81 at ages 65 or over, and to 61 at ages 80 or over 
(U.N., 2002). 
 
According to the 2006 Revision of the World Population Prospect, by 2045 the number of 
older persons in the world (those aged 60 years or over) will likely surpass, for the first 
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time in the history, the number of children (i.e., persons under age 15). This crossover is the 
consequence of long term reductions in fertility and mortality that are leading to the steady 
ageing of the world population (Figure I.1) (WHO, 2006). 
 




Source: World Population Prospects: The (U.N., 2006) Revision. Fact Sheet, Series A. 
Population Division of the Department of Economic and Social Affairs of the United 
Nations Secretariat Ed. New York: United Nations  
 
Sustained reductions of fertility slow down population growth and produce eventual 
reductions in the number of births and hence in the proportion of children in the population. 
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Furthermore, increases in longevity accelerate the growth of the proportion of older persons 
more than those of young people or adults. (WHO, 2006) 
 
Demographic transition is a model used to describe characteristics of national or regional 
population changes, with several stages. In the first of these, birth and mortality rates are 
high, which produces low population growth. In the second (truly transitional) stage, a 
reduction in mortality and a continuing high birth rate lead to an increase in population 
growth rates. In the third phase, known as advanced transition, mortality rates have fallen 
and birth rates decline too, which results in diminishing rates of population growth. In the 
post-transition phase, birth rates drop below the level of mortality rates, thus resulting in 
extremely low or even negative natural population growth (Chackiel, 2004 , Schkolnik, 
2007, Villa and González, 2004) 
 
Worldwide life expectancy at birth has increased about 20 years since 1950, to its current 
level of 68 years and is projected to rise to 76 years by 2050 (U.N., 2009). By 2050 20% of 
the older population will be aged 80 years or over. The change observed in the shape of 
survival curves, which has been termed rectanglearisation, shows that more and more 
individuals survive to very old age, and all of them die in a very narrow time window 
(Ferrucci et al., 2008). 
 
In order to provide context for this thesis, whose research questions particularly concern 
age-related conditions, brief summaries follow on the position of high income countries, 
from where most current research evidence derives, followed by a generic description of 
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low and middle income counties and then more specific illustrations from Latin America 
and the Caribbean as an example of a region with rapid demographic transformation.  
 
I.2 Population Ageing in High Income Countries 
 
In high-income countries, fertility rates have been falling since the 1950s reaching a 
minimum of 1.64 children per woman in 2010. Furthermore, infant mortality has reached 
the lowest rate in history: five per 1000 live births in Japan, and less than 10 per 1000 in 
most other HIC. Mortality rates are continuing to fall in these settings for both sexes at both 
extreme ages. The current life expectancy at birth of 77 years is projected to rise to 83 years 
by 2050.(U.N., 2009). Population growth in high-income countries fell from 1.21% per 
year in the 1950s to just 0.34% between 2000 and 2010. UN estimates suggest that the rate 
of growth in these countries is going to continue fall, reaching -0.07% by 2050 (U.N., 2009) 
 
In high-income countries the oldest population already accounts for 22% of the total 
population, and is estimated to reach 33% by 2050. In 2010, numbers in the older 
population surpassed those of the children (22% vs. 17%), and in 2050 it is projected that 
60 and more years old people will account for 33% and children 15% of the total 
population of high income countries (U.N., 2009) 
 
I.3 Population Ageing in Low and Middle Income Countries 
When information related to older population is consulted, inconsistencies about age ranges 
are found. Most developed world countries have accepted a chronological age of 65 years 
and above as a definition of 'the elderly' or older people. However, this merely reflects the 
age of pension receipt in some countries and, like many westernized concepts, has very 
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limited relevance for low and middle income countries where retirement is a more fluid or 
non-existent concept. At the moment, the UN agreed cut-off is 60+ years to refer to the 
older population.  
 
In many less developed regions of the world, the older population is growing at a much 
faster rate than has been observed in developed nations. In the last fifty years the rates of 
increase have tended to decline in the more developed regions and to increase in less 
developed regions. Currently in more developed regions the average annual growth rate of 
the population of persons 60 years or over is 0.9%, while less developed regions have an 
average of 2.5%. Furthermore, 66% of the increase of elderly population in the last half 
century has occurred in less developed regions compared to 34% in more developed 
regions. Gender distributions in the elderly population are not the same as those observed in 
developed countries; in less developed regions older women do not generally outnumber 
older men to the same extent as in developed countries and gender differences in life 
expectancy are generally much smaller. 
 
In contrast to developed countries, in less developed regions there are high proportions of 
older people remaining in the labour force because of less comprehensive pensions and 
support systems. By 2000 the labour force participation of the population aged 65 and over 
was 26% and in more developed regions 8% (U.N., 2002).  
 
Despite the improved life expectancy underlying these demographic trends, lack of 
education remains an  
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Issue, which has not been substantially addressed. Although illiteracy among older people 
has declined in the last decades, particularly among males, it still remains high in less 
developed regions. In 2000, 56 per cent of people aged 60 or over in the world were 
estimated to be illiterate (Kinsella and Wan, 2009).  
 
For the coming half-century, mixed trends are projected although in most countries the 
number and proportion of woman will increase. The evidence on which the projections are 
based suggests a somewhat faster growth in life expectancy among men than among 
women, particularly in the more developed regions. In 2050, the global number of men per 
hundred women is projected to rise to 85 at ages 60 or over, to 81 at ages 65 or over, and to 
61 at ages 80 or over. (U.N., 2002). 
 
A particularly rapid increase in the population aged 80 years or over is expected which 
means that demographic ageing in less developed regions will be characterized by people in 
more advanced old age. 
 
I.4 Demographic transition illustrated in Latin America and the Caribbean 
 
As described above, the initial stage of the demographic transition process is characterized 
by a change from high to low mortality rates and, subsequently, a steady decline in fertility, 
until both variables reach low levels (Schkolnik, 2007, Villa, 2005, Chackiel, 2004 ). This 
model was originally formulated to interpret the sociodemographic transformation that took 
place in European countries from the mid-eighteenth to the mid-twentieth century (Villa 
and González, 2004) but offers a good fit, albeit with certain differences, with the process 
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undergone by Latin America and the Caribbean in more recent times, taking place much 
more rapidly over less than 50 years. (ECLAC, 2004). 
Over this period, regional mortality for Latin America and the Caribbean has dropped by 10 
percentage points to give a gross mortality rate of 6.1 deaths for every 1,000 inhabitants 
between 2000 and 2005 (Huenchuan, 2009). 
 
Female life expectancy is longer than men throughout the region, due among other things to 
reductions in deaths during pregnancy and childbirth, causes of death which are usually 
controlled more successfully than those that prevail among men, such as cardiovascular 
disease, external causes (including violence) and certain cancers (ECLAC, 2004, CELADE, 
2006). 
 
Most countries in Asia or in Latin America and the Caribbean find themselves in the 
second stage of the transition where the population of working age (from 15 to 59 years) is 
still growing as a proportion of the whole population. By 2050 the median age is projected 
to increase by over 12 years in 32 of the 37 countries in this region, and by 2050 21 
countries in the region are expected to have a median age higher than 40, including Brazil 
and México (Huenchuan, 2009).  
 
The components of demographic change (fertility and mortality) have an impact both on 
the growth of the population in numbers and on its age structure. As demographic transition 
progresses and mortality and especially fertility decline, the population gradually ages 
(Chackiel, 2004 , ECLAC, 2004, Villa and González, 2004). This transition is best 
illustrated graphically, where the conventional outline of the age and gender structure of the 
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population, a pyramid with a wide base and narrow tip illustrating the preponderance of 
children and rarity of older age groups, first morphs into a more rectangular shape and 
subsequently inverts its initial form with the top wider than the base (Chesnais, 1990) 
Changing regional population structures in the latter half of the 20th Century are illustrated 




Figure I.2 Latin America and the Caribbean: average age and sex structures of the 
population, by stage of demographic transition of the region’s countries, 1950-2000. 
 
 
Modified from: Sandra Huenchuan ed.(2009), Envejecimiento, derechos humanos y 
políticas públicas, Libros de la CEPAL Nº 100 (LC/G.2389-P), Santiago de Chile, CEPAL 




According to a recent review of population projections conducted by the Latin American 
and Caribbean Demographic Centre (CELADE) - Population Division of ECLAC, changes 
in the pyramid structure will have become steadily more drastic by 2025, when children 
under 15 will represent only 23% of the population in this region and older adults will make 
up almost 15%. The larger cohorts born in previous decades also will be progressing 
through adulthood and broadening the central bands of the pyramid that will continue for 
decades to come. The new age profile is forming a pyramid with a narrower base and wider 
central sections, corresponding to an older population structure. Around 19% of the 
population in the most transitionally advanced countries will be aged 60 or over, while the 
percentage of children under age 15 will drop to 20%. The least transitionally advanced 
countries will have a smaller proportion of older adults (8%), which will slowly increase in 
line with the decrease in the population aged 0 to 14 years (32%). By 2050, the classic 
pyramid structure will be completely replaced by a rectangular shape where each age group 
represents practically the same proportion of the population. Children under the age of 15 
will represent 18% of the total regional population, and older adults will represent 24%. 
Countries that were already displaying population ageing in 2000 will have the highest 
proportion of older people (27%), while the least advanced countries in the transition will 
have considerably increased their proportion of people aged 60 and above to 15% of the 




Figure I.3 Latin America and the Caribbean: average age and sex structures of the 
population, by stage of demographic transition of the region’s countries, 2000-2050 
 
 
Modified from: Sandra Huenchuan ed. (2009), Envejecimiento, derechos humanos y 
políticas públicas, Libros de la CEPAL Nº 100 (LC/G.2389-P), Santiago de Chile, CEPAL 




As a result of demographic transition, the population of Latin America and Caribbean is 
gradually but inexorably ageing. The next few decades will see steady increases in both the 
proportion and the absolute number of people aged 60 and over. In absolute terms, the 
number of people aged 60 and over (currently 41 million) is expected to grow by 57 million 
between 2000 and 2025, and by 86 million between 2025 and 2050. This population group 
is growing at a faster pace than other younger groups (average annual growth rate of 3.5%). 
The rate of change within this age group will be between three and five times higher than 
among the total population in the periods 2000-2025 and 2025-2050. As a result, the 
proportion of people aged 60 and over in the total population will quadruple between 2000 
and 2050, such that one in every four people in Latin America and the Caribbean will be an 
older adult in the year 2050 (Figure I.4). 
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Figure I.4 Latin America and the Caribbean: population aged 60 and over, 1950-2050 




Modified from: Sandra Huenchuan ed. (2009), Envejecimiento, derechos humanos y 
políticas públicas, Libros de la CEPAL Nº 100 (LC/G.2389-P), Santiago de Chile, CEPAL 
(Economic Commission for Latin America and the Caribbean) 
 
The fact that countries are at various stages of demographic transition means that the ageing 
process is different in each one. In order to classify this region’s countries according to 
their stage in the process of population ageing, the global fertility rate was combined with 
the ageing index (ratio between the number of people aged 60 and over and the number of 




Figure I.5 Latin America and the Caribbean: position of countries according to stage 
of population ageing process, 2007 
 
 
GT= Guatemala, HA= Haiti, BO= Bolivia, HN= Honduras, GF= French Guyana, BZ= Belize, PY= 
Paraguay, NI= Nicaragua, DO= Dominican Republic, PA= Panama, EC= Ecuador, SV= El Salvador, VE= 
Bolivarian Republic of Venezuela, PE= Peru, SM= San Marino JM= Jamaica, CO= Colombia, GY= 
Guyana , BR= Brasil, LC= Saint Lucia , MX= Mexico, CR= Costa Rica, BH= Bahrain, AR= Argenitna, 
CL= Chile, TT= Trinidad y Tobago, GP= Guadeloupe, AN= Netherlands Antilles, UY= Uruguay, MO= 
Macao, PR= Puerto Rico, CU= Cuba, BB= Barbados 
 
         Modified from: Sandra Huenchuan ed. (2009), Envejecimiento, derechos humanos              
y políticas públicas, Libros de la CEPAL Nº 100 (LC/G.2389-P), Santiago de 
 Chile, CEPAL (Economic Commission for Latin America and the Caribbean) 
 
This figure shows that there are four distinct groups of countries. The first group has 
relatively high levels of fertility and a relatively low ageing index, and can be viewed as 
being at the incipient stage of the demographic transition process (eight countries). Three 
more groups follow this one, at increasingly advanced stages of demographic transition. 
The figure illustrates the heterogeneity in transition stages across the region and highlights 
the importance of considering countries’ specific situations with respect to age-related 




In Latin America and the Caribbean, the rapid pace of demographic transition has meant 
that there has been less time to make the necessary socio-economic and institutional 
adjustments to adapt to the emerging demographic situation – for example, slower and 
more volatile economic and social development. Over the next 50 years, older age groups 
themselves will age rapidly, with most dramatic expansion in those aged 75 and over 
(expected to remain above that of the population aged 60 and over during the period 1950-
2050). Although low and middle income countries share some similarities in demographic 
transitions, there is substantial heterogeneity: particularly in the pace of change (U.N., 
2009). 
 
For example, in Latin America and the Caribbean life expectancy has been increasing 
steadily and has now reached 70 for men and 76 for women. India and China on the other 
hand have experienced more dramatic increasing from only 38 years in the 1950s to a 
current level of 63 years in India, and from 41 to 73 years in China (U.N., 2009). However, 
in the poorest countries (mostly in sub-Saharan Africa) life expectancy remains only 56 











II.1 Worldwide health transition 
Declining fertility with increasing life expectancies has led to a marked increase in the 
older population globally both in relative and absolute terms. This trend has been 
accompanied by changes in life styles and urbanization that have contributed to an 
‘epidemic of chronic diseases’ (Nugent, 2008). Health systems need to be prepared to 
respond to these evolving health scenarios and find effective strategies for the needs of 
older people as a rapidly growing segment of the population. The health of the ageing 
population will also have implications for social and economic policies (U.N., 2011) 
 
As more people live until advanced old age, these demographic changes imply much more 
than just an increase in chronic morbidity. The same age-related susceptibility to chronic 
conditions in the same individual causes decrements in functional abilities as well as social 
and psychological problems that may have additional impacts on wellbeing and quality of 
life. Going beyond the demographic focus of counting and projecting the number of older 
people in the population, epidemiology has made additional contributions to our 
understanding of the health status and functional trajectory of older individuals. 
 
Dementia is an age-associated condition for which prevalence and incidence rates cannot be 
inferred from routine administrative datasets. Instead, because of the complexities of 
diagnosing dementia and the fact that it is frequently unrecognized in clinical settings, 
agencies requiring data on the occurrence of the condition must rely on well-designed 
epidemiologic studies in defined geographic areas. A large review of studies on dementia 
incidence from around the world supported an exponential increase in dementia with age 
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and suggested that rates tend to be lower in East Asia than in Europe and the United States 
(Ferrucci et al., 2008). 
 
The five leading causes of death: heart disease, cancer, stroke, chronic lower respiratory 
tract disease, and Alzheimer’s disease account for 69.5% of all deaths. Alzheimer’s disease, 
only recently included on the list of leading causes of death, was the seventh leading cause 
of death in older persons in 2000 and in 2003 rose to the fifth leading cause of death. This 
ranking is still likely a gross underestimation, and the contribution of 
Alzheimer’s disease in the future will probably grow substantially (Ferrucci et al., 2008). 
 
II.2 Low and Middle Income Countries health transition  
The increasing prevalence of chronic disease in developing countries can be partitioned into 
two main trends: rising average age of the population and changing epidemiologic profile 
of the population. 
 
Survey data, for example, show temporal increases in the proportion of the population that 
is overweight or obese, a major risk factor associated with chronic diseases. These 
increases appear across a wide range of developing countries, but with substantial variation 
among those countries in the prevalence levels and rates of increase (Nugent, 2008). 
 
In the world's developing regions people, high fat diets, smoking and sedentary lifestyles 
are becoming more common. Chronic non-communicable diseases (NCDs) linked to ageing 
– heart disease, stroke, cancer and dementia – are much more in evidence, and beginning to 
be recognized as a public health priority. While cancer and heart disease contribute mainly 
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to mortality, much of the burden of other NCDs (dementia, mental disorders, diabetes and 
stroke) lies in years lived with disability (Fuster and Voûte, 2005). 
 
In low-income countries the communicable diseases, maternal and perinatal conditions and 
nutritional deficiencies are still causing a big number of deaths, which are decreasing in an 
important way in the rest of the countries (lower middle, upper middle and high income 
countries) so the injuries have a similar pattern even but with a very lower number of 
deaths; meanwhile in the other hand chronic diseases represent the most important cause of 
death for the most of the countries with the exception of the LIC where they are increasing 


















Figure II.1 Projected deaths by major cause and World Bank income group, all ages, 
2005 
 
Source: World Health Organization (2005) Preventing chronic diseases: a vital investment : 
WHO global report. 
 
Chronic diseases such as cardiovascular disease (CVD), diabetes, obesity, cancer and 
respiratory diseases cause more than half of the 58 million deaths that occur each year 
worldwide and these are by no means confined to wealthy countries; instead, a large part of 
this burden falls on low- and middle-income countries.  For example, two-thirds of the 177 
million people with diabetes live in the developing world. Importantly, one quarter of 
chronic disease occurs in people younger than 60 years. The resulting long-term morbidity 
and premature death often pushes affected individuals and their families into poverty or 
keeps them there through loss of work opportunities and health care costs (WHO, 2006). 
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 The WHO has projected important increases in deaths and illness due to chronic diseases 
in low- and middle-income countries up to 2030 (Figure II.2). 
 
Figure II.2 Deaths attributed to Chronic Non-communicable Diseases by Word Bank 




Modified from: Adeyi, O. Smith, O and Robles, S (2007) Public Policy and the Challenge 
of Chronic Noncommunicable Diseases. World Bank. Washington, DC 
 
Latin American and Caribbean people spend a large portion of their lives in a state of poor 
health. The average people lives around 10 years of his or her life in bad health and, as 
various studies have shown, women are the hardest hit because of their higher morbidity 
rate and the cumulative effect of a lifetime of inequality (Anderson and Chu, 2007). 
 
Chronic non-communicable diseases are the main cause of disability and death worldwide. 
This reflects new risks factors (e.g., obesity) that tend to show a greater contribution 
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compared to more traditional risk factors for low and middle income countries (e.g., 
inadequate nutrition, unsafe water and sanitation (WHO, 2006) Figures II.3 and II.4 
 
Therefore, overall, lower-income countries suffer heavier disease burden. An analysis of 
lost years of health also shows that communicable diseases are much more of a burden for 
the poorest countries than for medium- to high-income countries. This pattern is repeated 
within countries themselves, where those on lowest incomes are subject to higher risks of 
communicable diseases (WHO, 2006). 
 
Figure II.3 Percentage of disability-adjusted life years (DALYs) attributed to 19 
leading risk factors, by country income level, 2004 
 





Figure II. 4 Deaths attributed to 19 leading risk factors, by country income level, 2004 
 
 
Source: WHO (2006). Global Burden of Disease and Risk Factors. New York: World 
Health Organization 
 
These epidemiological transitions in population health currently being experienced in low- 
and middle-income countries are compressed into a shorter time frame than that 
experienced historically in high-income countries. 
 
Much of the chronic disease burden in low and middle-income country settings can be 
attributed to environmental and lifestyle factors, including tobacco consumption and 
decreased physical activity. Variations in the risk of non-communicable diseases between 
high income countries and trends over time within countries also suggest that the factors 
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determining incidence are modifiable, and therefore that many non-communicable diseases 
are preventable (WHO, 2002, WHO, 2006). Despite this wealth of information, there is an 
important research gap between developing and developed countries.  
 
Research findings from developed settings are not necessarily appropriate to other contexts; 
thus, local knowledge is imperative (Miranda et al., 2008). For example, higher body mass 
index is more likely to be associated with lower socio-economic status and worse general 
health (e.g. cardiovascular risk) in a developed nation setting but with higher socio-
economic status and better health (e.g. improved nutrition) in a lower income setting. 
 
II.3 Conclusions 
As more people live until advanced old age, these demographic changes imply much more 
than just than aging and an increase in chronic morbidity. 
 
The epidemiological transition in high and LMIC, has important differences and needs. But 
they have in common, the increase of age-associated conditions, chronic diseases, disability 
and dependence. Among these age associate conditions, dementia is an important cause of 
disability and death. 
 
Chronic non-communicable diseases are the main cause of disability and death worldwide; 









III.1 The importance of mild cognitive impairment concept 
Having considered the importance of demographic ageing and the shift from communicable 
to non-communicable diseases in many low and middle-income countries, the aim of this 
chapter is to review mild cognitive impairment (MCI) as a construct of particular interest to 
rapidly ageing populations, with particular attention paid to the development of the concept 
and diagnostic criteria, issues which need to be considered when interpreting its 
epidemiology and correlates. 
 
If interventions are to be developed to reduce the impact of dementia, then waiting until the 
clinical manifestations become apparent is likely to be too late, given the long prodromal 
period for most causes of the disorder. Research into cognitive aging and dementia is 
therefore focusing increasingly on the characterization of the earliest stages of cognitive 
impairment (Petersen et al., 2001), and a variety of clinically defined pre-dementia 
syndromes with differing diagnostic criteria and nomenclature have been proposed to 
describe non-disabling but symptomatic cognitive deficits arising in older people (Panza et 
al., 2005). In this century, attention has focused on MCI as a term with growing usage in 
the international scientific literature on cognitive aging and dementia (Petersen, 2004). This 
fact is evidenced by an exponential increased in publishing articles utilizing this term 
(Figure III.1). In spite of the fact that MCI remains a controversial entity in terms of its 
precise definition and reliability, it is largely accepted as a ‘concept’ describing a situation 
where a person is more cognitively impaired than would be expected for their 
age/background and yet does not fulfil criteria for dementia.  
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The difficulty in standardising case definitions for MCI over the last 10 years, has led to 
several international consensus meetings, and publication of proposed criteria; for example, 
the meeting on “Current Concepts in Mild Cognitive Impairment” held in 1999 in Chicago 
(Petersen et al., 2001), the Annual Mild Cognitive Impairment Symposium (Bain, 2006), 
the first symposium of  the International Working Group on Mild Cognitive Impairment in 
Sweden(Winblad et al., 2004), or the 2006 International Psychogeriatric Association Expert 
Conference on Mild Cognitive Impairment (Gauthier et al., 2006). 
 
The MCI concept has tended to become more, rather than less, complex over time, leading 
to considerable debate over practice guidelines and competing sets of criteria (Ganguli and 
Petersen, 2008). To date, no single construct is universally accepted for defining MCI, and 
this has given rise to inconsistencies within and between clinical and research settings with 
heterogeneous populations and differences in aetiological factors, cognitive changes and 
clinical outcomes (Matthews et al., 2007, Panza et al., 2005). There is therefore a need to 



























McKeith, 2001) and at the same time, to develop studies using different samples and 
designs in order to achieve a more comprehensive picture of the phenomenon under 
investigation (Tuokko and Hultsch, 2006). However, important practical questions relating 
to the concept of MCI need to be addressed, such as its utility, limitations, implications and 
applicability. 
 
MCI as a construct will inevitably include both ‘normal’ and ‘abnormal’ trajectories of 
decline, the former encompassing a range of cognitive changes that accompany normal 
aging which do not progress to dementia, although which might place an individual at 
increased risk of this (Stephan et al., 2007). Factors potentially affecting so-called cognitive 
aging include education, intelligence, and sensory abilities (Drag and Bieliauskas, 2010) 
and, given these and the many other potential extraneous influences on the cognitive aging 
process, is not surprising that inter-individual variability increases with age (Ardila, 2007). 
It is recognised that some cognitive changes occur as a ‘normal’ consequence of aging. 
‘Cognitive aging’ is characterized by a decrease in the efficiency of some mental functions; 
these changes are varied, but they usually do not impact overall functionality. In general the 
main cognitive changes associated with age are related to information processing speed, 
executive function and memory (Finkel and Pedersen, 2000, Salthouse, 1996). It is clear 
that memory decline occurs in aging people; however, while changes in memory can be a 
normal part of aging, some forms of memory changes may indicate an underlying dementia 
(Zaudig, 2002, Smith and Rush, 2006). Usually prospective and working memory are most 
affected with semantic and procedural memory the most stable modalities (Backman, 2008, 




Cognitive function at a given age is a product of the level attained by early adult life, 
commonly referred to as ‘cognitive reserve’, as well as by intervening changes, whether 
pathological or ‘normal’. Indices of cognitive reserve are positively associated with 
cognitive performance in multiple domains including attention and memory (Corral et al., 
2006) and, as well as influencing the level of function from which age-related decline 
occurs, may also be a protective factor against the expression of age-related cognitive 
decline. For example, cognitive reserve has been suggested to moderate the relation 
between age-related pathology and cognitive functioning (Drag and Bieliauskas, 2010) 
 
III.2 Terminology and concept development for MCI and related constructs 
One of the first attempts to identify people with early stages of cognitive impairment 
(therefore assumed to be at risk of developing dementia) was carried out more than 45 
years ago, by Kral (1962) who proposed the terms ‘benign’ and ‘malignant’ ‘senescent 
forgetfulness’ to describe forms of cognitive decline distinguishable on the basis of 
symptoms, course and prognosis. Since then, a wide variety of criteria and definitions have 
been proposed, offering a problematically large number of options: 
1. Benign senescent forgetfulness (BSF) (Kral, 1962)  
2. Malignant senescent forgetfulness (MSF) (Kral, 1962) 
3. Limited cognitive disturbance, (LCD) (Gurland et al., 1982) 
4. Age-associated memory impairment (AAMI) (Crook et al., 1986)  
5. Late-life forgetfulness (LLF) (Blackford and La Rue, 1989) 
6. Mild cognitive impairment (MCI) (Zaudig, 1992) 
7. Mild cognitive disorder (MCD) (Christensen et al., 1997) 
8. Aging-associate cognitive decline (AACD) (Levy, 1994) 
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9. Age-related cognitive decline (ARCD) (Levy, 1994) 
10. Mild neurodegenerative decline (MND) (Rediess and Caine, 1996) 
11. Cognitive impairment no dementia (CIND) (Graham et al., 1997)  
12. Mild cognitive impairment (MCI) (Petersen et al., 2001) 
 
A PUBMED search was carried out in order to compare the number of publications using 
terms different to MCI, the results are summarised in Figure III.2. A comparison between 
Figures III.1 and III.2 suggests that the MCI term is ten times more often cited than all the 
others taken together. 
 




PDS= Pre-Dementia Syndromes, AACD= Age-associated cognitive decline, ARCD= Age-related cognitive 
decline, CIND= Cognitive impairment no dementia 
 
 
The MCI term has been applied in different ways. In the 1980s it was used in conjunction 
with two independent staging systems for progressive aging and dementia associated with 
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the Global Deterioration Scale (GDS) (Reisberg et al., 1988), where MCI is equivalent to a 
CDR score of 0.5 (‘questionable dementia’) and/or a GDS score of 3. 
 
Redies and Caine (1996), in an attempt to summarize and organize the different proposals, 
identified and described a five cluster spectrum of cognitive function, from optimal 
cognitive aging through to dementia: 1) successful or optimal cognitive aging; 2) age 
related cognitive decline or age-associate memory impairment (Crook et al., 1986); 3) age 
associated cognitive decline (Levy, 1994) and MCI (Zaudig, 1992, Smith et al., 1996) 4) 
questionable dementia and mild neurocognitive disorder (Rediess and Caine, 1996); and 5) 
dementia (ranging from mild to severe). This proposal represents a very complete spectrum 
integrated for five different levels of cognitive functioning in older people. Further details 
of this system are provided in Table III.1 
 
III.3 Actual MCI diagnostic criteria and classification. 
In 2001, Petersen proposed a practice parameter, providing a landmark in the “rediscovery” 
of the entity, as well as the popularization of the terminology (Reisberg and Gauthier, 2008), 
that was defined by the following criteria: (1) memory complaint preferably corroborated 
by an informant; (2) objective memory impairment; (3) normal general cognitive function, 
(4) intact activities of daily living, (5) no dementia. 
 
Currently, attempts are being made to broaden the definition of mild cognitive impairment 




Petersen et al. later developed the original MCI (amnestic MCI) into a broader concept of 
MCI. Amnestic MCI  (aMCI) is an individual with memory impairment, and there may be 
pure (single domain affected) or aMCI multiple-domain, when in the showing deficits thera 
are othe cognitive functions alterations (for example: language, attention, executive 
function, and spatial recognition). In this way, the MCI can be subdivided into subtypes, 
multiple-domain MCI with and without amnesia, and single non-memory domain MCI. 
These subclassifications of MCI (Fig.III.3) may correspond to the prestage of Alzheimer’s 
disease, Lewy body disease, frontotemporal dementia or vascular dementia (Petersen et al., 
2001) 
 
Figure III.3 MCI Clinical classification 
 









In conclusion, previous criteria for mild cognitive impairment were specific to isolated 
deficits in memory; however, developments have extended them so that the definition of 
mild cognitive impairment now includes a broad range of cognitive deficits and clinical 
subtypes with many potential causes. In the past, mild cognitive impairment and ‘cognitive 
impairment no dementia’ (CIND) could be distinguished by the fact that mild cognitive 
impairment referred to isolated memory deficits—now called amnestic mild cognitive 
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impairment (aMCI)—whereas CIND included global cognitive impairment and deficits in 
several cognitive domains (Gauthier et al., 2006). 
Clinical criteria for a-MCI as proposed by the Mayo Clinic group include (Petersen et al., 
1999). 
1) memory complaint, preferably corroborated by an informant 
2) abnormal scores on memory tests relative to age  and education matched 
healthy people                
3) normal general mental status,  
4) normal daily functioning  
5) absence of dementia 
In 2004 a report was published by the International Working Group on MCI, where specific 
recommendations for general MCI criteria were presented: i) the person is neither normal 
nor demented; ii) there is evidence of cognitive deterioration shown by either objectively 
measured decline over time and/or subjective and/or informant report of decline in 
conjunction with objective cognitive deficits; and iii) activities of daily living are preserved 
and complex instrumental functions are either intact or minimally impaired (Winblad et al., 
2004).  
 
Another attempt to integrate the different terms and definitions relating to MCI arose from 
a systematic review of the literature carried out by Matthews et al (Matthews et al., 2007), 
where they identified eighteen definitions of early cognitive impairment and mapped them 




A clinical definition of MCI has served investigators for more than 15 years. Recent 
proposed alternative definitions of the entity have moved increasingly closer to its original 
clinical definition. Given the volume of research into biomarkers for dementia risk, future 
definitions may well incorporate biological findings (Reisberg and Gauthier, 2008). MCI 
therefore remains a term in evolution and, while it still seeks precise and reliable 
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Figure III.4 Schematic Overview of the Approach Used to Classify MCI across Different Definitions in the Medical Research 
Council Cognitive Function and Ageing Study 
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Source from: Matthews et al. (2007). Operationalization of mild cognitive impairment: a graphical approach. PLoS Med, 4, 1615-9
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III.4 MCI progression to dementia 
Many longitudinal studies have found an increased risk of developing dementia in people 
defined with MCI (Morris et al., 2001, Panza et al., 2005, Bennett et al., 2002, Petersen, 
2004); however, precise diagnostic criteria and delineation of the distinction with dementia 
have been more elusive. Mild Cognitive Impairment has been associated with an increased 
risk of developing dementia at a rate of 10 to 15% per year, while the rate of healthy 
controls is only 1 to 2% per year. In clinical samples, annual progression from MCI to 
dementia ranges from 12 to 17%, whereas substantially lower progression rates have been 
observed in community-based studies (4 to 15% per year) (Manly et al., 2008).  
 
III.5 Conclusions 
MCI is a construct of particular interest now that the world is having a marked increase in 
the older population, and mainly for those rapidly ageing populations. 
 
MCI concept has been showing an important development along the time, previous criteria 
for mild cognitive impairment were very focus on memory deficits; however, they have 
been extended and now include a broad range of cognitive deficits and clinical subtypes 
associated to potential aetiologies.  
 














IV.1 Importance of definition and methodology 
As has been described, the concept of Mild Cognitive Impairment (MCI) has undergone a 
number of changes and remains ambiguously defined, so that the prevalence of this entity 
may vary substantially between studies according to the definition applied, as the 
methodology, setting and sample size (Busse et al., 2003a). 
 
IV.2 Community prevalence studies 
A systematic review of community prevalence studies of MCI within the last 10 years was 
carried out first for MCI as a broad construct, studies were only selected as relevant if they 
had sample sizes of at least 1000 and findings are summarized in Table IV.1. As described 
earlier, the methodology of MCI studies is recognised to be potentially highly important 
and this was considered in the review. Measurements of cognitive function used to derive 
case operational definitions have varied substantially, clearly illustrated in the instruments 
column of Table IV.1 where we can see for example, in Frisioni et al. (2000) study, that 
only the Mini-Mental State Examination (MMSE) was used, but with several different 
approaches in terms of calculating cut-offs (for example, varying in the use of age and 
education standardization), contrasting with Manly´s (2005, 2008), Gavrila (2009) and 
Petersen´s (2001, 2010) studies where more than five instruments were used. 
Community studies with 1000 and more subjects chosen for this review has reported a wide 
range of prevalence (from 2 to 31%), this variability being associated substantially with the 
definition criteria of MCI used. 
 
A more focused systematic review of community prevalence studies of aMCI within the 
last 10 years was carried out next (Table IV.2), but in this case without the selection 
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criterion related to sample size, because the number of community studies for this particular 
subtype is small. When aMCI was defined according to Petersen’s revised criteria (Petersen 
et al., 2001), the observed prevalence ranged from 2.1% (Palmer et al., 2008) to 11.5% 
(Petersen et al., 2010) and was most commonly found to be around 3-5% (Busse et al., 
2003a, Ritchie et al., 2001) with a few exceptions in older samples (Dickerson et al., 2007, 
Rapp et al., 2010, Yaffe et al., 2011, Petersen et al., 2010). 
 
Reports of the community prevalence of aMCI have been predominantly derived from 
European and North American populations. Estimates of aMCI prevalence were 6% in 
Kolkata, India (Das et al., 2007), and 4.5% for Chongqing, China (Li et al., 2011). Higher 
prevalences have reported for Malaysia (15.4%) (Lee et al., 2011) and for South Korea 














Instrument Overall study objective 
Frisoni (2000) 1435 75-95 Sweden 
Cross 
sectional 
15.9 MMSE Relationship between physical health and MCI 
Kivipelto (2001) 1449 65-79 Finland 
Cross 
sectional 
6.1 MCADRC Prevalence of MCI in elderly 
Larrieu  
(2002) 
3777 65 France Cohort 2.8 to 3.5 
MMSE, BVRT, Katz, 
ADLS 
Estimate age-specific incidence rate of MCI according to sex 
and educational level 
Busse et al.(2003a) 1045 >75 Germany Cohort 3.1 SIDAM 
Age-specific prevalence, incidence and predictive validities 
for MCI concepts 
Fisk, 
(2003) 
1790 >65 Canada 
Cross 
sectional 
2 to 3 MMSE 
Prevalence estimates and 5 year outcomes of various case 
definitions of MCI 







Age-specific prevalence, incidence and predictive validities 
for MCI concepts 
Lopez (2003) 2470  USA Cohort 19 
Neuropsychological 
testing CHS 
Prevalence of (MCI) and its diagnostic classification  
Meguro, 
(2004) 
1501 >65 Japan Cohort 4.9 
MMSE, CASI, GDS, 
Daily, functioning, 
CDR  
Prevalence and neuropsychological features of MCI 
Manly, 
(2005) 
1315 >65 USA Cohort 5 
DFLS, BFAS, SRT, 
MMSE, BVRT, 
WAISR, MDRS 
Operationalized diagnostic criteria for MCI and  
prevalence in ethnically and linguistically diverse elders 
Busse, 
(2006) 
1045 >75 Germany Cohort 19 
SIDAM,SIDDA 
MMSE 
Time dependent evolution from MCI to dementia 
Ekman, 
(2007) 
1800 45-84 Sweden 
Cross 
sectional  
31 CDR, TTO Community-based health utilisation  
Manly, 
(2008) 
2364 >75 USA Cohort 5.1 
DFLS, BFAS, MMS, 
SRT, BVRT, WAISR, 
MDRS, BNT, CWA, 
BDAE, RDT 
Frequency and course of MCI in a multi-ethnic community 
Anstey, 
(2008) 
2222 60-64 Australia Cohort 4.2 
CDR, BDAE, CERAD, 
RAVLT, MMSE 
Estimate incidence rates of MCI and related  
disorders, and conversion to dementia 
Gavrila, 
(2009) 





HIS BFAS, HDRS, 
RGDS,  
Prevalence of dementia and MCI in general elderly population 
and associated socio-demographic factors 
Petersen (2010) 1969 70-80 Olmsted Cohort 16 
DRS, FAQ, STMS, 
WAISR, TMT, BNT 




MCI = Mild Cognitive Impairment, MMSE= Mini-Mental State Examination, MCADRC= MCI criteria suggested by Mayo Clinic Alzheimer´s Disease Research Center, BVRT= 
Benton´s Visual Retention Test, SIDAM= neuropsychological test battery (MMSE, clinical judgment, psychosocial impairment), DRS= Dementia Rating Scale, GDS= Geriatric 
Depression Scale, CASI= Scale wish contains nine domains (long-term memory, short-term memory, attention, concentration/mental manipulation, orientation, visual construction, 
abstraction and judgment, list-generating fluency, DFLS= Disability and Functional Limitations Scale, BFAS= Blessed Functional Activities Scale, SRT= Selective Reminding 
Test, BVRT= Benton Visual Retention Test, WAIS= Wechsler Adult Intelligence Scale , WAISR= Wechsler Adult Intelligence Scale Revised, MDRS= Mattis Dementia Rating 
Scale, BNT= Boston Naming Test, CWA= Controlled Word Association, BDAE= Boston Diagnostic Aphasia Examination RDT= Rosen Drawing Test, SIDDA= Structured 
Interview for Diagnosis for Dementia Alzheimer-type, TTO= Time Trade-off method, CERAD= Consortium to Establish a Registry for Alzheimer´s Disease, TMT= Trail Making 
Test , VSF= Verbal and Semantic Fluidity, ROF= Rey- Osterrieth Figure, WCST= Wisconsin Card Sorting Test, GDSAPDD= Global Deterioration Scale For Assessment of 
Primary Degenerative Dementia, IADLS= Instrumental Activities Daily Living Scale (Lawton and Brody), BADLI= Barthel Activities Daily Living Activities Index, CAMDEX= 
Cambridge Mental Disorders of the Elderly Examination, HDRS= Hamilton Depression Rating Scale, RGDS= Reisberg Global Deterioration Scale, HIS= Hachinski Ischemic 
Scale, FAQ= Functional Activities Questionnaire, STMS= Short Test of Mental Status, PHQ= self-administered Patient Health Questionnaire from the Primary Care Evaluation of 
Mental Disorders (PRIMEMD),  RAVLT=Rey Auditory Verbal Learning Test, CHSNP= Cardiovascular Health Study Neuropsychological Testing (Modified Mini-Mental State 
Examination, the Digit Symbol Test, Benton Visual Retention Test Informant Questionnaire for Cognitive Decline in the Elderly and Dementia Questionnaire modified version of 
the Center for Epidemiologic Studies–Depression Scale), PFAQ= Pfeffer Functional Activities Questionnaire. 
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Age Range aMCI Prevalence 
(Hanninen, 1996) Finland 592 68-78 26.6% AACD 
(Graham et al., 1997) Canada 2914 65 + 16.8% 
(Di Carlo et al., 2000) Italy 3425 65-85 10.7% PCIND 7.5% 
ARCD 
(Ritchie et al., 2001) France 833 60+ 3.2% 
(Hanninen et al., 2002) Finland 806 60-76 5.3% 
(Busse et al., 2003a) Germany 1045 65+ 3.1% 
(Palmer et al., 2003) Sweden 1435 75-95 18% future dementia 
cases 
(Lopez et al., 2003) USA 927 75+ 6% 
(Ganguli et al., 2004) USA 1248 65+ 4% 
(Meguro et al., 2004) Japan 1501 65+ 4.9% 
(Jungwirth et al., 2005) Austria 302 75 0.5%  
(Manly et al., 2005) USA 1315 65+ 5.0% 
(Das et al., 2007) India 960 50+ 6.04% 
(Di Carlo et al., 2007) Italy 2768 65-84 7.0% 
(Dickerson et al., 2007) 
(retrospective) 
USA 244 65+ 11.1% 
(Manly et al., 2008) USA 2364 65+ 21.8% 
(Palmer et al., 2008) Sweden 1379 75-95 2.1% 
(Ravaglia et al., 2008) Italy 1016 65+ 4.1% 
(Gamaldo et al., 2010) USA 554 50-95 4% 
(Boyle et al., 2010) USA 761 70+ 40% 
(Dlugaj et al., 2010) Germany 4145 50-80 3.5% 
(Ganguli et al., 2010) USA 2036 65+ 2.27% 
(Kochan et al., 2010) Australia 987 70-90 4.6%  
(Petersen et al., 2010) USA 1969 70-89 11.5% 
(Rapp et al., 2010) USA 447 65+ 
women 
6.3% 
(Kim et al., 2011) Korean 1673 65+ 9.7% 
(Lee et al., 2011) India 318 60+ 15.4% 
(Yaffe et al., 2011) USA 1299 ≥85 
women 
aMCI = 7.9  
(13.0% if aMCI single + 
multiple domain) 
aMCI= amnesic Mild Cognitive Impairment 
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IV.3 MCI Associations with demographic status 
Demographic associations of principal interest have been age, gender and education, as 
summarized in Table IV.3. Female gender, increased age, lower education and lower socio-
economic status are associated with dementia (Fratiglioni et al., 2010) and have also been 
described in association with MCI (Manly et al., 2005). 
 
IV.3.1 Age 
A consistent relationship between increased age and MCI has been found reasonably 
consistently, in 13 of the 17 studies in Table IV.3 with only one study reporting no 
association and three not reporting analyses of this. 
 
IV.3.2 Gender 
Of the 17 studies in table IV.3 five reported a positive association mainly with male gender 
more strongly associated with the development of MCI (Anstey et al., 2008, Gavrila et al., 
2009, Lopez et al., 2003, Petersen et al., 2010), and only one with female gender (Fisk et al., 
2003) while eight did not report this and four no association (Frisoni et al., 2000, Larrieu et 
al., 2002, Busse et al., 2006, Ekman et al., 2007, Busse et al., 2003a).  
 
IV.3.3 Education 
Eight of the 17 studies found a positive association between higher education and lower 












Setting Prevalence % 
Associations with demographic 
status 
Age Gender Education 
Frisoni, 
(2000) 
1435 75-95 Sweden 15.9 Negative NR NS 
Kivipelto, 
(2001) 










Busse, 2003 1045 >75 Germany 3.10 Positive NR NR 
Fisk, (2003) 1790 >65 Canada 3.02 Positive Female NS 
Busse, 2003 1045 >75 Germany 1 -15* Positive NS NR 
Lopez, 2003 2470  USA 19 Positive Men NR 
Ganguli, 
(2004) 
1248 >65 USA 3 to 4 NR NR NR 
Meguro, 
(2004) 
1501 >65 Japan 4.9 Positive NR 
Less years of 
education 
Manly, (2005) 1315 >65 USA 5 Positive NR 
Less than 9 
years of 
education 
Busse, (2006) 1045 >75 Germany 19 -42* Positive NS NR 
Ekman, 
(2007) 
1800 45-84 Sweden 31 Positive NS NR 
Arboleda, 
(2008) 
1040 >65 Colombia 9.7 NR NR NR 
Manly, (2008) 2364 >75 USA 5.1 Positive NS 





2222 60-64 Australia 4.2 NR Men 




1074 65-95 Spain 8.7 Positive Men 




1969 70-80 Olmsted 16 Positive Men 
Less years of 
education 
*depending on subset employed 





IV.4 Associations with neuropsychiatric symptoms/status  
Recent studies suggested that MCI is associated with neuropsychiatric symptoms (Feldman 
et al, 2004; Liketsos et al, 2002; Cummings, et al, 2003), cited as being of potential 
importance for defining sub-groups at higher risk of developing dementia in the future. 
Two studies have reported associations between depression and MCI prevalence (Frisoni et 
al., 2000, Kivipelto et al., 2001) although with limited information on syndrome definition.   
 
IV.5 Other associations 
Poor physical health has been implicated in relation to early stages of cognitive 
deterioration, although associations with cognitive disturbance may have other pathways 
besides dementia (Frisoni et al., 2000). Higher mortality rates have been reported to be 
associated with MCI, supporting the association with worse health. 
 
IV.6 Conclusions 
Epidemiological studies of MCI and aMCI have shown considerable heterogeneity in 
output, at least some of which has arisen because of methodological sources of variability 
such as in case definition, instruments used for evaluating cognitive functioning, 
populations studied and methods used to analyse and present results (Fisk et al., 2003, 
Golomb et al., 2004, Panza et al., 2005, Busse et al., 2003a). MCI and aMCI have been 
challenging constructs to apply in population-based studies because of ambiguities in the 


















V.1 Introduction, concept and definitions 
Before reviewing empirical data, it is important to consider the terminology, concept and 
definitions, which are many and varied. In essence, the conceptual basis behind these 
approaches is related to the concerns of a person’s view of their memory or another aspect 
of cognitive function, in particular, identifying instances where people feel that their 
cognitive function is poor or has declined and report this – either spontaneously or to direct 
questioning. Terminology describing this in research studies has been variable, including 
the following phrases:  
-subjective memory and/or cognitive complaints  
-subjective memory and/or cognitive impairment 
-subjective memory and/or cognitive problems 
-subjective memory and/or cognitive deficits 
 
For this chapter the term “subjective memory complaint” will be used because it was the 
most prevalent term found in this review and it describes best the relevant criterion for MCI. 
Almost without exception instruments applied in surveys of older people ask about memory 
rather than other cognitive functions and they tend to focus on perceived memory deficits 
which are problematic or noticeable – i.e. better expressed as ‘complaint’ rather than 
‘impairment’, although community studies have tended to screen for the complaint through 
direct questioning rather than investigate spontaneous reporting of this or self-initiated 
clinical presentations.  
 
Variability in the definitions of subjective memory complaint (SMC) (also frequently 
termed subjective memory impairment (SMI) was highlighted in the review by Abdulrab 
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and Heun (2008) where, of 515 citations identified, only 44 contained definitions. 
Specifically, it was concluded that there was a lack of consistency in how SMC was defined 
and the authors proposed a set of criteria aimed to increase specificity of memory 
complaints and recommended international consensus on such criteria by experts in the 
field. 
 
In the literature reviewed for this chapter, various types of questions have been employed to 
determine the presence of SMC: 
• Use of a single question on deficient memory/cognition with a yes/no response  
(SMC categorized by yes or no response) 
• Use of a single question on deficient memory/cognition with a scaled/graded 
response (SMC categorized by certain responses) 
• Use of scales composed of a set of question with yes/no responses. A person must 
answer a minimum number of questions in the affirmative to be categorized with 
SMC 
• Use of a questionnaire or subscale composed of questions with scored responses. 
The overall score must be over a threshold to indicate SMC (SMC categorized by 
cut-off score) 
 
Abdulrab and Heun (2008) recommended for future studies in SMC that it might be helpful 
to include a comprehensive set of criteria to help identify people with memory complaints 
who are at a higher risk of memory decline and future dementia. These criteria could be 
used as a guide for further research to determine what aspects of memory complaints are 
most relevant in predicting future cognitive decline. These are displayed here for 
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illustrative purposes; however, they run the risk of creating yet another ‘MCI equivalent’ 
and lack empirical data to support their application at present.  
 
Proposed essential criteria include: 
• Age at presentation, for example over the age of 50 years. 
• The presence of memory complaints in a specified length of time - for 
example in the past 6 months. 
• The belief that one’s memory is worse compared to earlier periods of life - 
for example when one was in high school or college. 
• Provision of a valid example in which memory problems occur in everyday 
life. 
• Frequency of memory problem for example at least every week; and 
• Normal objective memory performance (i.e. without dementia). 
Cause specific criteria may be taken into account: 
• Gradual onset - potentially indicating DAT (dementia of Alzheimer’s type). 
• Sudden or staggered onset - potentially indicating vascular dementia. 
Non-essential but supportive criteria may include: 
•  The belief that memory is worse than others of similar age. 
• Memory worsening affirmed by an informant (close relative or friend who is 
in contact with subject at least monthly). 
• Subject spontaneously mentioning memory problems if asked about any 
general medical concerns; and 





V.2 Community prevalence studies 
 A review of studies reporting prevalence of SMC or a related construct, was conducted. As 
in the previous chapter, given the large volume of previous literature and the 
epidemiological nature of the study to be described, the focus for this literature review was 
on community studies with a sample size of 1000 or more. 
 
Several international population based studies have estimated the prevalence of subjective 
memory complaints (SMC). Jonker et al (2000) reviewed studies of the prevalence of 
memory complaints and the relationship between memory complaints and impairment or 
decline (or dementia) in older people. In this review, the prevalence reported ranged from 
25% to over 50%. 
 
Findings on prevalence for the SMC community studies with 1000 or more participants was 
from 4.6 to 69%, the most of them fall around Jonker´s reported range and only few of 
them are much lower, such as those in the study by Geerlings et al (1999) where the 
prevalence was 10.8% and that that reported by Van Oijen (2007) of 18.9%. Most used a 
single question and those reporting the highest prevalences tended to involve this approach, 
suggesting that the nature of the question is important in determining the likelihood of a 
positive response. Surveys using more than one item or a scale and cut-off have tended to 
give prevalence’s in the range of 10-30% and are most likely ascertaining complaints, 
which are both, present and felt to be problematic or noticeable (Table VI.1) 
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Table V.1.Summarizing community studies with sample sizes of at least 1000 









Country SMC ascertainment Methodology Preval
ence 
(%) 
Cuttler (1988) 14,783 ≥ 55 USA Single question 













2,679 ≥ 55 Spain Single question Longitudinal 40.0 
Gagnon 
(1994) 
2,276 ≥ 65 France Single question Cross 
sectional 
33.5 











1,637 >64 Spain Single question Cross 
sectional 
32.4 
Dik (2001) 1,168 62 – 85 Netherlands Single question Longitudinal 
study 
25.5 
St John (2002) 1,416 ≥65 Canada Single question Longitudinal 
study 
21.0 
Comijs (2002) 2,032 55 – 85 Netherlands Single question Longitudinal 
study 
23.0 
Palmer (2003) 1,435 75 – 95 Sweden Single question Longitudinal 
study 
32.0 





Wang (2004) 1,883 ≥ 65 USA Scale and cut-off Longitudinal 
study 
4.6 
Jorm (2004) 2,546 60 – 64 Australia 2 questions Cross 
sectional 
10.1 
Park (2007) 9,477 ≥ 65 South Korea Single question Cross 
sectional 
57.3 
Oijen (2007) 7,983 ≥ 55 Netherlands Single question Longitudinal 
study 
18.9 






Stewart (2008) 1,779 ≥ 65 France Scale cut off (GMS) Cross 
sectional 
22.2 






USA= United States of America, CAMDEX= Cambridge Mental Disorders of the Elderly Examination, GMS= Geriatric 
Mental Status Schedule 
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V. 3 Principal findings on factors associated with SMC 
V.3.1 Demographic factors – age, gender and education 
Findings from the studies cited above with respect to demographic associations are 
summarised in Table V.2. Associations between age and SMC prevalence have not been 
entirely consistent, older age  more often was not associated with higher SMC prevalence  
(Cutler and Grams, 1988, Blazer, 1997, Dik et al., 2001, Comijs et al., 2002, Wang et al., 
2004, Park et al., 2007, Stewart et al., 2008) and studies which have reported no association 
with age have tended to have smaller (<1000) sample sizes (Tobiansky et al., 1995, Riedel-
Heller et al., 1999, Wang et al., 2000, Stewart et al., 2001b, Jungwirth et al., 2004, Balash 
et al., 2010, Trouton et al., 2006, Park et al., 2007, Stewart et al., 2008), although they do 
include four of the studies cited in Table V.1 above (Gagnon et al., 1994, Kim et al., 2003, 
Jorm et al., 2004, Jessen et al., 2010). 
 
Similar to older age, SMC prevalence is most often found to be higher in women than men 
(Cutler and Grams, 1988, Gagnon et al., 1994, Kim et al., 2003, Stewart et al., 2008, Jessen 
et al., 2010, Park et al., 2007) although Jorm (2004) and Wang (2004) found the opposite 
association with higher prevalence in men. 
 
Regarding education, most have found SMC prevalence to be higher in groups with lower 
education (Jonker, 1996, Comijs et al., 2002, Jorm et al., 2004, van Oijen et al., 2007, 
Jessen et al., 2010) although several studies have found no significant association with 
education (Kim et al., 2003, Wang et al., 2004, Jessen et al., 2007, Blazer, 1997) and one 
reported an association with higher education (Geerlings et al., 1999). 
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Table V.2. Summarizing community studies with sample sizes of at least 1000 reporting associations between SMC and demographic 
factors (age, gender and education) 




Significant associations between SMC and demographic variables 
Age Gender Education 
Cutler,(1988) 14,783 55 + USA Older age Female - 
Park, (2007) 9,477 ≥ 65 Korea Older age Female Lower 
Oijen, (2007) 7,983 > 55 Netherlands Older age N/A Lower 
Blazer,(1997) 4,162 ≥  65 USA Older age N/A N/A 
Geerlings,(1999) 3,778 65 – 84 Netherlands N/A N/A Higher (>8 years) 
Jorm,(2004) 2,546 60 – 64 Australia N/A Male Lower 
Jonker,(1996) 2,537 65 – 84 Netherlands - N/A Lower IQ 
Jessen,(2010) 2,415 >75 Germany Older age Male Lower 
Jessen,(2007) 2,389 75 – 89 Germany N/A N/A N/A 
Gagnon,(1994) 2,726 ≥  65 France N/A Female N/A 
Comijs,(2002) 2,032 55 – 85 Netherlands Older age N/A Lower 
Wang, (2004) 1,883 >65 USA Older age N/A Lower 
Stewart,(2008) 1,779 >65 France Older age Female Lower 
St John,(2002) 1,416 >65 Canada Older age Male Lower 
Kim, (2003) 1,204 >65 South Korea N/A Female N/A 
Dik, (2001) 1,168 62 – 85 Netherlands Older age N/A N/A 




V.3.2 Depression, social activity and physical health 
Reported associations between SMC and depression-related outcomes in larger surveys are 
summarized in Table V.3 and can be seen to be uniformly positive whether depressive 
symptoms have been modelled as a continuously distributed scale or a binary ‘case’ 
outcome derived from a scale cut-off or diagnostic instrument (e.g. GMS).  
SMCs have been reported to be associated to lower social activity in an unadjusted 
secondary analysis of one large survey (Stewart et al., 2008), but this association has 
received little other evaluation. Other reported associations with SMC in larger surveys 
have included poor physical health and decreased physical activity (Jonker et al., 2000, 
Minett et al., 2008, Mitchell, 2008) (Table V.3).  
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Table V.3 Associations between SMC and depression 
 






Blazer (1997) 4162 65+ USA CES-D Continuous Positive 




Comijs (2002) 3107 55-85 Netherlands CES-D Continuous Positive 




Jorm (2004) (a) 2546 60-64 Australia GHQ Continuous Positive 
Jonker (1996) 2537 65-84 Netherlands GMS Continuous Positive 
Jessen (2010) 2415 75+ Germany GDS Continuous Positive 
Jessen (2007) 2389 75-89 Germany GDS Continuous Positive 
Grut, (1993) 2368 75+ Sweden CPRS Binary Positive 
Schmand (1997) 2114 65-84 Netherlands GMS Continuous Positive 
Wang (2004) 1883 65 + China GDS Continuous Positive 
















CES-D= Centre for Epidemiologic Studies Depression Scale , GMS= Geriatric Mental State Schedule, GHQ= General Health Questionnaire, GDS= Geriatric Depression Scale, 
CPRS= Comprehensive Psychopathological Rating Scale 
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V.3.3 Cognitive impairment 
The prevalence of objective memory impairment has been suggested to be approximately 
half that of SMC (Mitchell, 2008) and .the ‘‘accuracy’’ of SMC in terms of associations 
with objectively measured cognitive function is controversial. In their review paper, Reid 
and McLlullich (2006) concluded that SMCs were inconsistently related to current 
cognitive impairment. Focusing on larger community studies only a few report a significant 
association in unadjusted analyses (Gagnon et al., 1994, Jessen et al., 2007, van Oijen et al., 
2007) and others only after adjustments (Jorm et al., 2004, Stewart et al., 2008). Several 
large studies did not find an association between SMCs and cognitive functioning (Blazer, 
1997, Geerlings et al., 1999, Dik et al., 2001, van Oijen et al., 2007, Park et al., 2007, 
Jessen et al., 2010, Jonker, 1996, Wang et al., 2000) (Table V.4) . Considering those, which 
did find an association, it is possibly noteworthy that most reported relatively low SMC 
prevalence (Table V.1) suggesting that the specificity of the question(s) may have some 
influence over the associations observed. Specifically, it is possible that a broad question 
asking about any memory deficit may have too high a level of measurement error whereas 
one which asks about problematic and/or frequent deficits may more readily identify 




Table V.4 – Summarising associations between SMC and cognitive impairment in larger 












Domain Test Result 
Park, (2007) 9,477 ≥ 65 
South 
Korea 
Global MMSE N/A 
Oijen,(2007) 7,983 > 55 Netherlands Global MMSE + 
Blazer,(1997) 4,162 ≥ 65 USA Verbal memory SPMSQ N/A 
Geerlings,(1999) 3,778 65 – 84 Netherlands Global MMSE N/A 
Jorm, (2004) 2,546 60 – 64 Australia 












+ after adj 
Crystallized 
Intelligence 





Attention Digits backwards N/A 
Jonker, (1996) 2,537 65 – 84 Netherlands 
Global MMSE N/A 
Factual memory 








Verbal memory + * 
Verbal abstraction + * 
Orientation place + * 
Orientation time N/A 
Verbal fluency + * 
Jessen, (2010) 2,415 >75 Germany 
Global MMSE N/A 
Orientation SIDAM SISCO N/A 
Language SIDAM SISCO N/A 
Perception SIDAM SISCO N/A 
Praxis SIDAM SISCO N/A 
Reason & problem 
solving 
SIDAM SISCO N/A 
Jessen, (2007) 2,389 75 – 89 Germany 
Verbal fluency CERAD + 
Verbal memory SIDAM + * 
Gagnon, (1994) 2,276 ≥ 65 France 
Visual memory BVRT + 
Verbal memory WMS + 
Comijs, (2002) 2,032 55 – 85 Netherlands Global MMSE + 
Wang, (2004) 1,883 >65 USA Global CASI N/A 
Stewart, (2008) 1,779 >65 France Global MMSE + * 
St John, (2002) 1,416 >65 Canada Global MMSE + 
Kim, (2003) 1,204 >65 
South 
Korea 
Global MMSE + * 




MMSE= Mini-mental state examination, SPMSQ= Short Portable Mental Status Questionnaire, CVLT= California Verbal 
Learning Test, N/A= Not Available, SIDAM SISCO= Structured Interview for the Diagnosis of Dementia of the Alzheimer Type, 
CERAD=Consortium to establish a registry for Alzheimer Disease, SIDAM=Structured Interview for the Diagnosis of Dementia 
of the Alzheimer Type, BVRT= Benton Visual Retention Test, WMS= Wechsler Memory Scale, CASI= Scale wish contains 
nine domains (long-term memory, short-term memory, attention, concentration/mental manipulation, orientation, visual 
construction, abstraction and judgment, list-generating fluency), AVLT= Auditory Verbal Learning Test 




The SMC prevalence in population based studies over 1000 subjects, ranged very widely 
from 4.6% to 57.3%. Most of these studies used a single question to define and identify 
SMC, which may have given rise to differences in findings. The selected community 
studies (i.e. those with sample sizes of at least 1000 subjects) report reasonably consistent 
associations for SMC with older age and lower education; however, associations with 
gender are inconsistent. Strong and consistent associations are reported between SMC and 
depression. Those with cognitive impairment on the other hand are inconsistent, although 
positive associations may be more likely to be observed for narrower definitions of SMC 
where reported memory difficulties are relatively severe. This literature review supports the 
conclusion of Abdulrab and Heun (2008) that SMCs are frequent among older people, 
although their prevalence and correlates do vary substantially between studies, possibly 
related to differences in definitions and methods of ascertainment; as well as the fact that 

































VI.1 Introduction, concept and definitions 
There are several kinds of approaches which clinicians can use to assess cognitive 
impairment in their patients: cognitive testing, self-report of cognitive deficits by the 
patient, observation of everyday performance by staff, and informant reports of everyday 
cognitive functioning (Jorm, 1996). 
 
The most explored approach has been objective cognitive assessment, whether involving 
brief or extended evaluations, although it may be difficult to establish at mild stages of 
impairment how much current function differs from lifelong ability, in addition to what 
impact any impairment is exerting on daily function. Self-reported cognitive function (i.e. 
with impairment reflected in SMC as described in the previous chapter) captures an 
individual’s awareness of and belief about their own cognitive competence in daily life 
(Grut et al., 1993), particularly in relation to what the individual believes is or should be 
their normal function, allowing an assessment of everyday memory and cognitive problems 
that may not be captured by standardized neuropsychological tests, and thus providing 
clinicians with another perspective of understanding memory and cognitive function in old 
age (Chung and Man, 2009). However, not all people will be willing or able to recognise 
and/or report objective deficits.  
 
Lack of insight concerning cognitive and functional deficits is a symptom in many 
neuropsychiatric disorders. Different terms have been used to describe the phenomenon, 
including anosognosia, unawareness of deficits, and lack of insight (McGlynn and Schacter, 
1989). Anosognosia is not a unitary construct, and various approaches have been taken to 
develop methods for assessment of awareness. Most of these have limitations (Claire, 2002) 
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and no “gold standard” test for examining insight exists, which complicates the 
comparability of different studies (Vogel et al., 2004). Four main approaches have been 
taken in assessing the level of awareness: 
a. Evaluation by a clinician (Lopez et al., 1994, Reed et al., 1993) 
b. Discrepancies in scores on parallel version of rating scales or questionnaires given to the 
patient and a close relative (Michon et al., 1994, Vasterling et al., 1997) 
c. Discrepancies between patient self-ratings and their scores on objective memory tests 
(Dalla Barba et al., 1995)  
d. Combinations of the above (Clare et al., 2002). 
 
Evaluation by a clinician is by far the most commonly used method for assessment of 
awareness; however, few studies have examined if the use of additional methods provides 
useful information not elicited by short categorical stratifications (Vogel et al., 2004). 
Knowing the potential limitations of self-reported information, informant reports have been 
used as a complementary source of information about memory and other domains of 
cognitive function in older people, and have been suggested to be more robust in 
differentiating individual with normal cognition from those with dementia and in predicting 
future incidence of dementia (Carr et al., 2000). 
 
In community-based dementia studies, researchers have often combined the two approaches 
to augment the discriminating ability of dementia diagnostic schedules although previous 
studies have found that informant reports performed equally as well as cognitive 
assessment in this respect (Law and Wolfson, 1995, Hall et al., 1993, Cacchione et al., 2003, 
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Knafelc et al., 2003, Mackinnon et al., 2003, Mackinnon and Mulligan, 1998, Slavin et al., 
2010, Tierney et al., 2003) (Table VI.1) 
 
There are now a wide range of validated informant instruments for screening and 
assessment of dementia (Jorm, 1996). A meta-analysis of studies comparing an informant 
instrument with a brief cognitive test found that informant scales perform as well as 
cognitive screening tests (Jorm, 1997) meaning that the cognitive performance tests have 
validated the informant report. Pooled data from 10 studies showed that informant scales 
had a sensitivity of 86% and a specificity of 80%, compared with a sensitivity of 79% and 
specificity of 80% for brief cognitive tests. 
 
Although head-to-head comparisons of the two approaches are informative, in actual 
clinical practice, they should be viewed as complementary rather than competing, and each 
approach has strengths and weaknesses relative to the other. Tierney (2003), for example, 
found that the inclusion of informant ratings with the MMSE significantly improved its 
accuracy in the prediction of probable AD, although this finding required replication.  
 
For informant-based screening measures, strengths include (Jorm, 2003). 
a) Relevance to everyday cognitive functioning. Informant-based measures draw upon 
the cognitive demands of a person’s everyday life, in contrast to cognitive screening 
tests, which rely on a standard set of artificial tasks. 
b) Cultural fairness. Level of education and cultural background are known to 
influence cognitive tests. Level of education affects informant-based measures 
much less, and informant based measures may have greater cross-cultural 
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portability because they assess aspects of everyday life that are common to many 
cultures (e.g. remembering people’s names) 
c) Direct assessment of change. In screening for dementia, it is important to  know that 
a given degree of cognitive impairment reflects a deterioration from normal  
function; however, serial cognitive assessments are seldom feasible, and clinical 
decisions must be made on the basis of cross-sectional assessment. With informant-
based measures, the informant knows about the patient’s earlier functioning and can 
retrospectively report on cognitive change. 
d) Acceptability to patients. Cognitive assessment can be an unpleasant experience for 
a patient because it draws attention to their deficits. By contrast, informant-based 
measures do not require the patient to demonstrate cognitive failures. 
 
Balanced against these advantages one of the major limitations is that patients or 
participants will sometimes lack a suitable informant, particularly if a longitudinal 
perspective is required. Another weakness is that some informants will provide less valid 
accounts than others. Nevertheless, relatively little is known about the influence of 
informant characteristics on validity (Jorm, 2003, Jorm, 1996), although those that have 
been identified include less accurate reports from informants who do not live with the 
patient, who have seen them relatively infrequently, and who are older and less educated at 
the time of questioning. These informants tend to overestimate the patient’s capabilities. 
The caregiver in addition may be more or less aware of the index person’s behavioural and 
functional disorders. This subjective perception is influenced by the clinical presentation, 
by the presence of different symptoms and their severity, by the degree of kindred and 
  
85
family ties, and by caregiver factors such as time dedicated to the patient, psychological 
status, knowledge of the illness, and cultural and professional status (Onor et al., 2006). 
 
VI.2 Informant memory report studies in MCI and dementia  
The most of the studies in MCI and dementia that have evaluated informant-reported 
cognitive impairment have been done recently in high-income countries, with small sample 
size, clinical settings (few of them in the community); and using a variety of informant 
report instruments. Studies evaluating informant report measures are displayed 
descriptively in Table VI.1  
 
Artero (2003) concluded that tests supplemented by information from proxies and 
observations may detect prodromal cognitive disorder or MCI. In the other hand Onor 
(2006) reported the perception of cognitive, behavioural and functional problems in MCI 
and AD patients, finding that these perceptions are more affected in AD patients than in 
those with MCI. Another observation was that subjective reports were not associated with 
decrements in memory while informant and clinician report had a positive association 







Table V1.1 Summarizing studies which have evaluated the usefulness of informant reports in people with MCI or dementia 
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To examine the 
relation between the 
change in memory 
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and self and 




were not associate 
with decrements in 
memory, informant 
and clinician report 
had a positive 
association 
DSM-III= Diagnostic and Statistical Manual of Mental Disorders, AD= Alzheimer disease, MCI= Mild cognitive impairment, NPI= Neuropsychiatric Inventory, ADL= Activities of  
Daily IADL= Inventory Activities of Daily Living, DSM-IV= Diagnostic and Statistical Manual of Mental Disorders IV, DECO= Deterioration Cognitive Observed, NINCDS-ADRDA= 
National Institute Of Neurological and Communicative disorders and Stroke and the Alzheimer Disease´s and Related Disorders Association, MMSE= Mini-mental state examination, 




VI.3 Informant memory report and cognitive functioning 
Informants have been shown to be a reliable and a valid source of information in 
determining the presence of DAT, even in the mild stages. Carr et al testing the value of 
informant versus individual´s complaints of memory in early dementia, reported that 
informants were better in distinguishing subjects with and without dementia as judged by 
the clinician (Carr et al., 2000). Recently Potter et al (2009), compared direct testing 
(CERAD) and informant-reported of cognition (IQCODE) with clinical diagnosis of 
cognitive impairment and dementia in African American and white American samples and 
they found higher IQCODE scores associated with increased odds of dementia to a similar 
extent in both groups, but for cognitive impairment as an outcome the association was  
found only for the white American sample. 
 
VI.4 Informant memory report and subjective memory complaints 
Few studies have investigated the degree with which informant-reported and self-reported 
cognitive/memory impairment are correlated. One study (Farias et al., 2005) found that 
self- and informant-reported everyday memory and cognitive functioning were similar in 
MCI and normal controls, but differed in those with a dementia diagnosis, because in the 
last case the subjects affected did not recognize their cognitive  impairment.  
 
Some people with MCI may show signs of diminished awareness of their memory and/or 
cognitive function, as suggested by informant reports and neuropsychological assessment 
(Chung and Man, 2009, Onor et al., 2006) identified major differences between how people 
with MCI or mild AD and their caregivers perceived the index person’s cognitive and 
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behavioural disorders; the group with MCI or mild AD were found to underestimate their 
deficits, which were considered serious and disabling by their caregivers. 
 
In the Sydney Memory and Aging Study (Slavin et al., 2010), participants reported more 
memory complaints than informants reported problems, but there was weak agreement 
between participants and informants on the complaints themselves. The authors concluded 
that informant-based complaints may more accurately reflect cognitive status because a 
higher prevalence of informant complaints was found in participants who had objective 
cognitive impairment, and informant complaints were more strongly correlated with 
performance on neuropsychological testing. However, these correlations were still 
relatively small) and complaints were found to be common so it was concluded that both 
subjective and informant-reported impairment are likely to be influenced by a number of 
psychological factors besides observed cognitive function.  
 
From a French sample, it was concluded that approximately 50% of the population aged 65 
and over reported subjective cognitive deficits which were confirmed by proxies (Ritchie 





VI.5 Validity of informant reports 
Validation studies for informant reports of cognitive decline tend to have had better 
methodological design than studies of SMC and to use more similar instruments between 
them such as CAMDEX and IQCODE (Table VI.2). The accuracy of these informant 
evaluations have been assessed by investigating associations with standard screening tests, 
the most used being the MMSE. Only two of the revised studies were population based 
(Makinon and Fiske), the rest being carried out in clinical populations. 
 
Carr  (2002) found that informants were successful in distinguishing normal subjects from 
those with dementia and Tierney (1996, 2003) found that informant's perceptions 
contributed significantly to the prediction of AD and that the inclusion of informant ratings 
plus MMSE significantly improved the prediction of probable AD. This was supported by 
Mackinnon (2003) who pointed out that appropriate combination of existing tests may be a 
fruitful method of improving screening accuracy. 
 
Finke´s study (2005), concluded that informant reports of dementia onset are reliable and  
reasonably valid  but, on the other hand, Kemp (2002) reported that 40% of informant 






Table V1.2 Studies investigating the relationship between informant reports and cognitive impairment and/or dementia risk 
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CDR-W= Clinical Dementia Rating, AD= Alzheimer Disease, CAMDEX= Cambridge Mental Disorders of the Elderly Examination, MMSE= Mini-mental state 
examination, WAIS= Wechsler Adult Intelligence Scale, DSM III= Diagnostic and Statistical Manual of Mental Disorders III, IQ=Intelligence Quotient, 




Despite longstanding clinical practice of assessing dementia and mild cognitive impairment 
through cognitive assessment supplemented by information provided by informants, there 
is a lack of research into this combination of data and a lack of standardized informant 
instruments. In the assessment of cognitive impairment and dementia the use of informant 
reports provide several advantages including the opportunity to evaluate everyday cognitive 
performance, more acceptability than cognitive testing, a longitudinal perspective, 
retrospective evaluation, evaluations where cognitive assessment is not feasible, and 
evaluations using different forms of communication (e.g. face-to-face, by mail, by 
telephone). However, limitations have to be taken in account including difficulties in 
finding a suitable informant, or where there are requirements to evaluate specific cognitive 
functions. In the context of international studies, cultural differences may influence 
informant reports of prevalent CIND and dementia, and there is a need for more 










VII.1 Introduction, functional capacity and disability 
Functional capacity represents a wide range of everyday skills and abilities that are 
necessary for independent living within the home and community. These skills range from 
routine activities of physical self-care through to more cognitively complex behaviours 
such as financial tasks, use of transportation, and medication management (Marson D and 
Hebert K 2006). 
 
Although cognition has influences across this range of simple to higher-order functional 
activities, it also remains conceptually and analytically distinct from them. Functional 
incapacity in older people may occur with or without corresponding decline in cognition. 
Impaired sensory processes, acute or chronic medical illness, or any other physical 
limitation or injury affecting strength, balance, mobility, concentration, and endurance may 
adversely impact functional performance (Lowenstein and Mogosky, 1999). At the same 
time, it is important to bear in mind that a large proportion of functional decline in the 
elderly is intimately linked to cognitive impairment and that one of the most important risk 
factors for functional decline in older adults is the presence of a neurodegenerative disorder 
such as Alzheimer disease the prevalence of which increases dramatically with age and 
where functional decline is a required diagnostic criterion. As such, reliable and valid 
measures of functional ability are essential to diagnoses of dementia. 
 
MCI diagnostic criteria generally stipulate that functional capacity is preserved in order to 
distinguish this entity from dementia. Nevertheless, functional capacity will decline 
gradually with worsening cognition without a discrete point where this suddenly occurs. 
The supposed absence of functional decline in MCI may represent a true preservation of 
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functional abilities in the face of clinically significant memory loss; however, it may also 
reflect insufficiency of objective measures or expertise to detect subtle prodromal changes 
in functional performance at different degrees and domains of cognitive impairment.  
 
Activities of daily living (ADLs) and instrumental activities of daily living (IADLs) exist 
on a functional continuum and primarily reflect a method of categorization rather than 
independent constructs (Wolinsky and Tierney, 1998). This arbitrary classification is based 
on distinguishable levels of functionality that are hierarchically related and differentiated 
by their degree of cognitive complexity and their pattern of acquisition, loss and recovery 
(Lowenstein and Mogosky, 1999, Olver et al., 1996, Stern et al., 1990). 
 
ADLs typically include elemental activities for self-care such as washing, feeding, dressing, 
toileting and moving. IADLs on the other hand represent more complex activities from a 
broader range of higher level tasks, including shopping, using the telephone, housekeeping, 
preparing food, doing the laundry, using various types of transport, managing medication, 
or managing finances. 
 
VII.2 Evaluating functional status and disability 
The capacity to function independently is poorly described by the constellation of medical 
disorders alone. Similarly, performance on mental status testing does not necessarily 
predict functional status. Functional status should instead be evaluated independently of 
medical and cognitive assessments. The concept of disability clearly plays a crucial role in 
defining which measurement of disability will be adopted (Sousa et al., 2010). 
Measurements of disability are important for the design and provision of services, for 
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monitoring the levels of functioning in a population and their impacts, for evaluating 
interventions to prevent or minimize limitation and restrictions, and for evaluating the 
equalization of opportunities (Mont, 2007) 
 
Evaluation of functional status is not limited to the assessment of specific activities and 
tasks; this kind of assessment may also include significant events in a person’s life or 
family that have a bearing on the health status or situation (events of daily living), demands 
placed on the person from within or from the family or society (demands of daily living), 
the nature of the physical environment (environment of daily living), and the person’s 
values and beliefs that determine decisions and responses regarding health care (values and 
beliefs in daily living). 
 
According to some authors, functional disability can be measured through ‘independence 
difficulties’ scales; usually these can take three forms: severity of difficulties in performing 
certain activities, need of assistance, and degree of dependence to perform activities. A 
measure of dependence evaluates if a person needs help or assistance to perform an activity. 
A person is classified as dependent when he/she absolutely needs help to achieve some 
goals. On the other hand a dependence scale could help to tell us the real need of help of a 
person and to plan strategies to the future. The most widely used approaches to measuring 
functional disability in the literature are as follows:  
• A single question about self-reported “disability” 
• A check-list of common chronic diseases or impairments 
• Enquiry about basic activities of daily living (ADL) 




• Specific functions (dressing, walking.) 
• Specific illness 
• Health status questionnaires  
 
These indicators can be evaluated by means of the degree of difficulty and/or by means of 
the degree of dependence.  
 
There are many instruments for assessing ADL and IADL (Table VII.1), and can be 
classified into reports (self-report; informant report) and direct assessment methods 
(performance-based or clinician rating measures). Self- and informant-reports are the most 
commonly used methods. These involve the individual or (more typically) a caregiver or 
other knowledgeable informant (i.e., proxy) to provide ratings of the index individual’s 
ability to perform basic self-care and complex instrumental activities at home and in the 
community (Marson D, 2006). Self- and caregiver judgments of functional ability suffer a 
number of limitations (Wadley, Harrel & Marson, 2003; Wild & Cotrell, 2003), but are still 
commonly used because of their minimal cost and relative ease and brevity of 
administration and scoring (Lowenstein and Mogosky, 1999) (Angel & Frisco, 2001). Self-
reported measures of physical disability assess difficulty, inability or degree of assistance 
required to perform specific tasks of mobility, household management or personal care. 
However, because people with preclinical disability due to impairment are still able to 
accomplish a task under certain circumstances without perceiving a difficulty, the above 
measures may not be sensitive enough to recognize early functional decline. An effective 
self-report measure was developed to identify individuals in the pre-clinical stage of 
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disability by focusing on modification of usual methods of performing mobility tasks, 
which compensate for the impact of underlying health changes. On this instrument, self-
reported task modification and performance measures were found to be independent and 
strong predictors of incident mobility disability (Gibson et al., 2010)  
 
Disability has therefore been assessed with a wide variety of instruments; however, even 
when instruments contain the same items, they may differ in how they assess specific 
aspects of performing the task or the severity of limitation in performing the task. There is 
no single best way to perform a disability assessment, and there is no single instrument that 
is ideal. Moreover, the lack of standardization that results from the use of multiple 
competing instruments makes it difficult to compare prevalence’s of disability between 
studies(Ferrucci et al., 2008). Aiming to generate an ideal and universal adopted instrument 
to measure health and disability, the WHO developed the Disability Assessment Schedule 
2.0 (WHODAS 2.0) which has several convenient characteristics: it has been constructed to 
follow the ICF classification and has been proved to be reliable and valid across different 
populations and cultures, maintaining unidimensionality (with one single global disability 









Table VII.1 Instruments for assessment of ADL in people with MCI or dementia 
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A structured scale developed for 
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dementia, to rate the degree of 
dependency of or assistance needed by 
a patient 
Hall (1993) CSID 
30 
min. 
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Assessment of everyday activities 








Direct assessment of functional 
capacities in AD patients 




Instruments used by families to monitor 
functional disability in dementia 
Linn (1982) RDRS-2 
10 
min. 
Anyone who knows 
the subject, preferably 
with one training 
session 
To assess disability in elderly people 
Reisberg 
(1988) 
FAST 2 min. 
By clinician after 
interview with 
informant 
Assessment of functional change in 






By a clinician using 
information gathered 
as part of clinical 
practice 






By trained observer 
To rate the degree of physical inactivity 
impairment of intellectual and 
emotional capacities and behavioural 
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symptoms common in dementia 
Reisberg 
(1982) 
GDS 2 min. By clinician 
Staging instrument indicating 







Measure of dependency in elderly 
patients 













To measure self-care capacity in late-
life mental disorders 
Meer (1966) SGRS 
10 – 15 
min. 
By nurse career 
Rating of needs based on behaviour 
physical and mental functioning 
ADCS ADL = Alzheimer’s 
 Disease Cooperative Study Activities of Daily Living; ADL = Activities of daily living; ADL-IS = Activities of daily 
living international scale; BADL = Bayer Activities of Daily Living Scale; BADLS = Bristol Activities of Daily Living 
Scale; CDR = Clinical Dementia Rating; CPT = Cognitive Performance Test; CSADL = Cleveland Scale for Activities 
of Daily Living; DAD = Disability Assessment for Dementia; DAFS = Direct Assessment of Functional Status; FAST = 
Functional assessment staging; FDS = Functional Dementia Scale; GBS = Gottfries, Brune and Steen scale; GDS =  
Global Deterioration Scale; PGDRS = Psychogeriatric dependency rating scales; PTADL = Performance Test of 
Activities of Daily Living; RADL = Refined Activities of Daily Living Assessment Scale; RDRS = Rapid Disability 
Rating Scale; SAILS = Structured Assessment of Independent Living Skills; SGRS = Stockton Geriatric Rating Scale; 
TFLS =  Texas Functional Living Scale 
 
VII.3 Aetiology of disability in the elderly 
It is important to bear in mind that disability has a multi-factorial aetiology with complex 
interactions between the person and their environment (Sousa et al., 2010). Longitudinal 
studies in older populations have revealed the presence of multiple risk factors for disability, 
as well as illustrating the dynamics of disability onset and progression. As described earlier, 
disability is a product of the disease or diseases from which an individual suffers, a 
sedentary lifestyle or disuse, and physiologic declines that may themselves be the result of 
normal or accelerated ageing processes – not necessarily specific diseases but rather factors 
potentially influencing ‘frailty’ such as inflammatory or endocrine changes. These 
predisposing conditions may have an impact on the initiation of disability and on changes 




VII.4 Disability and cognition (dementia, MCI) 
Dementia is one of the major causes of disability in later life. The individual impact of 
dementia on disability involves a circular argument, since adverse effects of cognitive 
decline on function is a diagnostic criterion. However, the impact of dementia on disability 
and at a societal level is now increasingly recognized – both in terms of disability itself as 
an outcome and in terms of its economic consequences. The disability weight for dementia 
applied in the Global Burden of Disease report was higher than that for almost any other 
condition with the exception of spinal cord injury and terminal cancer. Among older people, 
dementia was the most burdensome neuropsychiatric disorder accounting for more than 
half of all disability adjusted life years in this domain of morbidity. People with dementia 
are heavy consumers of health services, but in developed countries most direct costs arise 
from community and residential care. In North America High Income, the total annual cost 
for dementia in 2010, was  $213.04 billions (US$); for Europe Western  $210.12 billions 
(US$); Latin America Central $6.56 billions (US$);  for Asia Central $0.94 billions (US$); 
Africa Central $0.07 billions (US$); (ADI Report 2010) The economic burden is unevenly 
distributed; families from the poorest countries are particularly likely to use expensive 
private medical services and to be spending more than 10% of per capita GNP on health 
care. Worldwide, family caregivers are the cornerstones of support for people with 
dementia. They experience significant psychological, practical and economic strain. 
Dementia care is particularly time intensive because of the need for close supervision. 
Many caregivers need to give up or cut back upon work in order to care. (WHO, 2009). 
 
As described earlier, dementia exists on a continuum of cognitive function. Relationships 
between cognition and disability are potentially complex to elicit when categories such as 
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dementia or MCI are applied because the presence or not of a given level of disability is 
used to define such categories. Nevertheless, a considerable body of research has examined 
the relationship between cognitive abilities and ADL/IADL functional performance, with 
particular reference to older adults. Cognitive ageing studies have addressed the 
relationship of functional performance to different and specific cognitive functions, and 
performance on various standardised psychometric measures for several mental functions 
(Marson D, 2006). In the remainder of this chapter, some representative studies in these 
areas will be considered in terms of the cognitive function continuum (cognitive aging, 
MCI and dementia). 
 
VII.4.1 Functional status and dementia studies. 
Because functional decline is necessary for a dementia diagnosis, it is not surprising that 
the literature is substantial and uncontroversial. Cognitive and functional changes in 
dementia are closely linked but with a reasonable degree of heterogeneity. For example, in 
a longitudinal study of people with dementia, Mortimer et al. (1992) found that only 40% 
of the variance in functional decline was accounted for y cognitive decline, suggesting that 
cognitive and functional capacity may reflect distinct yet parallel features of the disease 
process. Furthermore, they found that rates of cognitive and functional decline differed 
substantially with regard to neuropsychological predictors. Lower baseline scores on verbal 
tests of confrontation naming, learning and recall, fluency, abstraction, and immediate 
memory emerged as key predictors of faster rates of functional decline. Different predictors 
of functional and cognitive decline again suggest that they are distinct constructs in 
dementia (Marson, 2006). Global mental status measures, particularly neuropsychological 
measures of executive function, have been found to account for a significant portion of the 
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variance in ADL and IADL function. Taking a broader view, deficits in higher-order 
cognitive abilities have been found to correspond with difficulty in performing complex 
tasks of everyday living even in the preclinical stages of dementia (Griffith et al., 2003); 
however, as the disease progresses more general measures of global cognitive function 
emerge (Grigsby et al., 1998). 
 
VII.4.2 Functional status and MCI studies 
 According to MCI diagnostic criteria, individuals in this state do not present significant 
changes in their ADLs (Petersen et al., 1999). This point is a critical issue, because once 
functional decline is detected the diagnosis begins to shift from MCI to dementia. Thus 
under the Mayo criteria, people with MCI have been described as having “usually intact” 
ADLs (Ritchie et al., 2001) or “only slightly abnormal” ADLs (Petersen et al., 1999). 
Guidelines for functional change in MCI have been suggested to be vague and 
unsatisfactory as diagnostic criteria (Ritchie et al., 2001), and as probably reflecting 
currently limited empirical knowledge concerning the types and extent of functional change 
that occur in MCI (Marson D, 2006). Despite these problems with the diagnosis, emerging 
evidence does indicate that MCI is associated with at least some impairment in daily 
function (Daly et al., 2000, Ritchie et al., 2001, Morris et al., 2001, Touchon and Ritchie, 
1999, Tabert et al., 2002, Albert et al., 1999) and directly assessed aMCI was associated 




VII.4.3 Functional status in cognitive ageing studies.  
Several studies have also examined the association between cognitive and functional 
decline in what is termed ‘normal ageing’ (Barberger-Gateau et al., 1999, Mortimer et al., 
1992, Willis et al., 1992). In a longitudinal study of community-dwelling older adults 
(Willis et al., 1992), performance of measures of fluid intelligence, crystalized intelligence, 
and processing speed declined significantly over a 7-year period, as did performance on a 
measure of everyday task competence. Fluid reasoning ability emerged as the strongest 
longitudinal predictor of everyday task competence (accounting for 52% of the variance), 
as compared to crystalized intelligence (11%), processing speed (6%), memory (less than 
1%), age (5%) and education (6%). Interestingly, only 38% of the sample demonstrated 
significant longitudinal declines in everyday task competence, and this percentage was 
equivalent to the proportion of individuals who had significantly reduced fluid reasoning 
ability (37%) (Willis et al., 1992). The authors concluded that changes in functional 
performance are not the direct result of advancing age per se but instead are linked to a 
concurrent decline in those cognitive abilities that underlie everyday task competence. 
 
VII. 5 Conclusions 
Although functional and cognitive decline are separately measured, a large proportion of 
functional decline in the elderly is potentially attributable to cognitive decline and one of 
the most important risk factors for functional decline in older adults is the presence of a 
neurodegenerative disorder such as Alzheimer disease, the prevalence of which increases 
dramatically with age. Investigations of associations between dementia, MCI and functional 
decline are complicated by the fact that functional impairment is incorporated into the 
criteria used for defining both cognitive diagnoses. However, studies outside these groups 
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in so-called ‘normal ageing’ support a role for level of cognition in the aetiology of 
functional impairment.  
 
As an underlying issue, in this review it was evident that a wide variety of instruments have 
been used to investigate disability in older populations, with differences in underlying 
constructs being measured (e.g. IADL, ADL), in durations of instruments (2-60 minutes) 
and in the ratters (self, caregivers, experienced interviewers, nurses or clinicians). This lack 
of standardization from the use of multiple competing instruments makes it difficult to 
compare disability prevalences between studies (Ferrucci et al., 2008). The WHO Disability 
Assessment Schedule 2.0 (WHODAS 2.0) offers some potential for a more standardized 
approach, having found to be unidimensional, reliable and valid across different 









Population ageing will have profound impact on a broad range of economic, political and 
social conditions. In many less developed regions of the world, the older population is 
growing at a much faster rate than has been observed in developed nations. In the last fifty 
years the rates of increase have tended to decline in the more developed regions and to 
increase in developed regions.  
 
In parallel with these demographic changes an epidemiological transition is taking place 
from a burden of disease dominated by mortality from infectious causes to degenerative or 
chronic causes – currently being experienced in low- and middle-income countries is 
compressed into a shorter time frame than that experienced historically in high-income 
countries.  
 
Dementia, as an age-associated condition, is at the forefront of this transition, having a 
substantial impact on years lived with disability and mortality. In order to develop 
preventive interventions, it is important to identify the early stages of cognitive decline, but 
very little research has been carried out into this in low and middle-income countries, 
despite the rapid expansion in need. 
 
Research into cognitive aging and dementia is focusing increasingly on the characterization 
of the earliest stages of cognitive impairment, and a variety of clinically-defined pre-
dementia syndromes with differing diagnostic criteria and nomenclature, have been 





In 2001, Petersen proposed the following criteria: (1) memory complaint preferably 
corroborated by an informant; (2) objective memory impairment; (3) normal general 
cognitive function, (4) intact activities of daily living, (5) no dementia. While MCI and a 
sub-category amnestic MCI (aMCI) have been used extensively in clinical research settings, 
their application in epidemiological samples has been more problematic, with surveys 
showing considerable heterogeneity in findings because of methodological sources of 
variability such as case definition, instruments used for evaluating cognitive functioning, 
differences in the populations studied and the different methods used to analyse and present 
results. Several studies however have consistently found a positive association of MCI with 
age and depression. 
 
Key constructs underlying MCI are subjective memory complaint (SMC), informant-
reported memory deficit (IMD) in relation to objective cognitive function. An additional 
important component is the relationship between cognitive impairment and disability since 
the differentiation between MCI and dementia rests on the presence or absence of 
significant disability.  
 
Older people frequently report sMCs, although the prevalence varies considerably, 
depending on how it is ascertained and associations with objective cognitive impairment 
have not been consistent in community samples. However, despite this controversy, SMC 
has potential clinical importance because it constitutes a common reason for help-seeking 




Even though clinicians ascertain cognitive decline routinely through information provided 
by informants, there is a lack of research into this as a measure. International studies 
indicate potential cultural influences on informant reports of cognitive impairment and/or 
dementia.  
 
Functional disability in the elderly may occur with or without corresponding decline in 
cognition. At the same time, it is important to bear in mind that a large proportion of 
functional decline in the elderly is intimately linked to cognitive impairment and that 
dementia is one of the most important risk factors for functional decline in older adults. 
MCI and related constructs tend to specify that functional capacity is preserved using this 
criterion to distinguish them from dementia. Nevertheless, it remains unclear whether this 
absence of functional decline in MCI patients is a true preservation of functional abilities in 
the face of clinically significant memory loss or simply reflecting a lack of sufficiently 
sensitive measures to detect subtle prodromal changes in functional performance associated 




























The main goal of this series of analyses using data from a coordinated programme of 
surveys of older people in low/middle income countries, the 10/66 studies, was to describe 
the prevalence of amnestic mild cognitive impairment and to analyse its underlying 
constructs.  
 
The specific objectives were as follows: 
1. To generate site-specific norms for the cognitive test battery used in the 10/66 
studies (comprising tests of general cognitive function, verbal fluency and 
immediate and delayed verbal recall) and to investigate the degree and consistency 
across sites of associations with sociodemographic factors. 
 
2. Operationalizing Mayo Clinic criteria for amnestic MCI (aMCI), to describe its 
prevalence by age, gender, education and socio-economic status in the 10/66 survey 
sites, to investigate cross-sectional associations with disability and neuropsychiatric 
symptoms and to investigate the consistency of these associations between sites. 
 
3. To describe and compare between sites the prevalence of subjective memory 
complaints (SMC) and associations with dementia and with cognitive function in 
participants without dementia.  
 
4. To describe and compare between sites the prevalence of informant reported 
memory deficits (IMD) and associations with dementia, with SMC and with 




5. To describe and compare between sites the association between cognitive function 









X.1 Introduction and chapter plan 
This chapter describes the general methodology for the 10/66 Dementia Research Group 
population-based surveys, of relevance to each of the analyses presented in the subsequent 
five results chapters (XI to XV). The full protocol will be described in detail with a focus 
on the measurements used for analyses in this thesis. Statistical approaches will then be 
described in detail within each results chapter. 
 
X.2 The 10/66 surveys – design and settings  
The 10/66 Dementia Research Group studies are cross-sectional, comprehensive, one-phase, 
catchment area population-based surveys, which were carried out between 2003 and 2005. 
The full 10/66 population-based study protocols had been published in open access format 
(Prince et al., 2007). The primary sampling and recruitment waves of this study were 
undertaken in eleven geographically defined catchment area sites in seven countries (India, 
China, Cuba, Dominican Republic, Venezuela, Mexico, and Peru). The target sample size 
for every country was 2000–3000 participants (generally 2000) in each of the ten countries. 
Recruitment in China, India, Peru, and Mexico was split between urban and rural sites; all 
other countries included urban sites only. Most of the analyses described in this thesis are 
derived from these sites alone. However, several subsequent surveys have been completed 
and the aMCI prevalence analyses described in Chapter XII included data from a recently 
completed survey in Puerto Rico in which the same protocol was applied.   
 
For urban catchment areas, predominantly middle-class or professional areas with high-
income earners were deliberately avoided. Rural catchment areas were defined by low 
population density and traditional agrarian lifestyle. Catchment area boundaries were 
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precisely defined. Mapping was carried out to identify and locate all households, which 
were allocated household IDs. Households were then enumerated to identify possible 
eligible subjects (aged 65 and over). Age (and therefore eligibility) was formally 
determined on revisit for interview. For each household the genders and ages of all usual 
residents were recorded, with the names of those aged 65 years or over, on the census date. 
Household and participant details were stored in secure databases. These contained names, 
addresses, ID numbers, and contact details for neighbours, key informants and friends to 
facilitate tracing for potential follow-up. 
 
Tables X.1 and X.2 provide descriptions of the study catchment areas as well as detailed 
information about the study countries based on the most up to date health and economic 
indicators from the World Bank (Souza, 2010).  
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Table X.1 10/66 catchment areas information   
 





Health Insurance Cover** 
Cuba Brick houses and apartments. Every person in Cuba receives a pension 
from the government of 250 Cuban 
Pesos. Older people also receive a 
retirement pension. Cubans do not pay 
for education, health and housing. There 
is a fixed amount for electricity and 
water. 
Less than 250 
meters. There is one 
family doctor 
(General Practitioner) 
for every 160 
inhabitants 
5 to 10 kilometres 
or 10 to 15 minutes 
by public transport. 
Provided through the ministry 
of public health and covers 
100% of the population 
Dominican 
Republic 
All homes in Gazcue and Zona 
Colonial are made of cement, 
with plumbing systems, 
electricity, and potable water. But 
the conditions were very different 
in Villa Francisca and San Carlos 
where houses were comprised 
mostly of wood and maybe a 
cement floor, they were smaller 
houses, some even had zinc 
roofs. They all claimed to have 
electricity but on a schedule, no 
more than 6 hours a day. Shared 
bathroom between houses is 
common. 
The majority receives a government 
pension, which are about 5,000 pesos a 
month (US$139 per month). That plus 
any additional income takes them to an 
average of US$2000 a year. Some also 
rely on family members to support 
them. It depends on the amount of 
people who live in the home. If the 
person lived alone, the household 
income would be very low. Never 
exceeding US$2000 a year.  On some 
cases they would be earning about 
US$8000 a year. But this is a rare case 
and it implies a combined household 
income. 
There are a few 
unspecialized care 
centres very close-
by. About 10 
minutes away.  
The nearest hospital 
is in within the area 
or about 20 minutes 
away. But most 
people prefer to 
travel longer 
distances to go to 
the hospital they 
like the most. Often 
it would take them 
40 minutes to get 
there. 
Worker-employer prepayment 
schemes (Social Security 
Dominican Institute), prepaid 
private health insurance, self-





Brick houses. 50% houses and 
50% apartments/flats. All with 
plumbing system and electricity. 
Commercial. Most of older people have 
social security (retirement governmental 
pension). A number of older people live 
in their owned home with their children. 
Approximately 20 
minutes by car 
Approximately 1 
hour by car 
The public subsector comprises 
MINSA, the Social Security 
system and the health services 
of the armed forces and the 
police. Altogether, it has 51% 
of the country's hospitals, 69% 
of the health centres, and 99% 
of the health posts. Social 
security coverage was reduced 
from 40.7% of the 
economically active population 
in 1987 to 23.4 % in 1995. In 
Rural 
Peru 
Most houses are made of cane 
and plaster, adobe and some of 
them plywood. Majority of 
houses do not have plumbing 
system, and some do not have 
electricity. Roads are not paved. 











Health Insurance Cover** 
2000, 32% of the population 




Apartments with running water, 
electricity and plumbing system. 
Governmental pensions, private 
companies, street markets 
There is one Primary 
Care Centre and one 
geriatric centre; both 
of them are public 
and close to the 
catchment area. 
There is a public 
hospital 
approximately 1 km 
from the study area. 
The IVSS provided services to 
57%. The ambulatory network 
of the HSDM provides care to 
around 80% of the population. 
Large strata of the population 
do not have access or have 




Most houses are made of brick 
and have tile roofs, with a 
minority made of asbestos or 
metal foil and a marginal made of 
palm or wood shingles. Most 
houses are equipped with potable 
water, with the vast majority 
having plumbing system and 
electricity.  
The majority of the local economy 
involves provision of services to 
consumers and business. 
The study catchment 
area is inside a 
medical complex 
therefore primary 




Same for PCC 
Mexican Social Security 
Institute introduced family 
health insurance, which people 
may voluntarily obtain by 
paying a fee which is 
complemented with the 





Most houses have no potable 
water and are made of adobe and 
wood. 
Agriculture remains the main economic 
activity. Artisanal production of local 




30 minutes to 1 hour 
by public transport 
away from the 
nearest centre 
Approximately 1 






Courtyards or apartments/flats. 
All of them have plumbing 
system and electricity. The 
courtyards have shared toilets 
and self operated heating system 
with coal, while the 
apartments/flats have central 
heating system and independent 
toilets.  
Most of the older people receive 
retirement pension from the government 
as they worked for companies or 
government organizations. Others have 
allowance from the governments.  
Within 1 kilometre. 
But some of the 
elderly would rather 
go to higher-level 





Two employee-based schemes 
(1 for government workers and 






Brick houses. All of them have 
plumbing system and electricity. 
All of the houses have KANG* 
and/or electronic radiator to make 
the house warm during the 
Most of the older people do not have 
retired pension, as they were farmers. In 
recent years, the government started 
given some allowance to those without 
retirement pensions. A great deal of 
Every village has a 
village clinic, but 
only provide some 
basic medicine. The 





from the houses.  
Government contributes to a 
common fund, which covers 
healthcare costs, but only 
proportionate to the amount 
contributed. In 2005 coverage 
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Health Insurance Cover** 
winter. older people receives support from their 
children.  
centres are usually 
located within 5 
kilometres from the 
houses of the older 
people.  




Information not obtained Chennai has a diversified economic base 
anchored by the automobile, software 
services, hardware manufacturing, 
healthcare and financial services 
industries. 
14 mini health 
centres of voluntary 
health service are 
located within 1 km. 
Government  primary 
health centres in 
Chennai are located 
within 3 km 
Main hospital is 
located within 6-8 
km  
Social insurance is 
estimated to cover only 
4.2% of the population. 
Private health insurance 
constitute a negligible 
proportion (0.2%) Rural 
India 
(Vellore) 
Information not obtained The mainstay for people in the rural 
areas is not agriculture but industries 
like weaving, beady rolling, match-stick 
rolling, leather, chemical 
Proximity of primary 
health centres in 
Vellore will be 
within 2 km  
Christian medical 
college hospital can 
be reached in 5 -7 
km from the study 
area 
* KANG is a traditional long (2 meters or more) sleeping platform made of bricks or other forms of fired clay. Its interior cavity, leading to a flue, channels the exhaust from a wood 
or coal stove. The heat of a cooking fire may be used for maintaining comfort in cool weather. Typically, it occupies one-third to one half of the room, and is used for sleeping at night 
and for other activities during the day. Source: http://en.wikipedia.org/wiki/Kang_bed-stove. 
** Source: WHO and PAHO 







Table X.2 10/66 DRG Country Profiles based on estimates form the World Bank 
 
 Cuba Dominican 
Republic 
Peru Venezuela Mexico China India 
Population (millions) 11,204,735 9,952,711 28,836,700 27,935,000 106,350,434 1,324,655,000 1,139,964,932 
Population age 0-14 years  
(% of total) 
18.1% 31.8% 30.7% 30.2% 29.1% 20.5% 31.7% 
Population ages 15-64 years (% of 
total)  
70.3% 62.3% 63.5% 64.5% 64.7% 71.5% 63.5% 
Population age 65 and above (% of 
total) 
11.6% 5.9% 5.7% 5.3% 6.2% 7.9% 4.8% 
Population Growth Rate  
(Annual %) 
0.0% 1.4% 1.1% 1.6% 1.0% 0.5% 1.3% 
Life Expectancy at birth  
(total population) (years) 
79 73 73 74 75 73 64 
Mortality rate, infant 
(per 1000 live births)* 
4.8 27 22 16 15 18 52 
Birth rate, crude  
(per 1000 people) 
10 23 21 21 18 12 23 
Death rate, crude 
(per 1000 people) 
6.91 5.89 5.39 5.11 4.85 7.06 7.40 
Fertility rates, total  
(births per woman) 
1.51 2.65 2.57 2.54 2.10 1.77 2.74 
GDP per capita§ $9,600 $4,576 $4,477 $11,246 $10,232 $3,267 $1,017 
Health Expenditure, total (% of 
GDP)** 
10.4% 5.4% 4.3% 5.8% 5.9% 4.3% 4.1% 
Per capita government expenditure 




81 94 222 256 49 11 
Public health expenditure (% of 
total health expenditure)*** 
95.5% 35.9% 58.4% 46.5% 45.4% 44.7% 26.2% 
Out-of-pocket health expenditure 
(% of private expenditure on 
health)  
 





Net migration (migrants per 1000 
population) † 
-1.57 -2.4 -0.97 -0.84 -3.84 -0.39 -0.05 
Administrative divisions 14 provinces 
and 1 special 
municipality 
31 provinces 
and 1 district 
25 regions and 
1 province 





31 states and 
1 federal 
district 
23 provinces, 5 
autonomous 
regions, and 4 
municipalities 
28 states and 
7 union 
territories 
1 All estimates are for the year 2008 when not stated otherwise* Infant mortality rate is the number of infants dying before reaching one year of age, per 1,000 live births 
in a given year. Source: Inter-agency Group for Child Mortality Estimation (UNICEF, WHO, World Bank, UNPD, universities and research institutions). 
§ Gross domestic product divided by midyear population. Data are in current U.S. dollars. Source: World Bank national accounts data and OECD National Accounts 
data files. 
** Total health expenditure is the sum of public and private health expenditure. It covers the provision of health services (preventive and curative), family planning 
activities, nutrition activities, and emergency aid designated for health but does not include provision of water and sanitation for the year 2007. Source: World Health 
Organization National Health Account database (www.who.int/nha/en) supplemented by country data.  
*** Public health expenditure consists of recurrent and capital spending from government (central and local) budgets, external borrowings and grants (including 
donations from international agencies and nongovernmental organizations), and social (or compulsory) health insurance funds. Total health expenditure is the sum of 
public and private health expenditure. It covers the provision of health services (preventive and curative), family planning activities, nutrition activities, and emergency 
aid designated for health but does not include provision of water and sanitation. Source: World Health Organization National Health Account database 
(www.who.int/nha/en) supplemented by country data. 
¶ Out of pocket expenditure is any direct outlay by households, including gratuities and in-kind payments, to health practitioners and suppliers of pharmaceuticals, 
therapeutic appliances, and other goods and services whose primary intent is to contribute to the restoration or enhancement of the health status of individuals or 
population groups. It is a part of private health expenditure. Source: World Health Organization National Health Account database (www.who.int/nha/en) supplemented 
by country data. 
†The difference between the number of persons entering and leaving a country during the year per 1,000 persons (based on midyear population). An excess of persons 
entering the country is referred to as net immigration (e.g., 3.56 migrants/1,000 population); an excess of persons leaving the country as net emigration (e.g., -9.26 
migrants/1,000 population). The net migration rate indicates the contribution of migration to the overall level of population change. Source: CIA World Factbooks 18 
December 2003 to 18 December 2008. 
 
Reproduced with permission from PhD thesis submitted to King’s College London by R Sousa, 2010 
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X.3. Ethical approval 
The King’s College London Research Ethics Committee approved by local ethical 
committees the 6 studies. Informed consent was sought from all participants. If a 
participant could not read or write, they did not sign the consent form. In such cases 
interviewers were instructed to sign in the consent form that the participant had assented, 
witnessed if possible by an independent person who could read and write; preferably the 
same person who acted as the informant. Informants were also requested to sign separate 
informant consent for their interview. Next of kin provided written agreement in case of 
lack of capacity to consent.  
 
X.4 Pre-study preparation, interviewers and training 
The full 10/66 protocol and assessment instruments were translated using a five stage 
method:  
1) forward translation into the local language,  
2) back translation into English,  
3) back translation compared to the original English version,  
4) a final consensus version then presented to panels of local older people and local 
experts,  
5) the final version evaluated in an instrument pre-test pilot. 
 
Participant centres were advised to employ interviewers who were graduates. In most sites 
health professionals such as psychologists and social workers carried out the interviews. In 
China and Cuba interviewers were medical doctors, working in primary care. All 
interviewers received full training on the 10/66 protocols, carried out by the local principal 
investigator and the local study coordinator.  
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The key elements of the training comprised: 
a) overview of study aims and methodology,  
b) detailed training in the clinical assessments (e.g. Geriatric Mental State, structured 
neurological examination, cognitive examinations),  
c) general training in the fully structured interviews (informant interview,      
background and risk factor interview),  
d)  training in data handling and quality control procedures.  
 
For the structured neurological examination and Geriatric Mental State, standard training 
videos in English were produced and distributed to local centres which either dubbed or 
used them to produce local videos in their local language. 
 
X.5.  The samples 
X.5.1 Participant and informant identification  
All people aged 65 years and over living in the geographically defined catchment areas 
were invited to participate in the study. The target sample size for each country was 
between 2000 and 3000 (generally 2000). Catchment area boundaries were precisely 
defined and marked on a map used to identify and locate all households. A census date was 
used to determine eligibility. The rationale for discrete catchment areas was that we were 
able to work with the local community to ensure continuing cooperation and high rates of 
participation, as well as facilitating potential follow-up, since the assembling of a cohort for 
prospective research was envisaged at the outset. A door-knocking strategy was used to 
identify all possibly eligible participants, and to allocate a unique identifier to each 
household. For each household, the gender and ages of all permanent residents were 
recorded with the name(s) of those possibly or definitely aged 65 years or over on the 
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census date. Age and eligibility were formally ascertained and confirmed when the research 
workers returned to carry out the interview.  
 
Household and participant details were stored in secure databases which included names, 
addresses, study identifier (ID) numbers, and contact details for neighbours, key informants 
and friends to be used in the planned follow-up phase. For each participant an informant 
was identified to provide further information. The informant was chosen on the basis either 
that they knew the participant best or had spent the longest period of time with the older 
person. Although in most cases they were a co-resident of the older person and usually a 
family member, in some cases a non co-resident family member, or a friend or neighbour 
was better qualified. 
 
X.5.2 Sample size calculation for the surveys 
An overall sample of 2,000 for each country was chosen on the basis that it would allow the 
estimation of a typical dementia prevalence of 4.5% with what was felt to be an adequate 
precision of +/- 0.9%. Rural and urban samples of 1,000 each, where feasible, were chosen 
as allowing estimation of the same prevalence with a precision of +/- 1.2%.  
 
X.6. Other quality control procedures used 
In addition to the rigorous training given to interviewers, the 10/66 group produced a 
standardized operating procedure (SOP) manual distributed to PIs and SCs describing every 
element of the study protocol in detail, focusing in particular on data quality control. 
Quality control was primarily achieved through interview supervisions and diagnostic 
validation. Local SCs were responsible for vetting the early stages of data collection during 
fieldwork to assess for compliance with the study protocol as trained. Random reviews of 
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completed questionnaires were carried out by SCs looking for completeness, unusual 
patterns of response, and high levels of missing data. Any issues arising from these checks, 
and any problems in the fieldwork, were discussed during weekly meetings with the whole 
research team. If errors persisted through the quality control checks they were identified by 
the double data entry procedure and were dealt with before finalization of data entry. 
 
X.7. Data handling 
All data were coded onto paper versions of data coding sheets. The exception was in Cuba 
where all data were collected directly onto laptop computers using computerized Spanish 
questionnaires driven by EpiData (version 2.0) software. In all sites, data were double 
entered by a different data entry clerk using EpiData to minimize data transcription errors. 
The Chinese and India sites used the English version of the data entry files in EpiData. 
Both Spanish and English data entry files were identical, which facilitated data processing, 
data managing and processing.  
 
All data cleaning, and processing of derived variables were carried out centrally at the 
London coordinating centre in SPSS using prepared syntax files. Distributions of all 
variables were carefully checked for anomalies, and range checks applied. After algorithms 
had been processed (see below where relevant), data were exported from SPSS into 
STATA for analysis. 
 
X.8 Measurements  
From the participant and informant interview, the following summary information was 
generated: dementia status, mental health, physical health, anthropometric data, 
demographic information, risk factor information relevant to dementia and chronic diseases, 
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disability, health-service use, care arrangements, and caregiver strain. The sections below 
detail the full range of assessments carried out on all participants in the 10/66 surveys. 
Individual measures of interest for specific analyses will be delineated in each Results 
chapter.  
 
X.8.1Participant interview information 
X.8.1.1 Sociodemographic status 
a) Age of the participant was formally established during interview from stated age, official 
documentation, informant report, and, in the case of discrepancy, age according to an event 
calendar. 
b) Living circumstances (from a complete list drawn up of co-residents with ages and 
relationships).  
c) Marital status.  
d) Education was grouped as follows: i) none, ii) primary not completed; Iii) primary 
completed; iv) secondary completed; v) tertiary completed. In addition, literacy was 
ascertained.  
e) Religious affiliation and practice.  
f) Community social activity, social support, and social network 
g) Socio-economic status was calculated from the best occupation out of the participant and 
their spouse. Also recorded were current occupational status, income and sources of income, 
a household assets index (car, television, refrigerator, telephone, mains water, plumbed 
toilet), and food insecurity (assessed by the question “do you ever go hungry because there 
is not enough food to eat?”). 
d) Rural or urban residence across the life course and migration between the two (as well as 
age at migration).  
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X.8.1.2 Health Status 
a) Self-reported diagnoses or treatment for the following conditions were recorded: stroke, 
diabetes, hypertension, heart disease, hypercholesterolemia, TB, malaria, and cystercicosis. 
b) Physical impairments: participants were asked about the presence or absence of 11 
common and limiting physical impairments (arthritis or rheumatism; eyesight problems; 
hearing difficulty or deafness; persistent cough; breathlessness, difficult breathing or 
asthma; high blood pressure; heart trouble or angina; stomach or intestine problems; faints 
or blackouts; paralysis, weakness or loss of one leg or arm; skin disorders such as pressure 
sores, leg ulcers or severe burns). The total number of these was calculated and categorised 
into three groups (0, 1-2 and 3+).  
c) Disability was measured by the second World Health Organization Disability 
Assessment Schedule (WHO-DAS 12), specifically developed by the WHO as a culture-
fair assessment tool for use in cross-cultural comparative epidemiological and health 
services research 
d) Direct physical assessments were made of pulse rate, systolic and diastolic blood 
pressure (average of two resting sitting and two standing), waist circumference, waist/hip 
ratio, walking test (5 meters walk, turn and return-timed and paces counted), leg length, 
height, and skull circumference. A brief, fully structured neurological assessment was 
carried out with objectified quantifiable measures of lateralizing signs, parkinsonism, ataxia, 
apraxia and primitive 'release' reflexes. 
e) Reproductive status: women were asked about ages at menarche and menopause, and 
number of children 
f) Specific dementia risk factors were enquired about, namely head injury with loss of 
consciousness, family history of dementia, previous depression.  
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g) Relevant lifestyle factors were enquired about, namely alcohol use (volume and 
frequency currently and before the age of 60), lifetime smoking (never, ever and current 
status and pack year calculation), diet (intake of fish, meat and fruit and vegetables; food 
insecurity), exercise and activity levels current and in earlier adult life. 
h) Self-reported physical pain.  
 
X.8.1.3 Cognitive Status 
The core cognitive assessment comprised the cognitive component of the ‘Community 
Screening Instrument for Dementia’ (CSI 'D)(Hall et al., 1993) supplemented by the 10 
word list-learning test from the ‘Consortium to Establish a Registry for Alzheimer’s 
Disease’ (CERAD) (Ganguli et al., 1996) 
 
The CSI ‘D’ is a 32-item cognitive test administered to the participant lasting about 20 
minutes which is supplemented by a 26-item informant interview about the participant’s 
daily functioning and general health (lasting approximately 15 minutes).  
 
The CSI 'D' was used across cultures with the minimum of necessary adaptation. It was 
developed and first validated among Cree American Indians (Hall et al., 1993, Hendrie et 
al., 1993), further validated and used in population-based research (The US-Nigeria Study) 
among Nigerians in Ibadan and African-Americans in Indianapolis (Hendrie et al., 1995), 
and has also been validated among white Canadians in Winnipeg (Hall et al., 2000), and in 
Jamaica in conjunction with the CERAD battery (Unverzagt et al., 1999). The CSI 'D' test 
score distributions among those with dementia and controls, and the degree of 
discrimination provided were remarkably consistent across the aforementioned cultural 
settings (Hall et al., 2000). 
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Three summary scores can be generated from CSI ‘D’ using standard algorithms:  a 
cognitive score (COGSCORE) comprising an item-weighted total score from the 
participant cognitive test; an informant score (RELSCORE) comprising an unweighted total 
score from the informant interview; and a discriminant function score (DFSCORE), a 
weighted score combining COGSCORE and RELSCORE. COGSCORE and DFSCORE 
have validated cut-off points for probable and possible cases of dementia. The animal 
naming verbal fluency task from the Consortium to Establish a Registry of Alzheimer’s 
Disease (CERAD) can also be extracted from the cognitive test component of CSI ‘D’ (but 
is given little weight in COGSCORE), in which participants are asked to name as many 
different animals as they can in one minute. 
 
The CERAD ten-word list-learning task was adapted for the purpose of the 10/66 surveys. 
Six words were taken from the original CERAD English language list: butter, arm, letter, 
queen, ticket, and grass. The items pole, shore, cabin, and engine in the original were 
replaced with corner, stone, book, and stick, which were deemed more culturally 
appropriate. In the learning phase, the list is read out to the participant, who is immediately 
asked to recall the words they remember. This process is repeated three times, giving a total 
learning score out of 30. In the 10/66 protocol, approximately five minutes later, after a 
series of unrelated CSI ‘D’ questions (name registration, object naming, object function, 
repetition) the participant is again asked to recall the 10 words with prompting that they 
were read from a green card, giving a WLR score out of 10. 
 
X.8.1.4 Mental health status 
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A structured comprehensive clinical mental state interview was administered by all sites, 
the Geriatric Mental State (GMS), version B3 (Copeland et al., 1986). Responses to this 25-
40 minute interview are processed using a standard computer algorithm (AGECAT - 
Automated Geriatric Examination for Computer Assisted Taxonomy) (Copeland et al., 
1986) This algorithm generates symptom scores in nine diagnostic clusters: organic brain 
syndrome dementia); schizophrenia; mania; neurotic and psychotic depression; and 
obsessional, hypochondriac, phobic, and anxiety neuroses. Scores of 3–5 denote probable 
cases, scores of 1 and 2 denote subcases, and those of zero denote absent or negligible 
relevant symptoms. These stage-one diagnoses are organized into final stage-two diagnoses 
on the basis of a hierarchy imposed by a structured algorithm. The instrument has few 
cognitive items and mainly tests domains of orientation and short-term memory. 
 
A subset of 12 GMS items contributed particularly towards the determination of the stage 1 
organicity diagnostic confidence level. These comprise tests of cognitive ability 
(knowledge of date of birth and age; discrepancy between stated dates of birth and age; 
orientation for day, month, year and address; recall of name of interviewer; name of their 
country’s current and previous political leader) and two judgments made by the interviewer 
(presence of memory deficit, and problems with memory worse than problems with 
thinking). 
 
X.8.2 Informant interview  
Separate interviews were carried out with the chosen informant in which the following 
information was collected: 
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a) Socio-demographic information about the informant was gathered together with their 
mental health, self-assessed using the 20-item Self-Reporting Questionnaire (SRQ-
20)(Mari and Williams, 1985) administered to all informants.  
b) A caregiver questionnaire was administered only to informants who were providing 
significant care and included caregiver perceived strain as measured by the Zarit Burden 
Interview (Zarit et al., 1980, Zarit et al., 1986). 
c) The informant section of the CSI’D’ asking about cognitive and functional decline in the 
participant, was administered to all informants; 
d) The ‘History and Aetiology Schedule – Dementia Diagnosis and Subtype’ (HAS-DDS), 
which provides information on onset and course of dementia, was administered only when 
there was evidence from the informant section of the CSI’D’ of possible cognitive and/ or 
functional decline (a score of two or more). 
e) The Neuropsychiatric Inventory (NPI-Q) (Kaufer et al., 2000)was completed by all  
informants to assess behavioural and psychological symptoms in the index participants. 
f) Where the participant had communication difficulties as a result of dementia, severe 
mental illness, deafness or mutism, as much sociodemographic and risk factor information 
as possible was collected from the informant.  
 
X.8.3 Diagnosis of dementia 
The 10/66 diagnostic procedures for dementia have been described in detail in an open 
access publication (Prince et al., 2003). They were based on criteria specially developed 
and validated by the 10/66 group to be suitable for low education populations in the 
developing world and to allow comparisons across countries and cultures. The criteria were 
operationalized as a computer algorithm, applying clinical principles, based upon the 10/66 
cognitive tests, mental status interview and informant report: i) the Community Screening 
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Instrument for Dementia, (CSI’D’) COGSCORE, ii) the CERAD 10 word list learning and 
animal naming tests, iii) the GMS-AGECAT output (Copeland et al., 1986, Prince, 2004) 
and iv) the  History and Aetiology Schedule-Dementia Diagnosis and Subtype (Dewey and 
Copeland, 2001). DSM-IV was also operationalized as a computer algorithm and was 
validated against clinical diagnosis in Cuba (Prince et al., 2008). Dementia subtypes were 
derived using an algorithm following NINCDS ADRDA criteria(McKhann et al., 1984) for 
Alzheimer’s disease and NINDS-AIREN criteria (Roman et al., 1993) for vascular 
dementia. 
 
X.9 Statistical Analyses  
 
In the next five chapters several statistical analyses were conducted, in relationship with the 
objectives’ proposed in each of them, they are extensively described in chapters XI to XV. 
All analyses were carried out using STATA 9.2 (Stata Corp. 2007. Stata Statistical 





XI. – POPULATION NORMATIVE DATA 
 
The material contained in this chapter is an original transcript of the published paper 
and therefore repeats some earlier methodological description and does not maintain 
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Rapid demographic ageing around the world has important implications for health and 
social care. Cognitive decline and dementia have a high individual impact and are strongly 
age-associated (Prince et al., 2000), so that their overall prevalence and societal impact is 
increasing rapidly. A recent consensus report estimated that the number of people with 
dementia in the world would increase from 24 million to 82 million from 2000 to 2040 
(Ferri et al., 2005). This increase will be particularly marked in low and middle-income 
countries where epidemiological research into the aetiology and impact of dementia and 
cognitive decline is limited. The 10/66 Dementia Research Program was set up to facilitate 
research in these regions and to provide data that can be used for public health and service 
planning (Prince et al., 2000). Cognitive tests, covering multiple domains are an essential 
component of a definitive dementia diagnostic assessment, for the purposes of establishing 
the criterion of decline in at least two domains of cognitive function, including memory 
(American Psychiatric Association, 1994). Normative data are urgently required, given the 
influence of both education and culture on cognitive test performance (Berres et al., 2000; 
Stewart et al., 2002).  
 
The data presented in this paper were drawn from the 10/66 Dementia Research Group’s 
cross-sectional surveys of older people carried out in seven urban and four rural sites in five 
Latin American countries, China and India. The primary objective was to generate site-
specific norms for the cognitive test battery used in the 10/66 studies comprising tests of 
general cognitive function, verbal fluency and immediate and delayed verbal recall. Further 
objectives were a) to assess the independent influences of age, educational level and gender 
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and their homogeneity across sites and b) to assess the extent to which variance attributable 
to site could be attributed to the effects of region and/ or rural versus urban residence.   
METHOD 
Study design  
The design of the 10/66 Dementia Research Group (DRG) baseline population-based 
studies has been described in detail (Prince et al., 2007). Briefly, cross-sectional surveys 
were carried out; approaching all residents aged 65 and over within purposively selected 
geographically defined catchment areas at each site. Affluent districts were intentionally 
avoided. A target sample of 2000 persons aged 65 years and over, per country (3,000 in 
Cuba) was identified by means of door knocking the catchment areas. Peru, Mexico, China 
and India recruited both from rural and urban sites. Interviews followed a comprehensive 
one-phase design where all participants received a full assessment, including: cognitive and 
mental health evaluation, an informant interview, a physical and neurological examination, 
blood assays and genotyping, in addition to questionnaire measures of environmental and 
behavioural risk exposures, sociodemographic and socioeconomic status, and physical 
health status. Disability, health service utilisation, care arrangements and impact of 
providing care were also evaluated. 
 
Measurements 
For this analysis we considered the following socio-demographic independent variables: 
participants’ age divided into four groups (65-69 years, 70-74 years, 75-79 years, 80 years 
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and over), sex, and education level divided into five groups (none, some (but did not 
complete primary), completed primary, completed secondary, and tertiary).  
 
The 10/66 cognitive assessment battery was drawn principally from the Community 
Screening Instrument for Dementia (CSI’D’) developed by the Ibadan-Indianapolis study 
group (Hall et al., 1993) specifically for use in cross-cultural research, and in low education 
settings, and from the Consortium to Establish a Registry for Alzheimer's Disease (CERAD; 
Morris et al., 1989). As such, components of the battery have been very widely used in 
other population and clinical research. In our large multi-site pilot study (Prince et al., 2003) 
we developed and validated a culture and education-fair algorithm for dementia diagnosis 
across a wide variety of low and middle income country settings, comprising components 
of the cognitive test battery, in combination with the Geriatric Mental State and the 
informant section of the CSI’D’   
 
The analysis described here focussed on the four main tests included in the 10/66 cognitive 
test battery:  
1) Global cognitive function: The Community Screening Instrument for Dementia (CSI ‘D’; 
Hall et al., 1993) includes a 32 item culture and education-fair cognitive test assessing 
orientation, comprehension, memory, naming and language expression, which is used to 
generate a total cognitive score (COGSCORE). The CSI’D’ has been used across cultures 
with the minimum of necessary adaptation. It was developed and first validated among 
Cree American Indians (Hall et al., 1993; Hendrie et al., 1993), further validated and used 
in population-based research (The NIA US-Nigeria Study) among Nigerians in Ibadan and 
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African-Americans in Indianapolis (Hendrie et al., 1995), and has also been validated 
among white Canadians in Winnipeg (Hall et al., 2000), and in Jamaica (Unverzagt et al., 
1999). The CSI’D’ test score distributions among those with dementia and controls, and the 
degree of discrimination provided were remarkably consistent across these five very 
different cultural settings (Hall et al., 2000). 
2) Memory: The 10/66 battery includes two elements of the CERAD 10 word list learning 
test; world list memory (WLM) and word list recall (WLR); testing short term memory, 
registration and recall. WLR has been reported to be of particular value in distinguishing 
early dementia from normal aging (Welsh et al., 1991). WLM and WLR are taken from the 
adapted CERAD ten word list-learning task used in the Indo-US Ballabgarh dementia study 
(Ganguli et al., 1996). Six words; butter, arm, letter, queen, ticket, and grass; were taken 
from the original CERAD battery English language list (Guruje et al., 1995). Pole, shore, 
cabin, and engine were replaced with corner, stone, book and stick, which were deemed 
more culturally appropriate. In the learning phase, the list is read out to the participant from 
a green card, who is then asked to recall straight away the words that they remember. This 
process is repeated three times, giving a WLM score out of 30. Five minutes later the 
participant is again asked to recall the 10 words with prompting that they were read from a 
green card, giving a WLR score out of 10.  
3) Verbal fluency (VF):  the animal naming verbal fluency task from the CERAD is 
administered as part of the CSI ‘D’, however it is accorded very little weight within the 
algorithm for calculating the total CSI ‘D’ score. In the version of the test used in CSI ‘D’, 
after a brief practice naming items from another category (clothing), participants are 
encouraged to name as many different animals as they can in the space of one minute. The 
instructions read out to the participant stipulate: ‘think of any kinds of animal in the air, on 
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land, in the water, in the forest, all the different animals’. If the participant stops before the 
allotted time has elapsed they are encouraged to continue. The score is one point for each 
valid name. In the computation of the CSI ‘D’ cognitive test (COGSCORE) the VF score is 
divided by 23; weighted scores generally range between 0 and 1, the same as for a single 
CSI ‘D’ orientation item.  
 
VF, WLM and WLR are taken with minimal adaptation from the battery of cognitive tests 
proposed by the Consortium to Establish a Registry for Alzheimer's disease (CERAD). The 
CERAD neuropsychological battery has been adapted for use in India (Ganguli et al., 1996), 
Korea (Lee et al., 2004), Brazil (Bertolucci et al., 2001), Nigeria (Guruje et al., 1995) and 
Jamaica (Unverzagt et al., 1999), and norms have been provided for black and white 
persons in the USA, both with dementia (Welsh et al., 1995), and among the general 
population (Fillenbaum et al., 2001). While education effects are prominent, cultural or 
ethnic differences have been less evident, CERAD battery components each distinguish 
reliably between those with dementia and controls across cultures (Ganguli et al., 1996; 
Unverzagt et al., 1999).  
 
Statistical analysis 
For this analysis, all participants who had received a diagnosis of dementia according to 
either DSM-IV or 10/66 dementia criteria were excluded. Participants’ age, sex and 
education data were described by site. Means and standard deviations (SD) for each of the 
four cognitive tests were calculated by age, sex and education for each of the eleven sites. 
General linear models were used to determine the unadjusted and independent effects of 
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age, sex and education on cognitive test scores across sites. We then tested formally for 
effect modification by extending the models used to estimate the main effects of age, 
education and sex to include site by age, site by education and site by sex interaction terms. 
Finally, we estimated the proportion of the variance (eta2) in each cognitive test accounted 
for by age, education, gender and site. We further sought to disaggregate the variance 
accounted for by site by substituting this variable with two further variables sub-classifying 
sites into region (Latin America versus China, versus India) and rural or urban location. 
The effect of region (controlling for age, education, gender and rural/ urban location) is 
summarised as adjusted means and mean differences with 95% confidence intervals for the 
two contrasts; China versus Latin America and India versus Latin America. All analyses 
were carried out using STATA 9.2 (StataCorp. 2007. Stata Statistical Software: Release 10. 




Response rates across all countries ranged between 72% and 98%. In all 14,967 participants 
were fully evaluated. One thousand three hundred and eighteen of these met criteria for 
dementia and were excluded from further analysis, leaving a total of 13,649 participants, 
free of dementia (Table 1).  
 
Table 1 Sociodemographic characteristics of participants by site 
 
Region Latin America China India 
Country Cuba DR Peru Venezuela Mexico China India 
Rural or urban site Urban Urban Urban Rural Urban Urban Rural Urban Rural Urban Rural 
Total (n) 2,621 1,769 1,251 516 1,826 910 913 1,076 946 930 891 
Age in years (MV) 7 0 1 0 23 1 0 0 0 4 0 
65 – 69 years % 28.2 29.0 29.2 33.5 44.1 26.7 32.2 28.7 39.9 42.9 34.8 
70 – 74 years %  28.3 27.3 27.3 25.8 24.9 34.4 26.2 32.5 30.1 32.1 34.9 
75 – 79 years % 22.3 19.5 21.9 18.2 17.8 20.2 22.1 21.9 19.3 14.6 17.7 
80+ years % 21.3 24.3 21.6 22.5 13.1 18.7 19.5 16.8 11.0 10.5 12.6 
Females (MV) 0 2 0 0 60 0 0 0 0 15 0 
% 64.4 65.4 64.1 52.5 63.5 65.6 59.9 56.6 55.3 57.3 52.3 
Education (MV) 8 19 8 8 63 0 0 0 0 2 0 
No education. % 2.1 17.8 2.5 14.0 7.3 19.6 31.0 19.2 57.2 41.3 63.6 
Some education 
(did not complete 
primary) % 
20.9 51.8 6.4 25.6 22.1 35.7 52.3 12.8 11.5 24.2 21.0 
Completed 
primary % 
33.0 19.1 31.8 49.6 49.4 24.2 12.8 26.5 26.3 20.8 12.4 
Completed 
secondary % 
26.0 7.1 36.1 6.6 14.3 10.4 2.4 29.4 4.4 9.1 2.8 
Completed 
tertiary % 
17.9 3.7 22.8 3.1 5.0 10.1 1.5 12.1 0.5 4.4 0.2 
DR = Dominican Republic; MV= Missing Value 
 
All age groups were well represented. The Venezuelan, rural Chinese and Indian samples 
had a younger age distribution than other sites. The female/ male ratio exceeded 1 in all 
sites, but with a less striking preponderance of women in rural Peru, China and India. 
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Educational level showed considerable variation across sites, highest in urban Latin 
America sites (other than the Dominican Republic), and lowest in rural China and in India. 
Within country, educational levels were consistently higher in urban compared with rural 
sites.  
 
Tables 2 to 5 present normative data; stratified means and standard deviations for the four 
cognitive outcomes. Older age and lower levels of education were consistently associated 
with poorer cognitive test performance on scores for all four tests, across all sites. The 
effect of sex on cognitive test performance was smaller and more variable, both between 
tests and between sites. Men tended to perform marginally better than women on the 
COGSCORE, and on VF. For WLM and WLR, women performed better than men in Latin 
American sites, but there was no gender difference in China and India.  
 
Tests for interaction indicated that the effects of age, sex and education on cognitive test 
performance were each significantly modified by site, for all four cognitive tests. However, 
the effects were uniformly very modest in size, generally accounting for between 0.1% and 
0.3% of the overall variance. The two largest interaction effects were those between site 




Table 2 Mean (SD) scores for global cognitive function (CSI’D’ ‘COGSCORE’) by demographic status and site 
 
 Country 
 Cuba DR Peru Venezuela Mexico China India 
 Urban Urban Urban Rural Urban Urban Rural Urban Rural Urban Rural 
Age            
65 - 69 31.1 (1.9) 30.4 (2.3) 31.8 (1.3) 30.6 (2.9) 31.1 (1.8) 30.8 (1.7) 29.8 (2.1) 31.7 (1.2) 31.0 (3.9) 29.2 (3.0) 27.9 (3.2) 
70 - 74 30.8 (1.9) 30.2 (2.1) 31.3 (2.2) 30.4 (1.8) 30.6 (2.2) 30.1 (2.8) 29.3 (1.9) 31.4 (2.0) 30.7 (2.6) 28.3 (3.7) 27.3 (4.3) 
75 - 79 30.3 (2.1) 29.9 (2.1) 31.1 (2.4) 29.7 (2.7) 30.1 (2.5) 29.5 (2.8) 28.5 (3.4) 31.4 (1.5) 29.6 (4.3) 28.5 (4.0) 27.0 (3.6) 
80+ 29.5 (2.6) 28.7 (2.8) 29.6 (3.4) 28.9 (3.4) 29.0 (2.8) 29.3 (2.4) 28.3 (2.6) 30.9 (2.8) 29.1 (3.7) 27.6 (3.4) 25.3 (7.3) 
Crude β (95% 
C.I.) 
-0.5 
(-0.6 to -0.5) 
-0.5 
(-0.6 to -0.4) 
-0.6 
(-0.8 to -0.5) 
-0.6 




(-0.7 to -0.4) 
-0.5 
(-0.7 to -0.4) 
-0.2 
(-0.3 to -0.1) 
-0.7 
(-0.9 to -0.4) 
-0.8 
(-0.7 to -0.3) 
-0.8 




(-0.4 to -0.3) 
-0.5 
(-0.6 to -0.4) 
-0.6 
(-0.7 to -0.4) 
-0.5 
(-0.7 to -0.3) 
-0.5 
(-0.6 to -0.4) 
-0.4 
(-0.5 to -0.2) 
-0.5 
(-0.6 to -0.3) 
-0.2 
(-0.3 to -0.9) 
-0.6 
(-0.8 to -0.3) 
-0.5 
(-0.7 to -0.3) 
-0.8 
(-1.1 to -0.5) 
 Sex            
Females 30.4 (2.3) 29.6 (2.6) 31.0 (2.2) 29.9 (2.7) 30.4 (1.89) 29.9 (2.5) 29.0 (2.5) 31.2 (2.3) 30.2 (3.1) 27.9 (3.4) 26.0 (5.3) 
Males 30.7 (2.1) 30.2 (2.01) 31.1 (2.9) 30.2 (3.0) 30.7 (2.54) 30.2 (2.5) 29.2 (2.7) 31.6 (1.2) 30.7 (4.3) 29.7 (3.1) 28.5 (2.52) 
Crude β  
(95% C.I.) 
0.3 
(0.1 to 0.5) 
0.6 
(0.3 to 0.8) 
0.0 
(-0.2 to 0.3) 
0.3 
(-0.2 to 0.7) 
0.3 
(0.1 to 0.5) 
0.4 
(0.0 to 0.7) 
0.2 
(-0.1 to 0.5) 
0.4 
(0.2 to 0.7) 
0.5 
(0.0 to 0.9) 
1.9 
(1.4 to 2.3) 
2.6 




(-0.1 to 0.2) 
0.4 
(0.1 to 0.6) 
0.0 
(-0.2 to 0.3) 
0.1 
(-0.4 to 0.6) 
0.2 
(-0.0 to 0.4) 
0.4 
(0.0 to 0.7) 
0.2 
(-0.1 to 0.6) 
0.2 
(-0.1 to 0.4) 
0.1 
(-0.5 to 0.6) 
1.0 
(0.6 to 1.4) 
1.4 
(0.8 to 2.1) 
Education            
No Ed. 28.3 (3.7) 28.2 (3.1) 28.7 (3.1) 27.9 (3.7) 29.1 (1.9) 28.5 (2.7) 27.8 (3.3) 30.6 (2.7) 30.1 (3.5) 27.0 (3.3) 26.1 (5.0) 
Some Ed. 29.3 (2.5) 29.8 (2.2) 29.8 (2.6) 29.9 (2.2) 29.7 (2.3) 29.5 (2.9) 29.4 (2.1) 30.7 (1.4) 30.3 (3.5) 29.0 (3.3) 28.5 (1.9) 
Primary 30.4 (1.8) 30.8 (1.6) 30.6 (2.4) 30.6 (1.9) 30.8 (1.6) 30.6 (1.7) 30.3 (1.8) 31.5 (2.1) 31.0 (4.2) 29.8 (3.5) 30.0 (1.6) 
Secondary 31.1 (1.5) 31.1 (1.7) 31.3 (2.7) 30.1 (5.6) 31.1 (3.2) 31.3 (1.3) 30.7 (1.6) 31.9 (1.1) 32.0 (0.7) 31.1 (1.2) 30.9 (1.3) 
Tertiary 31.7 (2.2) 31.1 (1.7) 31.7 (1.4) 31.1 (0.9) 31.3 (1.5) 31.6 (1.2) 31.5 (1.2) 32.0 (0.9) 31.4 (1.8) 31.0 (1.5) 31.4 (1.7) 
Crude β (95% 
C.I.) 
0.8 
(0.7 to 0.8) 
0.7 
(0.6 to 0.8) 
0.6 
(0.5 to 0.7) 
0.6 
(0.4 to 0.8) 
0.4 
(0.3 to 0.5) 
0.7 
(0.6 to 0.8) 
0.8 
(0.7 to 0.9) 
0.3 
(0.2 to 0.4) 
0.3 
(0.2 to 0.5) 
0.9 
(0.8 to 1.0) 
1.2 
(1.0 to 1.5) 
Adj. β 3 
(95% C.I.) 
0.7 
(0.6 to 0.7) 
0.6 
(0.5 to 0.7) 
0.5 
(0.3 to 0.6) 
0.6 
(0.4 to 0.7) 
0.5 
(0.4 to 0.6) 
0.6 
(0.5 to 0.7) 
0.7 
(0.6 to 0.9) 
0.3 
(0.2 to 0.4) 
0.2 
(0.1 to 0.4) 
0.8 
(0.7 to 0.9) 
0.9 
(0.7 to 1.2) 
DR = Dominican Republic 
1. Adjusted for sex and education 
2. Adjusted for age and education 
3. Adjusted for age and sex 
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Table 3 Mean (SD) scores for CERAD verbal fluency (animal naming) test by demographic status and site 
 
 Country 
 Cuba DR Peru Venezuela Mexico China India 
 Urban Urban Urban Rural Urban Urban Rural Urban Rural Urban Rural 
Age            
65 - 69 18.1 (6.2) 15.0 (4.8) 19.3 (5.5) 17.1 (4.9) 20.1 (6.3) 16.9 (5.1) 14.9 (4.2) 17.3 (4.6) 16.2 (5.7) 8.9 (3.3) 10.4 (3.6) 
70 - 74 16.9 (5.8) 14.2 (4.9) 18.2 (5.3) 16.1 (5.1) 18.0 (6.0) 15.7 (5.1) 14.1 (4.4) 16.8 (4.7) 15.8 (5.1) 8.6 (3.4) 10.1 (3.8) 
75 - 79 15.9 (5.4) 13.7 (4.3) 16.9 (4.8) 15.2 (3.7) 16.8 (5.7) 15.2 (4.8) 13.0 (4.5) 16.3 (4.5) 14.1 (5.2) 8.4 (3.3) 9.5 (3.3) 
80+ 14.7 (5.6) 12.3 (4.4) 14.3 (5.1) 14.4 (5.0) 14.8 (5.8) 14.3 (5.1) 13.0 (4.6) 15.8 (4.8) 13.1 (5.0) 7.4 (2.5) 9.1 (4.4) 
Crude β (95% C.I.) 
-1.1 
(-1.3 to -0.9) 
-0.9 
(-1.1 to -0.7) 
-1.6 
(-1.9 to -1.3) 
-0.9 
(-1.3 to -0.5) 
-1.7 
(-2.0 to -1.4) 
-0.8 
(-1.1 to -0.5) 
-0.7 
(-1.0 to -0.5) 
-0.5 
(-0.8 to -0.3) 
-1.0 
(-1.4 to -0.7) 
-0.4 
(-0.6 to -0.2) 
-0.4 








(-1.7 to -1.2) 
-0.8 
(-1.2 to -0.5) 
-1.4 
(-1.7 to -1.1) 
-0.6 
(-0.9 to -0.2) 
-0.7 
(-0.9 to -0.4) 
-0.5 
(-0.8 to -0.3) 
-0.7 
(-1.1 to -0.4) 
-0.4 
(-0.6 to -0.1) 
-0.4 
(-0.6 to -0.2) 
 Sex            
Females 15.9 (5.6) 13.5 (4.5) 17.2 (5.3) 15.6 (4.7) 18.1 (6.2) 15.5 (5.1) 13.5 (4.3) 16.1 (4.6) 14.8 (5.1) 8.1 (3.1) 9.3 (3.7) 
Males 17.7 (6.3) 14.6 (5.1) 17.8 (5.9) 16.2 (5.0) 18.7 (6.6) 16.1 (5.2) 14.4 (4.7) 17.4 (4.6) 15.9 (5.9) 9.4 (3.5) 10.7 (3.6) 
Crude β  
(95% C.I.) 
1.8 
(1.4 to  2.3) 
1.1 
(0.6 to 1.6) 
0.5 
(-0.1 to 1.2) 
0.6 
(-0.2 to 1.4) 
0.6 
(0.0 to 1.2) 
0.6 
(-0.1 to 1.3) 
0.9 
(0.3 to 1.5) 
1.2 
(0.7 to 1.8) 
1.1 
(0.4 to 1.8) 
1.3 
(0.9 to 1.8) 
1.4 




(0.9 to 1.7) 
0.9 
(0.4 to 1.3) 
0.5 
(-0.1 to 1.1) 
0.5 
(-0.3 to 1.3) 
0.2 
(-0.4 to 0.8) 
0.6 
(-0.1 to 1.2) 
0.9 
(0.4 to 1.5) 
0.8 
(0.3 to 1.4) 
-0.1 
(-0.8 to 0.7) 
0.9 
(0.4 to 1.3) 
0.9 
(0.4 to 1.3) 
Education            
No Ed. 13.6 (4.5) 12.8 (4.3) 14.3 (4.5) 13.4 (4.1) 14.8 (5.0) 14.0 (4.4) 12.6 (4.0) 15.3 (4.4) 14.3 (5.1) 7.7 (3.1) 9.3 (3.6) 
Some Ed. 13.9 (5.0) 13.4 (4.4) 14.7 (4.6) 15.7 (5.0) 16.7 (6.6) 14.5 (4.7) 14.1 (4.5) 15.2 (5.1) 14.3 (5.1) 8.9 (3.4) 10.3 (3.3) 
Primary 15.6 (5.28) 14.8 (5.0) 16.1 (4.9) 16.5 (4.5) 18.8 (6.1) 16.2 (4.9) 14.8 (4.2) 17.1 (4.4) 17.5 (5.7) 10.0 (3.0) 12.0 (3.2) 
Secondary 17.2 (5.5) 15.8 (5.2) 17.7 (5.6) 16.9 (6.3) 19.7 (6.0) 18.1 (4.3) 18.0 (4.5) 17.6 (4.2) 17.6 (6.4) 10.3 (3.5) 14.0 (4.1) 
Tertiary 20.7 (6.4) 16.8 (5.7) 19.7 (5.7) 16.1 (6.2) 21.7 (7.3) 19.4 (6.0) 18.3 (5.0) 17.2 (5.2) 17.6 (2.7) 9.7 (3.03) 16.0 (2.8) 
Crude β (95% C.I.) 
1.9 
(1.7 to 2.1) 
0.7 
(0.6 to 0.9) 
1.4 
(1.2 to 1.7) 
0.8 
(0.4 to 1.1) 
1.2 
(0.9 to 1.4) 
1.1 
(0.9 to 1.3) 
0.9 
(0.7 to 1.1) 
0.5 
(0.4 to 0.7) 
0.9 
(0.7 to 1.1) 
0.5 
(0.4 to 0.6) 
0.9 
(0.7 to 1.1) 
Adj. β 3 
(95% C.I.) 
1.6 
(1.4 to 1.8) 
0.6 
(0.4 to 0.8) 
1.1 
(0.8 to 1.4) 
0.6 
(0.3 to 0.9) 
1.3 
(1.1 to 1.6) 
1.0 
(0.8 to 1.2) 
0.8 
(0.6 to 1.1) 
0.4 
(0.2 to 0.6) 
0.7 
(0.5 to 1.0) 
0.4 
(0.3 to 0.6) 
0.8 
(0.5 to 1.0) 
DR = Dominican Republic 
1. Adjusted for sex and education 
2. Adjusted for age and education 








Table 4 Mean (SD) scores for CERAD word list memory test by demographic status and site 
 Country 
 Cuba DR Peru Venezuela Mexico China India 
 Urban Urban Urban Rural Urban Urban Rural Urban Rural Urban Rural 
Age            
65 - 69 17.0 (3.9) 15.07 (3.65) 16.9 (3.8) 14.0 (3.8) 16.3 (4.0) 15.0 (3.6) 13.7 (3.6) 18.7 (4.2) 15.5 (4.3) 13.5 (4.8) 8.9 (3.9) 
70 - 74 16.0 (4.1) 14.37 (3.78) 15.7 (3.5) 13.2 (3.7) 15.0 (3.9) 13.5 (4.0) 12.4 (3.9) 18.0 (4.0) 14.6 (3.6) 12.3 (4.5) 7.9 (3.7) 
75 - 79 15.1 (3.8) 13.43 (3.52) 14.4 (3.9) 11.9 (3.9) 14.3 (4.3) 12.1 (3.7) 11.3 (4.0) 17.5 (4.4) 13.0 (4.2) 11.6 (4.6) 8.0 (3.9) 




(-1.1 to -0.8) 
-0.9 
(-1.1 to -0.8) 
-1.4 
(-1.6 to -1.2) 
-0.8 
(-1.1 to -0.5) 
-1.1 
(-1.2 to -0.9) 
-1.1 
(-1.4 to -0.9) 
-0.9 














(-0.8 to -0.6) 
-0.9 
(-1.0 to -0.7) 
-1.2 
(-1.4 to -1.0) 
-0.7 
(-0.9 to -0.4) 
-0.9 
(-1.1 to -0.7) 
-0.9 
(-1.1 to -0.6) 
-0.7 










(-1.0 to -0.5) 
 Sex            
Females 15.6 (4.2) 14.1 (3.8) 15.4 (4.0) 13.4 (4.1) 15.4 (4.2) 13.7 (3.9) 12.9 (3.9) 17.5 (4.1) 14.1 (3.8) 12.2 (4.5) 7.5 (4.1) 
Males 15.5 (4.0) 13.5 (3.9) 14.5 (4.0) 12.3 (3.72) 14.9 (4.1) 12.5 (4.3) 11.5 (3.9) 18.3 (4.5) 14.8 (4.5) 13.0 (4.9) 8.5 (3.7) 
Crude β  
(95% C.I.) 
-0.1 
(-0.4 to 0.2) 
-0.6 
(-1.0 to -0.2) 
-1.0 
(-1.4 to -0.5) 
-1.1 
(-1.8 to -0.5) 
-0.5 
(-0.9 to -0.1) 
-1.2 
(-1.7 to -0.6) 
-1.3 
(-1.8 to -0.8) 
0.8 
(0.3 to 1.3) 
0.8 
(0.2 to 1.3) 
0.8 
(0.1 to 1.4) 
1.0 




(-0.7 to -0.1) 
-0.8 
(-1.2 to -0.5) 
-1.0 
(-1.4 to -0.5) 
-1.4 
(-2.0 to -0.7) 
-0.8 
(-1.2 to -0.4) 
-1.1 
(-1.6 to -0.6) 
-1.2 
(-1.7 to -0.7) 
0.1 
(-0.4 to 0.7) 
0.1 
(-0.5 to 0.7) 
-0.3 
(-0.9 to 0.3) 
-0.1 
(-0.7 to 0.5) 
Education            
No Ed. 13.4 (4.9) 13.0 (3.8) 12.3 (4.7) 10.6 (3.49) 12.1 (4.0) 11.7 (3.8) 11.3 (3.6) 16.3 (4.0) 13.8 (3.9) 11.0 (4.3) 7.2 (3.8) 
Some Ed. 13.9 (4.0) 13.5 (3.7) 13.1 (3.7) 12.8 (3.91) 14.5 (4.3) 12.2 (3.8) 12.5 (3.9) 16.1 (3.7) 14.1 (4.1) 12.2 (4.1) 8.8 (3.5) 
Primary 15.2 (3.9) 14.7 (3.6) 14.3 (3.9) 13.4 (3.76) 15.6 (3.9) 13.9 (3.7) 13.1 (3.7) 17.7 (4.2) 15.4 (4.3) 14.0 (4.3) 10.1 (4.1) 
Secondary 16.2 (3.9) 15.7 (4.1) 15.4 (3.9) 13.5 (4.65) 15.9 (4.0) 15.1 (3.6) 14.9 (3.7) 18.9 (4.1) 17.0 (4.7) 16.0 (5.2) 10.8 (3.9) 




(1.0 to 1.3) 
0.6 
(0.5 to 0.8) 
1.0 
(0.8 to 1.2) 
0.8 
(0.5 to 1.0) 
0.8 
(0.6 to 0.9) 
1.0 
(0.8 to 1.1) 
0.7 
(0.5 to 0.9) 
0.7 
(0.5 to 0.9) 
0.6 
(0.4 to 0.7) 
1.0 
0.8 to 1.2) 
0.9 
(0.7 to 1.1) 
Adj. β 3 
(95% C.I.) 
1.0 
(0.8 to 1.1) 
0.6 
(0.4 to 0.7) 
0.8 
(0.6 to 1.0) 
0.8 
(0.5 to 1.0) 
0.9 
(0.7 to 1.1) 
0.9 
(0.7 to 1.1) 
0.7 
(0.5 to 0.9) 
0.7 
(0.5 to 0.8) 
0.4 
(0.2 to 0.6) 
1.0 
(0.8 to 1.2) 
0.9 
(0.7 to 1.1) 
DR = Dominican Republic 
1. Adjusted for sex and education 
2. Adjusted for age and education 





Table 5 Mean (SD) scores for CERAD word list recall test by demographic status and site  
 Country 
 Cuba DR Peru Venezuela Mexico China India 
 Urban Urban Urban Rural Urban Urban Rural Urban Rural Urban Rural 
Age            
65 - 69 5.7 (1.9) 4.8 (1.9) 5.7 (1.8) 4.8 (1.9) 5.6 (2.0) 5.1 (1.7) 4.8 (1.8) 7.0 (1.6) 4.2 (1.75) 4.63 (1.96) 3.2 (1.8) 
70 - 74 5.3 (1.8) 4.4 (1.8) 5.2 (1.8) 4.5 (1.9) 5.2 (2.0) 4.6 (1.8) 4.1 (1.9) 6.8 (1.7) 3.9 (1.67) 4.19 (1.97) 2.9 (1.7) 
75 - 79 4.9 (1.9) 4.1 (1.8) 4.6 (1.8) 3.6 (1.8) 4.8 (2.1) 4.0 (1.8) 3.6 (2.0) 6.5 (1.9) 3.3 (1.72) 3.87 (2.17) 2.8 (1.7) 




(-0.5 to -0.4) 
-0.4 
(-0.5 to -0.4) 
-0.6 
(-0.7 to -0.5) 
-0.5 
(-0.6 to -0.3) 
-0.5 
(-0.6 to -0.4) 
-0.5 
(-0.6 to -0.4) 
-0.4 
(-0.5 to -0.3) 
-0.3 
(-0.4 to -0.2) 
-0.4 
(-0.5 to -0.3) 
-0.4 
(-0.6 to -0.3) 
-0.3 




(-0.4 to -0.3) 
-0.4 
(-0.5 to -0.3) 
-0.6 
(-0.6 to -0.5) 
-0.4 
(-0.5 to -0.3) 
-0.4 
(-0.5 to -0.3) 
-0.4 
(-0.5 to -0.3) 
-0.3 
(-0.5 to -0.2) 
-0.3 
(-0.4 to -0.2) 
-0.3 
(-0.4 to -0.2) 
-0.4 
(-0.6 to -0.3) 
-0.3 
(-0.4 to -0.2) 
 Sex            
Females 5.1 (1.9) 4.4 (1.9) 5.1 (2.0) 4.4 (2.1) 5.3 (2.0) 4.6 (1.9) 4.3 (2.0) 6.6 (1.8) 3.7 (1.7) 4.2 (1.94) 2.7 (1.7) 
Males 5.0 (1.9) 4.0 (1.8) 4.6 (1.9) 3.9 (1.9) 4.9 (2.0) 4.1 (1.9) 3.8 (1.9) 6.8 (1.9) 4.0 (1.8) 4.3 (2.2) 3.1 (1.8) 
Crude β  
(95% C.I.) 
-0.1 
(-0.3 to 0.0) 
-0.3 
(-0.5 to -0.2) 
-0.5 
(-0.7 to -0.2) 
-0.5 
(-0.8 to -0.2) 
-0.3 
(-0.5 to -0.1) 
-0.5 
(-0.8 to -0.3) 
-0.5 
(-0.8 to -0.3) 
0.3 
(0.1 to 0.5) 
0.2 
(0.0 to 0.5) 
0.2 
(-0.1 to 0.4) 
0.4 




(-0.4 to -0.1) 
-0.4 
(-0.6 to -0.3) 
-0.4 
(-0.7 to -0.2) 
-0.6 
(-0.9 to -0.3) 
-0.4 
(-0.6 to -0.2) 
-0.5 
(-0.7 to -0.21) 
-0.5 
(-0.7 to -0.2) 
0.0 
(-0.2 to 0.3) 
0.0 
(-0.3 to 0.2) 
-0.2 
(-0.5 to 0.04) 
0.0 
(-0.3 to 0.2) 
Education            
No Ed. 4.2 (2.1) 4.0 (2.0) 4.0 (2.0) 3.1 (1.8) 4.1 (1.7) 3.9 (1.9) 3.7 (2.1) 6.2 (1.9) 3.6 (1.7) 3.7 (2.0) 2.6 (1.6) 
Some Ed. 4.4 (1.9) 4.1 (1.8) 4.3 (1.9) 4.1 (2.2) 4.9 (2.1) 4.0 (1.8) 4.2 (1.9) 5.7 (1.8) 4.0 (1.7) 3.9 (1.8) 3.2 (1.8) 
Primary 5.0 (1.8) 4.5 (1.7) 4.5 (1.9) 4.4 (1.8) 5.3 (2.0) 4.7 (1.8) 4.5 (1.8) 6.8 (1.7) 4.2 (1.8) 4.8 (2.0) 3.7 (1.8) 
Secondary 5.3 (1.8) 4.9 (1.9) 5.1 (1.8) 4.8 (1.7) 5.3 (1.9) 5.3 (1.9) 5.1 (2.2) 7.1 (1.7) 4.6 (1.9) 5.5(2.1) 4.1 (1.7) 




(0.4 to 0.5) 
0.2 
(0.1 to 0.3) 
0.4 
(0.3 to 0.5) 
0.4 
(0.2 to 0.5) 
0.3 
(0.2 to 0.4) 
0.3 
(0.3 to 0.4) 
0.3 
(0.2 to 0.4) 
0.3 
(0.2 to 0.3) 
0.2 
(0.1 to 0.3) 
0.3 
(0.3 to  4.0) 
0.3 
(0.2 to 0.4) 
Adj. β 3 
(95% C.I.) 
0.4 
(0.3 to 0.5) 
0.2 
(0.1 to 0.3) 
0.3 
(0.2 to 0.4) 
0.4 
(0.2 to 0.5) 
0.3 
(0.2 to 0.4) 
0.3 
(0.2 to 0.4) 
0.3 
(0.2 to 0.4) 
0.2 
(0.2 to 0.3) 
0.2 
(0.1 to 0.2) 
0.4 
(0.3 to 0.4) 
0.3 
(0.2 to 0.4) 
DR = Dominican Republic 
1. Adjusted for sex and education 
2. Adjusted for age and education 
3. Adjusted for age and sex 
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Table 6, summarises the independent effects of age, sex, education and site on cognitive 
test performance. Site accounted for the highest proportion of variance for all four scores 
followed by education and then age, apart from WLR where the effect of age was stronger 
than education. The contribution of sex to the models was uniformly low. Most of the effect 
of site could be more parsimoniously accounted for by region (Latin America versus China 
versus India), and, to a lesser extent, rural versus urban location, with marginally poorer 
performance on WLM and WLR in rural compared with urban settings. Controlling for age, 
education, sex and rural/ urban location, performance on all cognitive tests was best among 
Chinese participants, intermediate among Latin American participants, and worst among 
Indian participants. Chinese participants scored one point more and  
Indian participants one and a half point less on the COGSCORE than did participants in 
Latin American sites. Indian participants generated nearly six fewer animals on verbal 
fluency than did participants in China and Latin America. Compared with Latin American 
participants Chinese participants remembered nearly three more words out of 30 on WLM 
and one more word out of 10 on delayed WLR; Indian participants recalled two and a half 
words fewer on WLM and half a word fewer on WLR.  
 
 145
Table 6 The independent effects of age, education, sex and site on the four 
cognitive assessments, further decomposing the effect of site into region and 
rural/ urban location 
 The independent, mutually adjusted 
effects (eta2 %) of age, education, 
sex and site on cognitive test 
performance 
Unpacking ‘site’ – the 
independent effects 
(eta2 %)  of region and 
rural/ urban location
The effect of region, adjusting for age, education, sex 
and rural/ urban location 
Cognitive test Age Education Sex Site Region 
Rural/ 
Urban 
Parameter Latin America China India 
CSI’D’ 
COGSCORE















(-1.7 to -1.4) 
Verbal 
Fluency 















(-6.1 to -5.5) 
Word list 
memory 















(-2.8 to -2.3) 
Word list 
recall 















(-0.6 to -0.4) 
 
DISCUSSION 
We have provided normative data by age group, sex and educational level for widely used 
neuropsychological tests of global cognitive function, verbal fluency and immediate and 
delayed recall for seven LAMICs.  Those with all degrees of dementia, including 
questionable dementia were excluded. These norms have been rigorously generated 
applying a standardized testing procedure amongst representative community dwelling 
samples. To our knowledge this is the largest study to date on neuropsychological tests 




With the exception of rural India, our norms for CERAD WLM and WLR are well aligned 
with those previously reported from affluent western countries (Welsh et al., 1994; Stewart  
et al., 2001; Collie et al., 1999). Our norms for CERAD VF are comparable to previously 
determined norms from both Europe and North America countries (Tombaugh et al., 1999; 
Tallberg et al., 2008; Stewart et al., 2001; Collie et al., 1999) and from Latin America (del 
Ser Quijano et al., 2004; Brucki et al., 1997; Acevado et al., 2000). We found that older age 
and lower educational level corresponded to poorer performances in all four tests and 
across all sites. The influences of age and educational level on test performances were large, 
and consistent in size and direction with other norm studies from western countries. Sex 
had a much weaker influence, and can probably be safely ignored when constructing 
reference norms.  Likewise, while the site by age, education and sex interactions were 
statistically significant for all cognitive tests, these were very modest effects, and the beta 
coefficients (Tables 2 to 5) are remarkable mainly for their consistency across sites.  
 
There was a considerable residual effect of site upon cognitive test performance, not 
accounted for by compositional differences between samples in the distribution of age and 
education. Further analyses clarified that the between site difference was most 
parsimoniously accounted for by the effect of region, with smaller effects of rural versus 
urban location evident for the two memory tests. We should still be cautious about 
attributing the effect of region to that of language and culture. Firstly, other compositional 
differences, not directly linked to culture, but relevant to cognitive performance and 
differently distributed across sites, may not have not been taken into consideration in our 
analyses. One such effect may be the quality and nature of education received that may not 
be adequately summarised in terms of level of education (Manly et al., 1999). Second, 
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while we have included a fairly wide variety of Latin American and Hispanic Caribbean 
countries and shown fairly consistent norms between them, the norms derived from the 
Tamil speaking Indians in Tamil Nadu, and the Mandarin-speaking Chinese in and around 
Beijing clearly cannot be generalised to the vast and diverse populations of India and China 
as a whole.  
 
By design, the two cognitive tests included in the 10/66 Dementia diagnosis, the CSI’D’ 
COGSCORE and the CERAD WLR, were those that showed the smallest cultural 
influences and the most robust cross-cultural discriminating properties (Prince et al., 2003). 
This finding has now been replicated in part in the population-based phase of our study, and 
is reassuring with respect to the cross-cultural validity of that diagnosis. However, in the 
light of the findings with respect to other tests, it may be necessary in the future to use 
region-specific norms in the identification of impairment of memory and verbal fluency for 
the identification of those meeting cognitive impairment criteria (1.5 standard deviations 
below the age- and education-specific norms for those with no dementia) for DSM-IV 
dementia (Prince et al., 2008), and amnestic and non-amnestic mild cognitive impairment. 
The general effect of such a change would be to lower still further the already negligible 
prevalence of DSM-IV dementia in Indian sites, and to increase slightly the prevalence of 
DSM-IV dementia in Chinese sites.    
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XII. – PREVALENCE, DISTRIBUTION AND POTENTIAL IMPACT OF 
AMNESTIC MILD COGNITIVE IMPAIRMENT  
 











The majority of older people, and the majority of people with dementia, live in low and 
middle-income countries (LAMICs). Mild cognitive impairment (MCI) is known to be an 
important early sign of dementia crucial for targeting and evaluating preventative 
interventions. However, very little is known about the community prevalence of MCI in 
LAMIC settings. 
 
In this study, using data from the cross-sectional phase of the 10/66 Dementia Research 
Group (DRG) programme on dementia, non-communicable diseases and ageing in 
LAMICs (Prince et al., 2007), we estimated the prevalence of Mayo Clinic defined a-MCI 
(Petersen et al., 1999), in eleven urban and rural sites in seven countries, and analysed 




The analysed sample was as described in Chapter X with the exception that data collection 
had been completed with an additional site (Puerto Rico), which recently finished its 
crossectional survey, site that only will be included for this analysis.  
 
XII.2.2 Measures 
The following measurements were included in this analysis:  
1. The participant interview section of the Community Screening Instrument for Dementia 
(CSI ‘D’). A memory subscale was derived from the CSI ‘D’ using the items addressing 
immediate and delayed recall of a three word list, recall of the name of the interviewer, 
and recall of five elements of a short story (logical memory).  
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2. The Modified CERAD 10-word-list-learning-task generating an immediate word list 
memory score with a maximum total of 30 and a word list delayed recall score with a 
maximum total score of 10.  
3. Disability (WHO-DAS)  
4. Informant-reported neuropsychiatric symptoms (NPI-Q) were measured and the 
following binary symptom categories were selected for further analyses: depression, 
anxiety, apathy, and irritability.  
5. Demographic covariates (as defined in Chapter X) were age, gender, education (5 
groups), number of assets and illiteracy.  
6. Additional health-related covariates: depression (GMS), number of self-reported limiting 
physical impairments, self-reported hypertension, self-reported stroke, psychotic 
disorder (GMS), self-reported regular pain.  
 
 Case definition of amnestic MCI (aMCI) 
 
Mayo Clinic defined a-MCI was diagnosed based on the following criteria: (1) objective 
memory impairment beyond that expected for age; (2) subjective memory complaint, 
preferably confirmed by an informant; (3) no, or only mild impairment in core activities of 
daily living, and (4) no dementia. Each criterion was operationalized as follows:  
 
 Objective memory impairment 
A composite memory score was created using results from the memory subscale of the CSI 
‘D’, immediate and delayed word recall scores from the modified CERAD 10 word list. For 
all tasks impaired performance was defined as a score 1.5 standard deviations or more 
below the mean adjusted for age and education.  Norms were derived from controls without 
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dementia from the 24-centre 10/66 pilot study (Prince et al., 2007). Participants were 
excluded if hearing impairment had prevented cognitive assessment.   
 
 Subjective memory impairment 
An ordinal scale ranging from 0 to 8 was created by summing item scores from relevant 
questions in the GMS including: 1) Have you had any difficulty with your memory? 2) 
Have you tended to forget names of your family or close friends/ where you have put things? 
3) Do you have to make more efforts to remember things than you used to? Using this scale, 
subjective memory impairment was defined as present when an individual scored three or 
more, as defined in previous research.(Ganguli et al., 1996, Kim et al., 2003) 
 
Normal activities of daily living (ADL)/Instrumental Activities of Daily Living (IADL) 
Based on responses from the CSI ‘D’ informant interview, normal ADL/IADLs were 
defined as very mild or no impairment in either carrying out household chores, pursuing 
hobbies, using money, feeding, dressing or toileting. The definition of impairment did not 
include problems arising only from physical impairments.  
 
No dementia  
Diagnoses of dementia were applied using the 10/66-dementia algorithm and DSM-IV 
criteria (Prince et al., 2008). Participants meeting either criterion were excluded from the 
analysed sample. 
 
XII.2.3 Statistical analysis. 
Analyses were carried out on the 10/66 data archive release 3.1. All analyses used STATA 
version 10.1 (STATA, 2007). As mentioned above, participants with dementia were 
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excluded from all analyses as has been standard practice in a-MCI epidemiological research. 
Sample characteristics across countries were described including age, gender, education, 
number of household assets, global disability scores (WHODAS-12), and NPI-Q symptoms.  
 
In order to determine the potential impact of a-MCI we assumed that, while both ADLs and 
IADLs would be expected to be intact in people with a-MCI, subtle functional impairment 
may already be present as well as possibly non-specific and mild BPSD (STATA, 2007). 
Zero-inflated negative binomial regression (ZINB) count models were used to assess the 
association between a-MCI and WHODAS-12 disability and NPI-Q scores using identical 
models to those previously reported for these samples (Fratiglioni and Rocca, 2001). This 
approach deals with skewness of the dependent variable characterized by excessive zeros 
(inflation) and distinguishes a group whose members have always zero counts (referred to 
as “certain zero”), from one in which members have either zero or positive counts. ZINB  
generates a logistic model for the former group and a negative binomial for the latter, and 
then combines the two. Log scale coefficients and 95% confidence intervals were back-
transformed. We determined the appropriateness of the ZINB model against a standard 
negative binomial model using the Vuong test post-estimation and adjusted for the relevant 
covariates listed above, followed by Poisson regression models to generate prevalence 
ratios for NPI-Q symptoms as binary dependent variables. 
 
Prevalence of a-MCI was reported for each country by age and gender and adjusted for 
household clustering. Direct standardization, using the whole sample as the reference 
population, was used to compare prevalence estimates across countries after adjustment for 
age, gender and education. For each country, associations with age (continuous variable), 
gender, education (ordinal variable) and number of household assets (ordinal variable) for 
 153
a-MCI prevalence were calculated using mutually adjusted (as appropriate) prevalence 
ratios (PRs), with robust 95% confidence intervals, using Poisson working models.  
 
To determine the pooled effects for all analyses, the statistical outputs for each country 
were combined into fixed effect meta-analyses. Random effect models were not used as we 
wished to summarise the countries within this study rather than generalise to a hypothetical 
population of centres. We then calculated Cochrane Q heterogeneity and Higgins’ I2 (95% 
CIs). The latter statistics set the degree of heterogeneity between studies that is not 
explained by chance, and is expressed as a percentage with values up to 25%, 50% and over 
75% representing mild, moderate and high heterogeneity, respectively.(Sousa et al., 2009) 
 
XII.3. Results 
 Sample characteristics 
The results were derived from a total of 15,376 participants aged 65+ and without dementia 
across the different countries. Response rates were higher than 80% in all countries. 
Missing data on the variables of interest were present in less than 1% of the sample. 
Descriptive data by country are displayed in Table XII.1. Age was not evenly distributed 
across groups (65-69; 70-74; 75-79 and 80+ years) across countries, the samples from 
Venezuela, China and India being slightly younger. In all countries more women 
participated than men. Educational level was highest in Cuba, and the number of household 
assets was lowest in Mexico and India.  
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Rep. Peru Venezuela Mexico China India 
Puerto 
Rico 
Sample size (n) 2,620 1,767 1,767 1,820 1,821 2,014 1,802 1,765 
Response rate (%) 94 95 82 80 85 83 83 93 
Age, n (%)         
65-69 years 738(28.2) 511(28.9) 538(30.5) 813(44.7) 537(29.5) 683(33.9) 703(39.0) 398(22.6) 
70-74 years 739(28.2) 483(27.3) 475(26.9) 450(24.7) 552(30.3) 634(31.5) 604(33.5) 439(24.9) 
75-79 years 582(22.2) 345(19.5) 368(20.8) 320(17.6) 384(21.1) 417(20.7) 290(16.1) 436(24.7) 
80+ years 555(21.2) 428(24.2) 386(21.8) 236(13.0) 348(19.1) 280(13.9) 201(11.2) 492(27.9) 
Gender (% of females) 1,686(64.4) 1,154(65.3) 1,073(60.7) 1,146(63.0) 1,143(62.8) 1,128(56.0) 974(54.0) 1,183(67.0) 
Educational level, n (%)        
No education 54(2.1) 314(17.8) 103(5.8) 133(7.3) 459(25.2) 743(36.9) 935(51.9) 47(2.7) 
Some education 548(20.9) 916(51.8) 212(12.0) 408(22.4) 802(44.0) 246(12.2) 411(22.8) 313(17.7) 
Complete primary 864(33.0) 338(19.1) 654(37.0) 913(50.2) 337(18.5) 532(26.4) 301(16.7) 356(20.2) 
Complete secondary 681(26.0) 126(7.1) 486(27.5) 262(14.4) 117(6.4) 358(17.8) 110(6.1) 661(37.5) 
Complete tertiary 468(17.9) 66(3.7) 301(17.0) 92(5.1) 104(5.7) 135(6.7) 43(2.4) 383(21.7) 
Three assets or fewer, n (%) 67(2.6) 256(14.5) 83(4.7) 33(1.8) 373(20.5) 104(5.2) 918(51.0) 4(0.2) 
Neuropsychiatric symptoms, n (%)       
Depression 117(4.5) 220(12.5) 86(4.9) 84(4.6) 73(4.0) 3(0.2) 139(7.7) 36(2.0) 
Anxiety 158(6.0) 233(13.2) 199(11.3) 263(14.5) 121(6.6) 7(0.4) 77(4.3) 101(5.7) 
Apathy 117(4.5) 226(12.8) 93(5.3) 138(7.7) 165(9.1) 15(0.7) 18(1.0) 58(3.5) 
Irritability  583(22.5) 412(23.3) 381(21.6) 383(21.3) 434(23.9) 26(1.3) 227(12.6) 254(15.2) 
WHO-DAS 12, mean (sd) 9.69(14.2) 13.91(17.3) 9.36(14.3) 9.18(13.8) 8.59(15.3) 5.30(12.0) 17.44(17.2) 12.13(16.6) 
WHO-DAS 12, mean (sd) omitting 
zeros 
16.55(15.2) 21.11(17.3) 15.91(15.7) 16.18(14.8) 18.03(17.9) 18.39(16.1) 22.19(16.4) 21.33(17.0) 
WHO-DAS 12: disability assessment schedule, 12-items; NPI-Q severity: total severity in neuro-psychiatric inventory. SD= Standard Deviation.
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 Associations between a-MCI and impact measures 
In each country there was a statistically significant zero-inflation in the distributions of 
WHODAS 12 scores (Vuong test for the whole sample, z=45.29 p<0.001) that confirmed 
the better fit of ZINB over negative binomial alone. Associations between a-MCI, disability 
and neuropsychiatric symptoms are summarized in Table XII.2 along with meta-analytical 
fixed-effect method pooled estimates, and between-country heterogeneity.  
 
After adjustment, disability was significantly higher in a-MCI cases compared to the 
remainder in Peru, India and Dominican Republic, although was lower in China. The 
pooled fixed-effect model meta-analytical estimate indicated a positive association with 
disability although there was moderate to high heterogeneity in these associations between 
countries.  
 
After adjustment, a-MCI cases were more likely to have informant-rated anxiety, irritability 
and apathy symptoms, with no significant between-country heterogeneity. However, there 
was no overall association with informant-rated depression in pooled estimates although the 
individual prevalence ratio was significant in Peru.  
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Table XII.2 Associations between aMCI and disability (WHO-DAS 12) and aMCI and neuropsychiatric symptoms (NPI-Q) 
(depression, anxiety, apathy, irritability) 
 
 ZINB* (95% CI) Adjusted1 PRs (95% CI) 
Individual study site estimates WHO-DAS 121 Depression2 Anxiety Apathy Irritability2 
Cuba 0.93(0.74-1.19) 0.96(0.23-3.93) 1.74(0.77-3.94) 1.66(0.59-4.67) 0.84(0.44-1.57) 
Dominican Republic 1.49(1.08-2.06) 1.04(0.47-2.30) 1.75(1.00-3.05) 1.54(0.76-3.12) 0.98(0.52-1.82) 
Peru 1.51(1.17-1.94) 2.14(1.01-4.54) 1.54(0.89-2.65) 1.38(0.57-3.33) 1.28(0.83-1.96) 
Venezuela 0.92(0.53-1.60) 2.14(0.47-9.74) 2.49(1.40-4.42) 3.59(1.94-6.65) 1.74(1.06-2.86) 
Mexico 1.12(0.78-1.62) 1.07(0.35-3.29) 1.59(0.76-3.31) 0.79(0.35-1.82) 1.11(0.73-1.69) 
China3 0.67(0.45-0.99) NC NC 10.2(1.40-74.5) 9.90(2.57-38.0) 
India 1.20(1.03-1.40) 0.69(0.31-1.53) 0.81(0.25-2.57) 1.18(0.13-10.8) 1.27(0.82-1.98) 
Puerto Rico 1.05(0.87-1.27) 2.60(0.90-7.54) 1.85(0.98-3.49) 1.68(0.65-4.34) 1.04(0.61-1.76) 
Pooled meta-analysis (fixed effect method)
 4 
Combined estimate 1.13(1.04-1.23) 1.31(0.91-1.89) 1.75(1.37-2.25) 1.83 (1.33-2.51) 1.24(1.03-1.49) 
Test for heterogeneity p-value 0.008 0.344 0.753 0.091 0.058 
I2 Higgins  (95% CI) 63%(20-83) 11%(0-74) 0%(0-71) 43%(0-75) 49%(0-77) 
*Exponentiated coefficients from zero inflated negative binomial (ZINB) models representing increase in disability of aMCI participants compared to normal. Zero 
inflation fitted using age, gender, educational level, number of household assets, depression, arthritis, visual problems, hearing problems, cough and breathing problems, 
heart problems, gastrointestinal problems, fainting, limb and skin  problems, hypertension and stroke. MCI= Mild Cognitive Impairment, WHO-DAS 12= World Health 
Organization - Disability Assessment Schedule, NPI-Q= Neuropsychiatric Inventory Questionnaire, CI= Confidence Interval, PRs= Prevalence Ratios 
  
1 Adjusted for age, gender, and educational level, number of household assets and of physical limiting impairments, psychosis and stroke. 
2 Depression and irritability were additionally adjusted for pain. 
3 China was not adjusted for psychosis  
4  The pooled fixed-effect model meta-analytical estimate for depression and anxiety were done without China  




 Prevalence and correlates of a-MCI and variation between countries 
The crude prevalence of a-MCI ranged from 0.8% in China to 4.3% in India. Country 
differences changed little (range: 0.6-4.6%) after standardization for age, gender and 
education level, as displayed in Table XII.3.  
 
Adjusted prevalence ratios (PRs) (95% CI) from Poisson regression models for independent 
associations with age, gender, education and assets are shown in Table XII.4. No pooled 
associations were found with age or education but there was a modest association with male 
gender and fewer assets. Overall little heterogeneity was found between nations in these 
associations.  
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Table XII. 3 Prevalence of amnestic mild cognitive impairment (a-MCI) by country, gender and age group 
 












Cuba (n)  738 739 582 555 1.8(1.3-2.3) 1.5(1.0-1.9) 
Males  1.5(0.0-3.0) 1.8(0.2-3.4) 0.0(0.0-0.0) 1.7(-0.2-3.6)   
Females   2.7(1.3-4.2) 2.6(1.1-4.0) 1.6(0.3-2.9) 0.8(-0.1-1.7)   
Dominican Rep. 
(n) 
511 483 345 428 1.4(0.9-2.0) 1.3(0.7-1.8) 
Males  1.7(-0.2-3.6) 2.2(0.0-4.4) 2.7(-0.4-5.7) 2.9(0.1-5.7)   
Females  0.9(-0.1-1.9) 1.7(0.2-3.1) 0.4(-0.4-1.3) 0.7(-0.3-1.7)   
Peru (n) 538 475 368 386 3.1(2.3-3.9) 2.6(1.9-3.3) 
Males  5.4(2.1-8.6) 2.7(0.3-5.1) 2.1(-0.3-4.5) 4.4(1.4-7.4)   
Females  2.3(0.7-3.8) 1.7(0.2-3.2) 3.6(1.1-6.0) 3.4(0.9-5.9)   
Venezuela (n) 813 450 320 236 1.2(0.7-1.7) 1.0(0.7-1.4) 
Males  1.3(0.0-2.6) 0.0(0.0-0.0) 2.6(-0.3-5.5) 0.0(0.0-0.0)   
Females  1.6(0.5-2.7) 1.4(0.0-2.9) 1.5(-0.2-3.1) 0.0(0.0-0.0)   
Mexico (n) 537 552 384 348 3.2(2.4-4.1) 2.8(2.0-3.6) 
Males  3.7(0.8-6.7) 4.3(1.5-7.0) 5.1(1.6-8.6) 4.0(0.8-7.2)   
Females  1.3(0.2-2.5) 4.1(2.0-6.2) 3.9(1.4-6.5) 1.0(-0.4-2.4)   
China (n) 683 634 417 280 0.8(0.4-1.2) 0.6(0.3-0.9) 
Males  1.0(-0.1-2.1) 0.4(-0.3-1.1) 1.7(-0.2-3.6) 0.0(0.0-0.0)   
Females  1.3(0.2-2.4) 0.6(-0.2-1.4) 0.8(-0.3-2.0) 0.7(-0.6-2.0)   
India (n) 703 604 290 201 4.3(3.3-5.2) 4.6(3.7-5.4) 
Males  7.0(4.1-9.9) 3.8(1.5-6.1) 4.8(1.3-8.3) 1.0(-1.0-2.9)   
Females  3.3(1.5-5.0) 4.4(2.2-6.6) 5.6(1.8-9.5) 1.1(-1.1-3.2)   
Puerto Rico (n) 398 439 436 492 3.9(3.0-4.8) 3.0(2.2-3.8) 
Males  3.9(0.1-7.8) 5.5(1.7-9.2) 4.1(0.8-7.3) 5.5(2.2-8.9)   
Females  4.4(2.1-6.8) 3.4(1.3-5.5) 3.5(1.3-5.6) 2.3(0.6-3.9)   
a-MCI= Amnestic Mild Cognitive Impairment, CI=Confidence Interval 
*Direct standardization for age gender and educational level using the whole sample as the standard population. 
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Table XII.4 Mutually adjusted prevalence ratios (PRs) (95% CI) for the independent effects of age, gender, education and assets on 




 PRs (95% CI) 






(more vs. less 
years) 
(more vs. less) 
Individual study site 
estimates 
        
Cuba  0.97(0.92-1.02) 0.63(0.33-1.21) 0.95(0.72-1.24) 1.52(1.00-2.30) 
Dominican Republic  1.03(0.97-1.09) 2.25(1.04-4.86) 1.27(0.83-1.96) 0.82(0.63-1.06) 
Peru  1.03(0.99-1.07) 1.29(0.75-2.22) 1.08(0.82-1.42) 0.81(0.64-1.03) 
Venezuela  0.95(0.88-1.02) 0.79(0.33-1.90) 0.91(0.55-1.52) 0.97(0.83-1.14) 
Mexico  1.01(0.97-1.04) 1.57(0.94-2.60) 1.24(0.95-1.61) 0.81(0.69-0.95) 
China  0.97(0.88-1.06) 1.00(0.40-2.51) 0.86(0.64-1.15) 0.80(0.50-1.27) 
India  0.97(0.94-1.01) 1.19(0.74-1.93) 1.14(0.89-1.47) 0.85(0.72-0.99) 
Puerto Rico 0.99(0.95-1.02) 1.46(0.91-2.33) 1.04(0.86-1.26) 0.94(0.70-1.27) 
Pooled meta-analysis  (fixed effect method) 









Test for heterogeneity 0.209 0.25 0.619 0.168 
Higgins (95% CI) 27% (0-67) 23% (0-64) 0% (0-68) 33% (0-70) 
1 Mutually adjusted for age, educational level, gender and number of assets as appropriate 
PRs= Prevalence Ratios, CI= Confidence Interval, a-MCI= Amnestic Mild Cognitive Impairment 
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XII.4 Discussion 
Using data from a large series of cross-sectional surveys applying standard sampling and 
measurements, we estimated the community prevalence of Mayo clinic defined a-MCI in 
six countries in Latin America, and in China and India. To our knowledge this is the first 
study to attempt to make direct comparisons of prevalence estimates of a-MCI across 
diverse cultures and world regions.  
 
Differences in prevalence between countries were marked and ranged from 0.8% (China) to 
4.3% (India) – i.e. greater than five-fold variation. After direct standardization for age, 
gender and education, using the whole population as the reference, these differences were 
not markedly attenuated. Inconsistencies in a-MCI prevalence observed between the 10/66 
study centres are likely to be due to components of the a-MCI diagnosis itself. In a cross-
cultural context, these support questions previously raised concerning its conceptual basis 
(Higgins and Thompson, 2002) and/or operationalization outside clinical settings (Ritchie 
and Touchon, 2000).  
 
Sample characteristics should be considered first, however, and one possible reason for 
heterogeneity is survival bias. The broader category of MCI has been reported to be 
associated with increased mortality in a prospective study (Hunderfund et al., 2006) and 
differences in aMCI-associated survival between country sites cannot be excluded as a 
factor influencing variation in prevalence.  
 
A second important issue concerns the ability to separate MCI constructs from dementia in 
epidemiological samples, particularly in a cross-cultural context. It should be noted that the 
10/66-dementia diagnosis showed much higher sensitivity than the DSM-IV criteria in both 
 161
pilot and clinical validation 10/66 studies (Prince et al., 2008, Prince et al., 2007). While 
the capability to detect early dementia cases represents an undoubted strength of the 10/66-
dementia criteria, it cannot be excluded that it may have been responsible of the unusually 
low a-MCI prevalence we have observed, by systematically lowering the hypothetical line 
between MCI syndromes and dementia. 
 
Compared to a-MCI prevalence reports from community based sites in Finland (5.3%) 
(Ganguli et al., 2004) Italy (7% and 7.7%), (Matthews et al., 2007, Manly et al., 2005) 
Japan (4.9%) (Di Carlo et al., 2007) and the USA (6%) (Palmer et al., 2003) both the crude 
and adjusted a-MCI prevalence reported here are relatively low. However, the estimates are 
similar to those reported by the British MRC CFAS study (2.5%) (Meguro et al., 2004) to 
the prevalence of cognitive impairment not dementia in the Canadian Study of Health and 
Ageing (Matthews et al., 2008) and to estimates for a-MCI prevalence in community 
samples from France (3.2%) (Graham et al., 1997), the USA (3.5%) (Busse et al., 2003b) 
and Germany (3%) (Ritchie et al., 2001). Low a-MCI prevalence in our Latin American 
sites contrast with the a-MCI prevalence (ranging between 3.8-6.3% depending on age) 
reported amongst American Caribbean Hispanics (Hanninen et al., 2002). As described 
above, differential mortality may explain these differences, but a potential role of the 
environment and lifestyle in the increased risk of a-MCI amongst Hispanic immigrants in 
North America cannot be excluded. Crude a-MCI prevalence in the Indian 10/66 sites 
(4.3%) is similar to the figure described by Das and colleagues in Northern India (Ritchie et 
al., 2001). Prevalence in China was the lowest (0.6%) but similar to that described in the 
VITA study in Vienna (Busse et al., 2003a). To our knowledge no Chinese studies on MCI 
or a-MCI prevalence have been published to compare with our results although screening 
instruments to detect MCI cases have been validated for use in the general Chinese 
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population.(Jungwirth et al., 2005, Lam et al., 2008) Overall, the results suggest that there 
is very little consistency in prevalence of a-MCI across world regions. This may possibly 
reflect diagnostic issues relating to a lack of specific criteria for the operationalization of 
MCI (i.e. cognitive batteries and specific cut-off scores for impairment) as well as 
unmeasured differences and cultural variations potentially relevant for some components of 
the a-MCI construct (i.e. subjective memory impairment, as described below).   
 
Female gender, increased age, lower education and lower socio-economic status are 
associated with dementia (Li et al., 2006) and have been described in association with MCI 
(Hanninen et al., 2002). In our study however, the effects of age and education on a-MCI 
prevalence were negligible across study sites, with no between-country heterogeneity in 
this respect. For education, this might reflect lower variance in the exposure or weaker 
underlying associations between education and other risk factor profiles in these samples. 
Lower socioeconomic status remained associated with a-MCI and this may be a better 
marker than education of relevant social disadvantage in this group. However, it is 
important also to bear in mind that education-adjusted norms were used to apply cognitive 
impairment criteria for the a-MCI diagnosis and the similarities between education groups 
may be artefact. The negative results for age may represent the same phenomenon, but 
could also possibly reflect a more rigorous exclusion of dementia in our samples with early 
cases responsible for age-MCI associations in other settings. The observed association with 
male gender contrasts with the higher reported age-adjusted prevalence of dementia in 
women compared to men (Fratiglioni et al., 2007), could again reflect the effect of 
dementia case exclusion or could suggest, as the Mayo Clinic Study of Aging reports that 
"women transition from normal cognition directly to dementia at a later age but more 
abruptly" (Petersen et al., 2010). 
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A key consideration with a-MCI applied as a construct in international research is its cross-
cultural validity. An advantage of the 10/66 study is that, identical measures were taken and 
identical algorithms applied for diagnosis across the study sites and the protocols for 
cognitive assessments in the 10/66 study were the result of a long and painstaking process 
of development and validation (Prince et al., 2007). Associations with disability and 
neuropsychiatric symptoms across sites can be viewed as further evidence for the validity 
of the construct since these are comparable with findings from other community samples 
(STATA, 2007, Okura et al., 2010). Heterogeneity in these associations between countries 
was also relatively low, providing further support for the cross-cultural applicability of the 
a-MCI construct as well as supporting evidence from other research for its potential impact, 
although cause and effect relationships cannot be inferred from the cross-sectional findings 
of this specific analysis.  
 
Strengths of the study include the very large sample size and the wide range of populations 
sampled in terms of culture, economy and population characteristics. Moreover, internal 
validity was maintained through rigorously pre-validated and standardised measurements 
applied consistently between countries in addition to common algorithms used to define a-
MCI. There are some limitations. The samples were drawn from specific geographic 
catchment areas and cannot be assumed to be representative of the source nation/site. The 
study was cross-sectional in design and the impact of survival cannot be evaluated.  
Furthermore, within the a-MCI category, participants who had developed this late in life 
could not be distinguished from those for whom it was a stable lifetime trait. Finally, a-
MCI diagnosis was determined without clinical judgment, which is difficult to obtain in 
large population-based studies and unfeasible in most of our study sites. Although a-MCI 
was originally derived as a diagnosis for secondary or tertiary care clinical settings, it is 
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being increasingly applied in epidemiological research and data from community samples 
is an important supplement, particularly if future community-level interventions are 
planned to prevent progression to dementia. Our analysis here is intended to extend this 
particular evidence base. Follow-up is currently underway in most 10/66 sites which will 














As discussed in Chapter V, subjective memory complaints (SMCs) in everyday life and 
those reported in clinical settings are frequent among older people, although their 
prevalence, correlates, diagnostic definition, predictive value and clinical meaning remains 
controversial (Mitchell, 2008). 
 
SMCs reveal an individual´s awareness of and belief about their own cognitive competence 
in everyday life (Grut et al., 1993); they assess everyday memory and cognitive problems 
that may not be captured by standardized neuropsychological tests, thus providing 
clinicians another perspective on understanding memory and cognitive function in old age 
(Chung and Man, 2009). They are also a central component of many MCI or equivalent 
construct criteria.   
 
The aim of the analyses described in this chapter was to investigate SMC prevalence and 
associations in the 10/66 samples, in order to understand better the particular relationship 
between subjective and objective impairment in low and middle-income countries 




The analysed samples were those described in Chapter X 
 
XIII.2.2 Measures  
The following measures were used in this analysis:  
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1. SMC was ascertained using responses to three questions assessing four relevant 
symptoms; these questions formed part of the Geriatric Mental State Examination (GMS) 
but do not contribute significantly to the AGECAT algorithm output. 
i. Have you had any difficulty with your memory? 
ii. Have you tended to forget things? 
a. Names of your family or close friends? 
b. Where you have put things? 
iii. Do you have to make more effort to remember things than you used to? 
Symptoms i, iia and iib were rated as 0 (normal), 1(abnormal but mild to moderate intensity 
or infrequent or fleeting), or 2 (abnormal and severe, frequent or persistent). Symptom iii 
was rated as simply absent (0) or present (1). Item scores were summed to form an ad hoc 
ordinal scale with a maximum possible score of 7. As in previous research using this 
particular scale, a participant was considered to have SMC on the basis of a score of three 
or above (Kim et al., 2003, Stewart et al., 2001b). 
 
2. For this analysis we considered the following socio-demographic measures as independent 
variables:  gender, participants’ age (divided into two groups: <75 and =>75 years old) and 
education level (5 groups as previously described). A dichotomous variable was created for 
number of household assets on the basis of three/less assets, or four/more assets. 
Participants were also defined as living alone or not.  
 
3. Cognitive function was measured using the following variables 
a) CSI-D COGSCORE  
b) Verbal fluency (animal naming) 
c) CERAD 10-word list learning task immediate recall 
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d) CERAD 10-word list learning task delayed recall  
 
4. Depression was determined according to the GMS AGECAT depression diagnosis. 
 
5. All those meeting criteria for either 10/66 dementia (Prince et al., 2003), or DSM-IV 
dementia (Prince et al., 2008) were classified as dementia cases.  
 
6. Any need for care was defined from screening items in the informant questionnaire. 
 
7. Disability was defined on the basis of an above 90th percentile score on the 12-item World 
Health Organization Disability Assessment Schedule version 2.0 (WHODAS 2.0).  
 
XIII.2.3 Statistical Analysis  
Analyses were carried out on the 10/66 data archive release 2.6, using STATA version 10.1. 
Global prevalence (combined samples) of SMC was described and then investigated in 
relation to age group, gender, educational level, assets, living alone, depression, dementia, 
need of care, disability, and cognitive functioning, using odds rations (ORs) with 95% 
confidence intervals and p-values from chi squared tests. The summary prevalence 
stratified by site was described for the whole sample and then separately by dementia status.  
Logistic regression models were used to describe further the association between SMC and 
the measures of cognitive function by site in participants without dementia, using three 
grouped models (unadjusted; adjusted for socio-demographic characteristics; and adjusted 
for socio-demographic and clinical characteristics). To determine the overall association 
between SMC and measured cognitive function, findings for the eleven study sites were 
combined by fixed effect meta-analyses and the degree of heterogeneity was estimated 
 169
using Cochrane Q and Higgins’ I2 (95% CI) (Higgins and Thompson, 2002) tests. The same 
procedures were carried out to investigate and compare associations between SMC and 
dementia.  
 
XIII.3. Results  
Analyses of SMC correlates in the pooled sample from all sites are summarized in Table 
XIII.1. SMCs were significantly associated with older age, females, fewer assets, living 
alone status, depression, dementia, need for care, and disability. Lower function on all four 
cognitive measures was also associated with SMC. No association, however, was found 
with education status.   
 
Table XIII.2 summarizes the prevalence of SMC by site and dementia status. The overall 
SMC prevalence was 33.5% and varied between the sites from 6.6% in rural China to 45.5% 
in rural Mexico, with prevalences in most of the remaining sites approximately one-third, 
with the exception of urban settings in Peru (45.4%) and urban China (25.3%).  
 
In participants without dementia to the overall prevalence was 31.2% with the lowest 
prevalence again found in rural China (3.9%) and the highest in Peru (44%), followed by 
rural Mexico (43.6%).  
 
In participants with dementia, the prevalence of SMC was more consistent, with between 
50-75% of these participants reporting SMC in most sites: highest in China and Venezuela 
and lowest in Dominican Republic.  
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Table XIII.1 Prevalence of subjective memory complaints (SMC) stratified by socio-
demographic and relevant clinical characteristics in the pooled 10/66 samples. 
 
Variable Categories Number %SMI OR(95%IC) 
Age group (years) 65-74 8,775 30.1 1 
75+ 5,986 37.3 1.33 (1.24-1.43) 
Gender Male 5,640 29.2 1 
Female 9,094 36.0 1.37 (1.47-1.28) 
Education None 3,106 33.1 1.16 (1.01-1.34) 
Some 3,871 37.4 1.4 (1.22-1.61) 
Completed primary 4,230 32.2 1.12 (0.97-1.28) 
Completed secondary 2,231 30.1 1.05 (0.91-1.23) 
Completed tertiary 1,263 29.9 1 
Assets More than 3 12,698 32.8 1 
3 or less 2,061 37.7 1.24 (1.12-1.37) 
Living alone No 13,634 33.2 1 
Yes 1,142 36.7 1.17 (1.03-1.32) 
Depression Absent 10,140 25.1 1 
Present 4,636 51.7 3.19 (2.97-3.44) 
Dementia Absent 13,589 31.2 1 
Present 1,187 59.7 3.28 (2.90-3.70) 
Need for care No 13,163 32.2 1 
Yes 1,240 47.3 1.89 (1.68-2.13) 
Disability (WHODAS) Below 90th percentile 13,421 31.8 1 
90th percentile or 
higher 
1,216 49.5 2.1 (1.87-2.36) 
Global cognitive 
functioning (CSI-D     cog 
score) 
Quartile 4 3,750 23.1 1 
Quartile 3 3,728 29.5 1.39 (1.25-1.55) 
Quartile 2 3,767 37.3 1.99 (1.79-2.20) 
Quartile 1 3,531 44.6 2.69 (2.43-2.98) 
Verbal fluency  (animal 
naming) 
Quartile 4 3,004 25.4 1 
Quartile 3 4,321 29.4 1.22 (1.1 -1.36) 
Quartile 2 3,544 37.3 1.75 (1.57-1.94) 
Quartile 1 3,907 40.8 2.03 (1.82-2.25) 
Immediate recall 
(CERAD word list) 
Quartile 4 3,265 24.1 1 
Quartile 3 3,254 27.2 1.18 (1.05-1.32) 
Quartile 2 4,547 34.8 1.68 (1.52-1.87) 
Quartile 1 3,705 45.6 2.65 (2.38-2.94) 
Delayed Recall  (CERAD 
word list) 
Quartile 4 2,562 24.3 1 
Quartile 3 4,694 30.3 1.36 (1.21-1.52) 
Quartile 2 2,608 33.2 1.55 (1.37-1.75) 
Quartile 1 4,912 41.4 2.19 (1.97-2.45) 
SMC= Subjective Memory complaints, OR= Odds Ratio, CI= Confidence Interval, WHO-DAS= World Health 
Organization - Disability Assessment Schedule, CSI-D= Community Screening Interview for Dementia, SMI= Subjective 
Memory Impairment, CERAD= Consortium to establish a registry for Alzheimer Disease  
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Cuba 283 55.5 2,617 30.9 2,900 33.3 
Dominican 
Rep 
226 45.1 1,769 29.4 1,995 31.2 
Peru Urban  90 64.4 1,249 44.0 1,339 45.4 
Peru Rural 34 67.6 514 31.3 548 33.6 
Venezuela 134 73.9 1,811 33.8 1,945 36.6 
Mexico Urban 91 63.7 909 33.6 1,000 36.3 
Mexico Rural 84 66.7 911 43.6 995 45.5 
China Urban  52 71.1 1,074 23.1 1,126 25.3 
China Rural  38 73.7 936 3.9 974 6.6 
India Urban  72 59.7 929 33.2 1,001 35.1 
India Rural  83 57.8 870 33.5 953 35.6 
Total 1,187 59.7% 13,589 31.2% 14,776 33.5% 
SMC= Subjective Memory complaints 
 
Findings of compared sites, unadjusted and adjusted associations between SMC and 
cognitive function of participants without dementia, are summarized in Tables XIII 3-6. For 
global cognitive function (CSI-D ‘cogscore’; Table XIII.3) associations in the unadjusted 
model were strongest for rural China (OR 3.67), weakest where still significant for the 
Dominican Republic (OR 1.18) and absent in the two Indian sites; in the partially adjusted 
model 2, most of the associations remained similar in strength apart from urban Peru. In the 
fully adjusted model 3, which included depression and need for care, associations in most 
sites again remained relatively stable, apart from Dominican Republic. Between-site 




Table XIII. 3 – Site-specific associations between lower global cognitive function 
and subjective memory complaints (SMC) in participants without dementia. 
 
 Site Odds ratio (95% CI) for SMC per descending quartile of  
CSI-D cog score 
 Model 1 Model 2 Model 3 
Cuba 1.32 (1.22-1.43) 1.35 (1.23-1.48) 1.32 (1.191.47) 
Dominican Republic  1.18 (1.07-1.30) 1.14 (1.02-1.28) 1.07 (0.95-1.21) 
Peru (urban) 1.20 (1.06-1.35) 1.12 (0.98-1.29) 1.04 (0.90-1.21) 
Peru (rural) 1.51 (1.22-1.85) 1.39 (1.11-1.75) 1.37 (1.08-1.73) 
Venezuela 1.36 (1.23-1.51) 1.30 (1.16-1.46) 1.20 (1.06-1.35) 
Mexico (urban) 1.47 (1.28-1.69) 1.51 (1.29-1.77) 1.48 (1.26-1.74) 
Mexico (rural) 1. 30(1.12-1.50) 1.29 (1.09-1.51) 1.25 (1.06-1.47) 
China (urban) 2.05 (1.73-2.42) 2.21 (1.84-2.66) 2.23 (1.82-2.71) 
China (rural) 3.67 (2.44-5.53) 4.17 (2.69-6.46) 3.48 (2.16-5.59) 
India (urban) 1.04 (0.91-1.18) 0.99 (0.85-1.16) 0.99 (0.83-1.17) 
India (rural) 0.88 (0.73-1.05) 0.68 (0.54-0.86) 0.90 (0.65-1.24) 
Pooled meta analysis     
Combined estimate 



























Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of care and 
disability. 
CI= Confidence Interval, CSI-D= Community Screening Interview for Dementia  
 
For verbal fluency (Table XIII.4), the strongest association was found in the rural China 
site (OR 2.16) with absent/weak associations in the Indian sites, as with the global 
cognitive outcome as well as in Venezuela and Dominican Republic. As previously 
observed, there was little change in most coefficients after adjustments and high, although 
slightly weaker, between-site heterogeneity. 
 173
Table XIII. 4 – Site-specific associations between  lower verbal fluency and 
subjective  memory complaint (SMC) in participants without dementia. 
 
 Site Odds ratio (95% CI) for SMC per descending quartile of 
verbal fluency score  (animal naming) 
  Model 1 Model 2 Model 3 
Cuba 1.37 (1.26-1.48) 1.35 (1.24-1.48) 1.31 (1.19-1.44) 
DR 1.08 (0.97-1.21) 1.04 (0.93-1.16) 1.01 (0.90 -1.13) 
Peru (urban) 1.22 (1.08-1.38) 1.17 (1.03-1.33) 1.16 (1.01-1.32) 
Peru (rural) 1.28 (1.04-1.58) 1.22 (0.97-1.53) 1.20 (0.96-1.52) 
Venezuela 1.05 (0.95-1.16) 1.00 (0.89-1.12) 0.98 (0.87-1.10) 
Mexico (urban) 1.50 (1.30-1.73) 1.48 (1.27-1.72) 1.45 (1.24-1.70) 
Mexico (rural) 1.21 (1.05-1.40) 1.18 (1.02-1.37) 1.17 (1.01-1.36) 
China (urban) 1.70 (1.45-2.00) 1.68 (1.43-1.99) 1.64 (1.38-1.94) 
China (rural) 2.16 (1.58-2.93) 2.20 (1.59-3.03) 2.18 (1.52-3.14) 
India (urban) 1.12 (0.88-1.41) 1.12 (0.87-1.43) 0.99 (0.77-1.29) 
India (rural) 1.13 (0.93-1.38) 1.09 (0.89-1.34) 1.10 (0.83-1.45) 
Pooled meta analysis    
Combined estimate 



























Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of 
care and disability. 
SMC= Subjective Memory complaints, CI= Confidence Interval, DR= Dominican Republic 
 
 
For immediate recall (Table XIII.5) and delayed recall (Table XIII. 6), the strongest 
associations continued to be found in the Chinese sites, similar to the findings for global 
function and verbal fluency, although were stronger in India than observed for the other 
tests, being most consistently weak in Venezuela and rural Mexico. High between-site 
heterogeneity was found.  
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Table XIII.5 – Site-specific associations between lower immediate word list 
recall and subjective memory complaint (SMC) in participants without 
dementia. 
 
 Site Odds ratio (95% CI) for SMC per descending quartile of 
CERAD immediate word list recall score  
  Model 1 Model 2 Model 3 
Cuba 1.40 (1.28-1.52) 1.43 (1.31-1.57) 1.35 (1.22-1.49) 
DR 1.35 (1.21-1.50) 1.36 (1.21-1.52) 1.27 (1.13-1.42) 
Peru (urban) 1.29 (1.16-1.45) 1.29 (1.14-1.47) 1.24 (1.09-1.42) 
Peru (rural) 1.16 (0.93-1.43) 1.05 (0.83-1.33) 1.05 (0.83-1.33) 
Venezuela 1.07 (0.97-1.18) 1.06 (0.95-1.18) 1.02 (0.91-1.14) 
Mexico (urban) 1.57 (1.35-1.83) 1.57 (1.33-1.86) 1.59 (1.34-1.88) 
Mexico (rural) 1.07 (0.93-1.23) 1.07 (0.93-1.25) 1.04 (0.89-1.20) 
China (urban) 2.25 (1.92-2.64) 2.38 (2.01-2.83) 2.32 (1.94-2.76) 
China (rural) 6.90 (3.40-14.0) 6.75 (3.25-14.0) 6.10 (2.79-13.3) 
India (urban) 1.27 (1.11-1.46) 1.31 (1.13-1.52) 1.18 (1.01-1.38) 
India (rural) 1.33 (1.02-1.74) 1.28 (0.98-1.67) 1.34 (0.95-1.90 ) 
Pooled meta analysis    
Combined estimate 



























Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of 
care and disability. 
SMC= Subjective Memory complaints, CI= Confidence Interval, CERAD= Consortium to establish a registry 




Table XIII. 6 Site-specific associations between lower delayed word list recall 
and subjective memory complaint (SMC) in participants without dementia. 
 
Site 
Odds ratio (95% CI) for SMC per descending quartile of 
CERAD delayed word list recall score 
 Model 1 Model 2 Model 3 
Cuba 1.25 (1.15-1.35) 1.27 (1.17-1.38) 1.21 (1.10-1.33) 
DR 1.33 (1.20-1.47) 1.33 (1.20-1.48) 1.29 (1.15-1.44) 
Peru(urban) 1.17 (1.05-1.30) 1.14 (1.01-1.28) 1.12 (0.99-1.26) 
Peru (rural) 1.25 (1.03-1.52) 1.19 (0.97-1.46) 1.18 (0.96-1.45) 
Venezuela 1.02 (0.92-1.13) 1.02 (0.92-1.13) 0.99 (0.89-1.10) 
Mexico (urban) 1.50 (1.31-1.71) 1.48 (1.28-1.71) 1.46 (1.26-1.69) 
Mexico (rural) 1.06 (0.93-1.20) 1.06 (0.92-1.22) 1.04 (0.91-1.19) 
China (urban) 2.09 (1.76-2.48) 2.11 (1.76-2.52) 2.07 (1.71-2.50) 
China (rural) 3.06 (1.59-5.89) 3.01 (1.52-5.96) 3.35 (1.55-7.24) 
India (urban) 1.13 (0.99-1.28) 1.13 (0.99-1.29) 1.08 (0.94-1.25) 
India (rural) 1.22 (1.01-1.47) 1.17 (0.97-1.42) 1.21 (0.95-1.55) 
Pooled meta analysis    
Combined estimate 



























Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of 
care and disability. 
SMC= Subjective Memory complaints, CI= Confidence Interval, CERAD= Consortium to establish a 




 In Table XIII.7, site-specific associations between SMC and dementia are summarised.  In 
contrast to findings for cognitive function in participants without dementia, the positive 
associations were strong and significant in all sites with lower levels of between-site 
heterogeneity and these largely driven by the very strong associations in the Chinese sites. 
Adjustments did not alter associations substantially or consistently.   
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Table XIII.7 – Unadjusted and adjusted OR (95% CI) for the independent effect of 
any dementia diagnosis on Subjective Memory Complaints prevalence. 
 
 Site Model 1 Model 2 Model 3 
Cuba  2.79 (2.17-3.59) 2.86 (2.19-3.73) 3.31 (2.36-4.63) 
Dominican Republic  1.98 (1.48-2.64) 1.88 (1.39-2.54) 1.74 (1.25-2.43) 
Peru (urban) 2.30 (1.47-3.61) 2.10 (1.31-3.36) 1.81 (1.06-3.07) 
Peru (rural) 4.58 (2.16-9.74) 3.99 (1.81-8.79) 3.79 (1.62-8.88) 
Venezuela 5.54 (3.71-8.28) 4.41 (2.83-6.86) 3.84 (2.28-6.45) 
Mexico (urban) 3.48 (2.24-5.41) 3.07 (1.90-4.97) 3.03 (1.78-5.18) 
Mexico (rural) 2.59 (1.62-4.15) 2.28 (1.38-3.76) 1.98 (1.15-3.41) 
China (urban) 8.22 (4.42-15.3) 7.24 (3.84-13.7) 6.19 (2.94-13.0) 
China (rural) 70.0 (31.8-154) 57.2 (24.6-133) 27.3 (9.78-76.3) 
India (urban) 2.99 (1.81-4.93) 2.98 (1.77-5.00) 3.76 (2.03-6.97) 
India (rural) 2.73 (1.70-4.37) 2.59 (1.60-4.20) 2.55 (1.37-4.77) 
Pooled meta analysis    
Combined estimate 



























Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of care and 
disability. 
OR= Odds Ratio, CI= Confidence Interval 
 
XIII.4 Discussion 
In what is likely to be the largest analysis of subjective and objective cognitive function, the 
following were key findings:  
 
Within the combined sample, associations with SMC were largely consistent with 
observations from other studies (to be discussed further below): in particular, strong 
associations with female gender, depression, and worse general health (e.g. disability). 
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 Within the combined sample, there were significant and reasonably strong associations 
between SMC and worse cognitive function. These associations were comparable in 
strength between the four tests. 
 
 SMC prevalence was particularly low in Chinese sites (6.6% rural, 25.3% urban) and 
ranged from 31-46% in the remaining samples. SMC prevalence in participants with 
dementia ranged from 45-74%.  
 
Associations between SMC and lower cognitive function in participants without dementia 
showed high levels of heterogeneity between sites. The strongest associations were found 
in the Chinese sites for all four tests with Indian sites tending to have the weakest 
associations. Overall strengths of association with SMC remained significant similar for the 
four tests in pooled analyses. Between-site heterogeneity was also similar between tests.   
 
 Associations between SMC and dementia were significant after adjustment in all sites. 
Between-site heterogeneity was high with strongest association in the Chinese sites. In 
contrast to findings for cognitive function, associations with dementia in India were similar 
in strength to those in the Latin American sites.    
 
Key strengths of these analyses were the large numbers of community residents recruited, 
the heterogeneity and diversity of countries surveyed the well-characterized samples, the 
systematic and standardized definition of SMC, and characterization of depression and 
dementia using standard criteria. The measure of SMC requires particular consideration. As 
discussed in Chapter V, definitions of this construct have varied considerably between 
studies and there is no agreed standard definition. We therefore adopted a pragmatic 
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approach, deriving it from questions in the GMS instrument and applying an identical cut-
off to that used in (to our knowledge) all other studies using the GMS for this purpose(Kim 
et al., 2011, Stewart et al., 2001a). An advantage is that the GMS is widely applied in 
international studies, allowing ease of replication in other cohorts. The SMC construct itself 
also has similarities to definitions applied in other settings – i.e. a complaint of poor 
memory and an indication that it is frequent and/or noticeable to the participant. However, 
severity was not directly assessed, nor was the precise nature of the complaint. Because 
SMC is by definition a symptomatic construct, there is no ‘gold standard’ against which to 
establish criterion validity (i.e. whether someone complaining of poor memory is truly 
experiencing this). Associations with objective cognitive function and dementia will be 
considered below. A further potential methodological weakness is that we analysed SMC as 
defined by the subject participating in the study without addressing the memory report from 
relatives or caregivers; however, these issues will be considered further in Ch XIV. 
 
Considering the overall prevalence, this was 33.5% for the combined sample and, with the 
exception of the prevalence in the rural site in China (6.5%), the range within the remaining 
sites was from 25.3% to 45.5%. This is very similar to the range reported in Jonker’s 
review of community based studies (25-50%) (Jonker et al., 2000). A key advantage over 
estimates derived from reviews was that the measure of SMC was identical in all sites and 
the sampling approaches were comparable, although as mentioned previously, individual 
sites cannot be assumed to be nationally representative. Participation rates were also 
relatively high for all sites. A key finding was therefore that there is an appreciable 
prevalence range even if SMC criteria and sampling are harmonised to what is likely to be 
the most feasible extent.   
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In addition to the comparable prevalence range, associations between SMC and contextual 
variables in the sample as a whole were also comparable to those observed in previous 
research from other populations. We confirmed, for example, in the combined samples, 
associations of SMC with age, gender and poverty reported by several authors. In our study 
an increase in the frequency of SMC was noted among older (aged 75 years and over) 
participants (OR 1.33, 95% CI 1.24-1.43), female participants (OR 1.37, 1.47-1.28) and 
participants with less than three household assets (OR 1.24, 1.12-1.37). As summarized in 
Chapter V, most studies have reported an increase in subjective memory problems in older 
subjects (Bassett and Folstein, 1993, Blazer, 1997, Gagnon et al., 1994, Jonker, 1996, 
Jonker et al., 2000) and among  females (Gagnon et al., 1994, Jonker, 1996, O'Connor et al., 
1990). Associations with educational attainment have been less consistent in the literature 
and in our unadjusted and un-stratified analyse we found no evidence for a clear trend. 
Depression has almost universally been found to be associated with SMC in previous 
research, as previously summarized, and a strong relationship was found in the pooled 
samples.  
  
The primary objective for the analyses discussed in this chapter was to clarify associations 
between SMC, cognitive function and dementia and to describe the consistency of these 
between sites. While some community samples of older people have revealed associations 
between memory complaints and memory impairment (Jonker et al., 2000), these findings 
are controversial  as others have not  found associations (Jonker et al., 2000, Mitchell, 2008, 
Stewart et al., 2001a, Trouton et al., 2006). Specifically within samples without dementia, a 
significant association was found between self-reported memory problems and poor 
memory performance in two studies (Bassett and Folstein, 1993, Blazer, 1997) independent 
of the level of depressive symptoms. In our study the participants with lowest cognitive 
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functioning had the highest prevalences of SMC, although with substantial and significant 
between-site heterogeneity as will be discussed further below.  
 
Interestingly associations between SMC and lower cognitive function when meta-analysed 
across the samples were very similar in strength whether the test was measuring global 
function, verbal fluency, immediate or delayed recall, with fully adjusted odds ratios 
weakest for delayed recall and verbal fluency (both combined estimates 1.19), followed by 
global function (1.25), with the strongest being for immediate word list recall (1.28). The 
weaker associations may reflect psychometric ‘distance’ from the specific complaint (i.e. 
for verbal fluency) and/or limitations in the measurement applied (i.e. delayed recall being 
measured only on a 10-point scale). A limitation imposed by the practical aspects of the 
10/66 programmes was that the cognitive assessments were inevitably limited in domains 
and depth, the primary purpose being to establish dementia prevalence rather than more 
subtle neuropsychological deficits. Established cross-cultural applicability is also limited 
for many assessments.  
 
Dementia has been found to be associated with memory complaints in several previous 
community surveys (Jonker et al., 2000, Trouton et al., 2006, Bolla et al., 1991, Jonker, 
1996), and we found strong and significant associations between SMC and dementia in all 
sites. In general, therefore, the ‘accuracy’ of SMC as a complaint was confirmed – i.e. 
overall, people with worse cognitive function were more likely to report it as a problem, at 
least in response to questions on memory. Given that the associations were cross-sectional, 
it is possible that the participants were responding particularly to the test environment (i.e. 
reporting SMC because they were aware they had performed relatively poorly). However, 
in the standard 10/66 schedules the questions on SMC are administered quite some time 
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after any cognitive assessments and reporting bias is unlikely. An important methodological 
point to note in this respect is that SMC items within the GMS schedule have negligible 
influence on the AGECAT algorithm output (M Dewey – personal communication) and so 
play no role in the 10/66 dementia diagnosis.    
 
A striking feature of the findings was their heterogeneity between sites. The Chinese sites 
exhibited the most consistent variations from the norm in this respect and require particular 
consideration. In particular, SMC prevalence was most rare in these samples, particularly 
the rural site, but its prevalence in people with dementia was highest – hence the strongest 
odds ratios between SMC and dementia. These findings were supported by consistent 
results for cognitive function in those without dementia where associations with SMC were 
also strongest in China. The results therefore indicate a higher level of ‘accuracy’ in some 
settings compared to others. One possible explanation for heterogeneity is that there are 
other competing influences on SMC as a symptom, or willingness to report it, besides 
actual level of cognitive function. In settings such as those in China, these ‘competing 
causes’ may be absent or have less influence so that cognitive complaints, when they do 
occur are more likely to represent worse underlying cognitive function. Other variation 
between sites was less substantial and less consistent. For associations with cognitive 
function, the weakest associations tended to be found in the two Indian sites. However, the 
same was not true for associations with dementia where the weakest associations were 
found in Dominican Republic, urban Peru and rural Mexico. This may reflect differences in 
thresholds at which cognition is noted to be problematic – potentially less for India 
compared to other sites.    
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XIV. 1 Introduction.  
As described in Chapter VI, the current knowledge is limited on how informant-reported 
memory deficits (IMDs) relate to memory self-appraised by the participant themselves and 
their measured cognitive functioning. Nevertheless, IMDs, as an alternative to subjective 
deficits, are becoming integral to the MCI construct. In community-based dementia studies, 
researchers have often combine the approaches to augment the discriminating ability of 
dementia although previous studies have found that informant reports perform as well as 
cognitive assessments (Law and Wolfson, 1995; Hall et al., 1996; Mackinnon and Mulligan, 
1998; Cacchione et al., 2003; Knafelc et al., 2003; Mackinnon et al., 2003; Tierney et al., 
2003; Slavin et al., 2010). The aims of the analyses described in this chapter were to 
describe and compare IMD prevalence and associations (particularly with cognitive 
function) in the 10/66 samples. 
 
XIV. 2 Method 
XIV. 2.1 Sample 
The samples were as described in Chapter X.  
 
XIV. 2.2 Measures 
The following measures were used in these analyses; they refer to characteristics of the 
participant unless stated otherwise:  
1. For this analysis we considered the following participant characteristics as independent 
variables: age, gender, education level (previously defined groups), household assets, living 
status (alone or not), subjective memory complaint (as defined in Chapter XIII) cognitive 
functioning (CSI-D cog-score, verbal fluency, immediate and delayed recall categorized as 
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defined in Chapter XIII), GMS depression, 10/66 or DSM-IV dementia, need for care 
reported by the informant and disability (WHODAS). 
2. IMD was ascertained using the 26-item informant interview (CSI-D ’relscore’), which 
enquires about the participant’s daily functioning and overall health status. The questions 
are derived originally from the Cambridge Examination for Mental Disorders (CAMDEX) 
(Roth et al., 1986; Hendrie et al., 1988) and the Blessed Dementia Scale (Morris et al., 
1993). The CSI-D informant interview includes questions about changes in the index 
participant’s activities of daily living. However, the informant is first asked to evaluate 
whether or not there have been any memory problems in the participant using the following 
6 questions: 
1. Does he/she forget where he/she has put things? 
2. Does he/she forget where things are usually kept? 
3. Does he/she forget the names of friends? 
4. Does he/she forget members of the family? 
5. Does he/she forget when he/she last saw you? 
6. Does he/she forget what happened the day before? 
The optional responses are: no’, ‘sometimes’ and ‘yes’ which are scored as 0, 0.5 and 1, 
respectively. The 7 items were summed to create an IMD score (0-7; referred to as 
informant memory score hereafter), with higher scores indicating worse memory function, 
and for this analyses a binary category was arbitrarily created on the basis of  a score of >=2 
and < 2 to define IMD. 
 
XIV. 2.3 Statistical Analysis 
Analyses were carried out on the 10/66 data archive release 2.6, using STATA version 10.1 
(STATA, 2007). Global prevalence (combined samples) of IMD stratified by age group, 
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gender, educational level, assets, living alone, depression, dementia, need of care, disability, 
and cognitive functioning, was reported with ORs (95% CI) calculated for between-group 
comparisons. The crude prevalence stratified by site was then described for the whole 
samples, and then for those with and without dementia. Logistic regression analyses were 
used to investigate unadjusted and adjusted associations between IMD and independent 
variables using three models: 1) unadjusted; 2) adjusted for age, gender and education; 3) 
adjusted additionally for assets, living alone, depression, need of care and disability. For 
separate analyses, SMC and dementia were entered as binary variables and measures of 
cognitive functioning (CSI-D cog-score, verbal fluency (animal naming), immediate and 
delayed recall (CERAD)) in participants without dementia were entered in defending 
quartile groups. To determine overall associations, outputs from the eleven-study site were 
combined into fixed effect meta-analyses estimating the degree of heterogeneity using 
Cochrane Q and Higgins’ I2 (95% CI) (Higgins JP, 2002) tests.  
 
XIV.3 Results  
Unadjusted associations between participant characteristics and IMD are summarized in 
Table XIV.1. Significant associations were found between higher IMD prevalence and 
older age, female gender, higher number of assets, depression, dementia, disability and 
need for care. Significant associations were also found with lower cognitive function and 
SMC. Highest risk was found in the group with some rather than no education at all; 
however, there was no consistent trend across the other education groups.  
 
Further descriptions of IMD prevalence are described in Table XIV.2. The overall IMD 
prevalence was 29.2% in the combined sample, although varied widely among the sites 
from 7.8% in rural India to 38.1% in Dominican Republic. The IMD prevalence was lowest 
 186
in both Indian sites followed by the Chinese sites, with a more homogeneous 28-38% range 
for the Latin American sites. Ranges in participants without dementia followed a 
comparable pattern between sites. Those in participants with dementia ranged from 71-93% 
in China and Latin America, with lowest prevalences of 19% and 61% in rural and urban 
Indian sites respectively.  
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Table XIV.1. Prevalence of informant-reported memory deficit (IMD) stratified by 
participant characteristics. 
Variable Categories Total % IMD OR (95%IC) 
Age (years) 65-74 8,853 24.4 1 
75+ 6,152 36.1 1.75 (1.63-1.88) 
Gender Male 5,724 25.0 1 
Female 9,248 31.6 1.39 (1.29-1.49) 
Education None 3,197 25.4 1 
Some 3,913 34.2 1.52 (1.37-1.69) 
Completed primary 4,282 28.5 1.17 (1.05-1.30) 
Completed secondary 2,263 26.5 1.06  (0.93-1.20) 
Completed tertiary 1,280 28.6 1.17 (1.01-1.36) 
Number of assets 3 or less 2,111 23.5 1 
More than 3 12,893 30.2 1.40 (1.26-1.56) 
Living alone No 13,872 29.3 1 
Yes 1,150 27.7 0.92 (0.80-1.05) 
 Depression No 14,123 27.9 1 
Yes 899 56.6 2.66 (2.32-3.04) 
Dementia No 13,643 24.1 1 
Yes 
1,379 79.9 12.5 (10.9-14.4) 
Need for care No 13,233 25.3 1 
Yes 1,415 61.3 4.68 (4.18-5.24) 
Disability (WHODAS) score Below 90th percentile 13,488 26.5 1 
90th percentile or above 1,381 53.7 3.22 (2.88-3.60) 
Global cognitive functioning 
 
 
Quartile 4 3,754 18.3 1 
Quartile 3 3,732 23.9 1.40 (1.25-1.57) 
Quartile 2 3,768 30.3 1.94 (1.74-2.17) 
Quartile 1 3,768 44.3 3.55 (3.19-3.95) 
Verbal fluency Quartile 4 3,007 21.7 1 
Quartile 3 4,328 24.7 1.18 (1.06-1.32) 
Quartile 2 3,547 31.0 1.63 (1.45-1.82) 
Quartile 1 4,140 37.9 2.21 (1.98-2.46) 
Immediate recall Quartile 4 3,272 19.1 1 
Quartile 3 3,255 24.5 1.37 (1.22-1.55) 
Quartile 2 4,553 29.2 1.74 (1.56-1.95) 
Quartile 1 3,937 41.6 3.01  (2.70-3.37) 
Delayed Recall Quartile 4 2,569 19.7 1 
Quartile 3 4,700 25.0 1.36 (1.20-1.53) 
Quartile 2 2,609 24.9 1.35 (1.18-1.55) 
Quartile 1 5,144 40.0 2.72 (2.42-3.05) 
Subject memory complaint No 9,831 19.8 1 
Yes 4,945 46.2 3.47 (3.22-3.75) 
IMD= Informant Reported Memory Deficit , OR= Odds Ratio, IC= Confidence Interval, WHO-DAS= World Health 
Organization - Disability Assessment Schedule, ICD= International Classification Disease 
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Cuba 323 93.2 2,621 26.8 2,944 34.0 
Dominican Rep 242 86.0 1,769 31.5 2,011 38.1 
Peru Urban  130 86.2 1,251 28.1 1,381 33.6 
Peru Rural 36 75.0 516 25.0 552 28.3 
Venezuela 145 91.7 1,820 26.9 1,965 31.7 
Mexico Urban 93 85.0 910 32.8 1,003 37.6 
Mexico Rural 87 75.9 913 31.2 1000 35.1 
China Urban  84 82.1 1,076 19.0 1,160 23.5 
China Rural  56 71.4 946 8.8 1002 12.3 
India Urban  75 61.3 930 13.9 1,005 17.4 
India Rural  108 19.4 891 6.4 999 7.8 
Total 1,379 79.9 13,643 24.1 15,022 29.2 
log likelihood 
model1 
 -8481.9579  -536.75528  -7178.829 
log likelihood 
model 2 
 -8732.3558  -614.73165  -7380.8507 
IMD= Informant reported Memory Deficit, LR= Likelihood ratio  
 
 
Logistic regression analyses for the association between IMD and SMC in participants 
without dementia are summarized in Table XIV.3. Odds ratios remained significant and 
relatively unaltered by adjustment across all sites. Associations in most sites were within a 
relatively small range (e.g. fully adjusted odds ratios from 2.0 to 3.4) apart from the two 
Chinese sites, particularly the rural sample, where these were substantially stronger.   
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Table XIV.3 – Logistic regression analyses of the associations between subjective memory 
complaint (SMC) and informant-reported memory deficit (IMD) in participants without 
dementia. 
 
 Site Odds ratio (95% CI) for the association between IMD and 
SMC 
 Model 1 Model 2 Model 3 
Cuba 3.22 (2.68-3.88) 3.26 (2.70-3.93) 3.40 (2.75-4.20) 
Dominican Republic  3.12 (2.52-3.86) 3.01 (2.42-3.74) 2.66 (2.12-3.33) 
Peru (urban) 2.50 (1.94-3.24) 2.46 (1.90-3.20) 2.33 (1.78-3.04) 
Peru (rural) 3.66 (2.42-5.55) 3.68 (2.37-5.71) 3.73 (2.39-5.82) 
Venezuela 3.69 (2.95-4.60) 3.52 (2.80-4.41) 3.41 (2.67-4.37) 
Mexico (urban) 2.06 (1.53-2.76) 2.07 (1.54-2.79) 2.00 (1.48-2.72) 
Mexico (rural) 2.31 (1.72-3.10) 2.18 (1.62-2.93) 2.22 (1.63-3.02) 
China (urban) 4.82 (3.46-6.73) 5.00 (3.55-7.05) 4.82 (3.39-6.86) 
China (rural) 14.6 (7.16-29.8) 14.9 (7.06-31.2) 11.4 (4.74-27.3) 
India (urban) 3.02 (2.07-4.41) 2.93 (2.00-4.29) 2.91 (1.91-4.43) 
India (rural) 2.36 (1.34-4.17) 2.30 (1.31-4.06) 3.01 (1.34-6.79) 
Pooled meta analysis     
Combined estimate 
Test for overall effect 
3.11 (2.85-3.39) 3.05 (2.79-3.33) 2.95 (2.69-3.24) 
I2 Higgins (95% CI) 77% (58-87) 77% (59-87) 71% (46-84) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of care and 
disability. 
IMD= Informant reported Memory Deficit, SMC= Subjective Memory complaints, CI= Confidence Interval 
 
Logistic regression analyses of associations between IMD and the four tests of cognitive 
function in participants without dementia are summarized in Tables XIV.4-7. Pooled 
associations were strongest for global function (CSI-D cog-score) and weakest for 
immediate recall, although within a small range (fully adjusted pooled ORs 1.15 to 1.28). 
However, significant between-site heterogeneity was again observed – highest for verbal 
fluency, lowest for delayed recall. In general, associations were strongest in the two 
Chinese sites (particularly the rural sample) and consistently weakest in the two Indian sites. 
Associations in rural Peru were weak for global function and verbal fluency but relatively 
strong for the two recall tasks.   
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Table XIV.4 – Site-specific associations between lower global cognitive function and 
informant-reported memory deficit (IMD) in participants without dementia 
 
 Site Odds ratio (95% CI) for IMD per descending quartile of 
CSI-D cog-score 
 Model 1 Model 2 Model 3 
Cuba 1.29 (1.18-1.40) 1.26 (1.14-1.39) 1.36 (1.22-1.52) 
Dominican 
Republic  
1.32 (1.19-1.45) 1.25 (1.12-1.40) 1.20 (1.07-1.35) 
Peru (urban) 1.05 (0.92-1.20) 0.99 (0.85-1.15)- 0.92 (0.79-1.08) 
Peru (rural) 1.56 (1.27-1.91) 1.43 (1.14-1.79) 1.41 (1.11-1.79) 
Venezuela 1.44 (1.29-1.60) 1.49 (1.31-1.69) 1.40 (1.23-1.59) 
Mexico (urban) 1.14 (1.00-1.31) 1.19 (1.02-1.39) 1.17 (1.00-1.37) 
Mexico (rural) 1.37 (1.17-1.60) 1.34 (1.13-1.59) 1.34 (1.13-1.60) 
China (urban) 1.54 (1.28-1.85) 1.83 (1.47-2.28) 1.62 (1.28-2.04) 
China (rural) 2.31 (1.85-2.89) 2.20 (1.75-2.76) 2.03 (1.58-2.60) 
India (urban) 1.07 (0.89-1.28) 1.08 (0.86-1.36) 1.10 (0.87-1.38) 





Test for overall 
effect 
1.32(1.26-1.37) 1.31(1.25-1.37) 1.28(1.22-1.35) 
I2 Higgins (95% 
CI) 
81%(68-89) 81%(67-89) 77%(58-87) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of 
care and disability. 




Table XIV.5 – Site-specific associations between lower verbal fluency and informant-
reported memory deficit (IMD) in participants without dementia 
 
 Site Odds ratio (95% CI) for IMD per descending quartile of 
verbal fluency  (animal naming) 
 Model 1 Model 2 Model 3 
Cuba 1.25 (1.15-1.36) 1.22 (1.11-1.34) 1.25 (1.13-1.39) 
Dominican Republic  1.14 (1.03-1.27) 1.07 (0.96-1.19) 1.04 (0.93-1.16) 
Peru (urban) 1.05 (0.93-1.19) 0.99 (0.86-1.14) 0.96 (0.83-1.11) 
Peru (rural) 1.14 (0.92-1.42) 1.01 (0.80-1.26) 0.96 (0.76-1.22) 
Venezuela 1.18 (1.05-1.31) 1.19 (1.06-1.34) 1.15 (1.02-1.29) 
Mexico (urban) 1.17 (1.01-1.35) 1.20 (1.03-1.40) 1.20 (1.02-1.41) 
Mexico (rural) 1.10 (0.95-1.28) 1.06 (0.91-1.24) 1.05 (0.90-1.23) 
China (urban) 2.70 (2.21-3.31) 2.98 (2.41-3.69) 2.87 (2.30-3.57) 
China (rural) 1.24 (1.02-1.51) 1.14 (0.92-1.41) 1.10 (0.88-1.37) 
India (urban) 0.82 (0.60-1.11) 0.79 (0.57-1.08) 0.74 (0.53-1.03) 
India (rural) 1.54 (1.06-2.25) 1.48 (0.98-2.21) 1.40 (0.92-2.12) 
Pooled meta analysis   
Combined estimate 
Test for overall effect 
1.21 (1.16-1.26) 1.17 (1.12-1.23) 1.15 (1.01-1.21) 
I2 Higgins (95% CI) 87%(79-92) 89%(83-93) 89%(82-93) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of care 
and disability. 







Table XIV.6 – Site-specific associations between lower immediate recall and 
informant-reported memory deficit (IMD) in participants without dementia 
 
Site 
Odds ratio (95% CI) for IMD per descending quartile of 
immediate recall (CERAD word list) 
 Model 1 Model 2 Model 3 
Cuba 1.30 (1.20-1.42) 1.27 (1.16-1.39) 1.29 (1.17-1.43) 
Dominican Republic  1.30 (1.18-1.45) 1.28 (1.15-1.43) 1.22 (1.09-1.37) 
Peru (urban) 1.20 (1.06-1.37) 1.21 (1.05-1.39) 1.18 (1.02-1.36) 
Peru (rural) 1.05 (0.85-1.30) 0.94 (0.74-1.19) 0.93 (0.73-1.18) 
Venezuela 1.21 (1.09-1.35) 1.27 (1.14-1.42) 1.23 (1.09-1.38) 
Mexico (urban) 1.12 (0.97-1.29) 1.17 (1.00-1.36) 1.16 (0.99-1.36) 
Mexico (rural) 1.25 (1.07-1.45) 1.25 (1.07-1.47) 1.27 (1.08-1.49) 
China (urban) 1.81 (1.55-2.11) 2.08 (1.76-2.47) 1.94 (1.63-2.30) 
China (rural) 2.32 (1.66-3.24) 2.17 (1.52-3.10) 2.02 (1.41-2.90) 
India (urban) 1.11 (0.94-1.32) 1.14 (0.94-1.38) 1.14 (0.93-1.40) 
India (rural) 1.59 (0.84-3.01) 1.48 (0.77-2.82) 1.39 (0.72-2.66) 
Pooled meta analysis   
Combined estimate 
Test for overall effect 
1.28(1.23-1.33) 1.29(1.23-1.35) 1.27(1.21-1.33) 
I2 Higgins (95% CI) 77%(59-87) 80%(65-89) 75%(55-86) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of care 
and disability. 
IMD= Informant reported Memory Deficit, CERAD= Consortium to establish a registry for Alzheimer 








Table XIV.7 – Site-specific associations between lower delayed recall and 
informant-reported memory deficit (IMD) in participants without dementia 
 
 
Odds ratio (95% CI) for IMD per descending quartile of 
delayed recall (CERAD word list) 
 
Site Model 1 Model 2 Model 3 
Cuba 1.18 (1.08-1.28) 1.13 (1.04-1.24) 1.16 (1.05-1.28) 
Dominican Republic  1.34 (1.21-1.48) 1.33 (1.20-1.49) 1.30 (1.16-1.45) 
Peru (urban) 1.19 (1.05-1.34) 1.18 (1.03-1.35) 1.17 (1.02-1.34) 
Peru (rural) 1.02 (0.84-1.24) 0.92 (0.74-1.14) 0.91 (0.73-1.14) 
Venezuela 1.08 (0.98-1.20) 1.13 (1.01-1.25) 1.10 (0.99-1.23) 
Mexico (urban) 1.12 (0.98-1.28) 1.16 (1.01-1.33) 1.15 (1.00-1.33) 
Mexico (rural) 1.20 (1.05-1.38) 1.20 (1.04-1.38) 1.21 (1.05-1.40) 
China (urban) 1.69 (1.42-2.00) 1.86 (1.56-2.24) 1.67 (1.38-2.03) 
China (rural) 1.98 (1.45-2.72) 1.80 (1.30-2.49) 1.82 (1.30-2.56) 
India (urban) 1.01 (0.85-1.20) 1.02 (0.84-1.24) 1.04 (0.86-1.27) 
India (rural) 1.15 (0.80-1.64) 1.08 (0.74-1.57) 1.04 (0.71-1.52) 
Pooled meta analysis   
Combined estimate 
Test for overall effect 
1.20(1.15-1.25) 1.20(1.45-1.25) 1.19(1.14-1.24) 
I2 Higgins (95% CI) 76%(57-87) 77%(60-87) 68%(39-83) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of 
care and disability. 
IMD= Informant Reported Memory Deficit, CERAD= Consortium to establish a 
registry for Alzheimer Disease, CI= Confidence Interval 
 
Logistic regression analyses of associations between IMD and dementia status are 
summarized in Table XIV.8. The two were statistically significant and strongly associated 
in all sites, the strongest associations being in Cuba (OR 27.4 in the fully adjusted model) 
and the weakest in rural India (fully adjusted OR 2.4). Again, adjustments did not have a 









Table XIV.8 – Site-specific associations between dementia and informant-reported 




Odds ratio (95% CI) for IMD and dementia 
Model 1 Model 2 Model 3 
Cuba 37.5 (24.1-58.4) 34.1 (21.5-53.9) 27.4 (16.5-45.3) 
Dominican Republic  13.3 (9.03-19.5) 11.8 (7.97-17.4) 11.2 (7.38-16.8) 
Peru (urban) 15.9 (9.56-26.4) 14.2 (8.37-24.1) 13.2 (7.28-23.8) 
Peru (rural) 9.00 (4.10-19.7) 7.89 (3.33-18.7) 6.04 (2.44-15.0) 
Venezuela 30.1 (16.5-54.8) 34.1 (17.1-67.6) 24.8 (12.2-50.6) 
Mexico (urban) 11.6 (6.38-21.0) 11.4 (6.08-21.3) 9.46 (4.88-18.3) 
Mexico (rural) 6.93 (4.14-11.6) 5.84 (3.43-9.94) 5.31 (3.05-9.25) 
China (urban) 19.7 (11.1-34.8) 23.0 (12.7-42.0) 13.9 (6.72-28.8) 
China (rural) 26.0 (14.0-48.3) 24.9 (12.8-48.7) 11.4 (5.21-24.9) 
India (urban) 9.85 (5.84-16.6) 10.5 (6.04-18.1) 10.3 (5.78-18.4) 
India (rural) 3.53 (2.01-6.21) 3.43 (1.87-6.29) 2.37 (1.28-4.41) 
Pooled meta analysis   
Combined estimate 
Test for overall 
effect 
14.1 (12.0-16.6) 13.4 (11.4-15.9) 10.5 (8.78-12.6) 
I2 Higgins (95% CI) 84%(74-91) 84%(72-90) 80%(65-89) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression, need of 
care and disability. 










The key findings from this analysis were as follows:  
 
IMD in the combined samples was associated with similar participant characteristics to 
SMC, namely increased age, female gender, depression, need for care and disability. Like 
SMC, there was no clear association with higher or lower education levels. Unlike SMC it 
was more common in participants who had more rather than less assets.  
 
The prevalence of IMD was more than threefold higher in participants with dementia 
compared to those without. It was also associated with lower cognitive function in the 
combined samples, to a similar extent with all four cognitive tests, and with SMC.  
 
In participants without dementia, IMD was significantly and independently associated with 
SMC in all sites and with lower cognitive function in most sites. Both associations were 
stronger in the Chinese sites, particularly in rural China and associations with cognitive 
function were weak or absent in Indian sites. The odds ratios were similar between 
cognitive tests., 
  
Significant associations were found between IMD and dementia in all sites but there was 
evidence of significant and high between-site heterogeneity with a markedly weaker 
association in rural India. 
 
As has been highlighted previously, key strengths of this analysis were the large sample 
sizes, the community samples with high response rates, the heterogeneity and diversity of 
countries surveyed spread across five world regions, and the characterization of the sample, 
 196
allowing adjustments for key measures of social and health status, including diagnostic 
assessments of depression and dementia. The definition of IMD was made a priori and had 
face validity, derived as it was from a well-used schedule with established cross-cultural 
applicability. However, there is yet to be a standard definition of IMD to apply in 
epidemiological research and findings can only therefore be viewed as preliminary and un-
replicated. Unlike SMC, a key limitation with IMD as applied here is that the CSI-D 
informant interview is a core component of the dementia diagnostic assessment, so that 
associations with dementia are inevitably circular and may be more reflective of the 
performance of the algorithm between sites than illustrating a feature of dementia per se.  
However, the same is likely to be the case in any epidemiological study of dementia since a 
history of cognitive decline is a core component in all-standard diagnostic systems and 
informants are a key source of that information in the absence of longitudinal cognitive data. 
This circularity should not; however, be an issue regarding any other measure particularly 
since the informant was not usually present at the participant interview (particularly in 
those without dementia) and so would be unaware of the cognitive performance and/or 
responses to SMC questions. As highlighted in Chapter XIII, cognitive assessments were 
limited in scope because of the logistics of the study and availability of cross-culturally 
applicable assessments. Although reliability of the IMD measure was not formally 
evaluated, rigorous quality control monitoring was in place to maximize consistency across 
sites. Furthermore, the questions were relatively straightforward ones administered 
verbatim to informants. Finally, any loss of reliability would more likely introduce non-
differential measurement error – i.e. bias true associations to the null and obscure rather 
than exaggerate them. 
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In the combined samples, the prevalence of IMD was 29.2%. The Latin American sites had 
relatively consistent prevalences of around 30% (28.7- 38.1) with lower values observed in 
China (23.5 and 12.3%) and India (17.4% and 7.81%). Rural India had the lowest crude 
IMD prevalence not only within the total sample but also, following stratification, in groups 
with and without dementia. In the combined samples, we found associations of IMD with 
older age and gender. As described earlier, most studies have reported an increase in 
subjective memory problems in older subjects and in women. The association with 
educational attainment is less consistent in the literature and in this report we confirm these 
findings even when we were able to find a tendency of higher prevalence of SMC among 
the less educated subjects that participated in our study.  
 
In terms of cognitive associations, those with dementia should be treated with caution as 
discussed earlier because of the incorporation of IMD within dementia diagnostic criteria 
(and within the 10/66 algorithm). However, taking this into account, the variation between 
sites is interesting – for example, the finding in the rural Indian site that in 80% of dementia 
cases the informant did not report the level of IMD that was present in over 90% of 
dementia cases in Cuba. However, in the absence of dementia, IMD remained significantly 
associated with SMC in all sites – i.e. reflecting participant and informant agreement about 
cognitive difficulties. To our knowledge, this association has not been assessed before in a 
large multicultural community population and clearly it has to be viewed as preliminary 
and in need of replication. It is possible that it may be stronger in cultures where there are 
close-knit families and where a complaint by one member is more likely to be noticed by 
another; however, the interrelationship between family members around perceived 
impairment in one of them has received little systematic evaluation, particularly at 
relatively early stages of cognitive impairment prior to dementia onset.  
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We also found associations between IMD and worse performance on objective tests of 
cognitive function by the index participant. In community samples of older people 
associations have been found between informant memory complaints and memory 
impairment. In the 10/66 sites, as with SMC, the strongest independent associations were 
observed for the measures of global function and immediate word list recall. Again, this 
may reflect a different domain measured in verbal fluency where impairment is less 
apparent to an informant. It is possible that the weaker association with delayed compared 
to immediate recall may reflect the same phenomenon – i.e. that deficient immediate recall 
is more evident to others than deficient delayed recall (possibly because of compensatory 
strategies available). Alternatively it may simply reflect the fact that immediate recall was 
measured on a 30-point scale and delayed recall on a 10-point scale.  
 
As with associations reported for SMC in Chapter XIII, there was significant between-site 
heterogeneity in most associations. In rural China, the particularly strong associations 
between SMC and cognitive impairment or dementia reported in Chapter XIII were also 
observed in relation to IMD in these analyses. Although SMC in Indian sites had been 
weakly associated with cognitive function in the absence of dementia, associations with 
IMD were comparable in strength to those in Latin American countries. However, 
associations between IMD and cognitive function were similarly weak to those between 
SMC and cognitive function in the Indian sites. The pattern has differences to that between 
SMC and cognitive function in China – here, SMC was relatively uncommon but much 
more ‘accurate’ (assuming accuracy to reflect a strength of association with observed 
function), whereas in India IMD was both uncommon and ‘inaccurate’. The competing 
cause hypothesis discussed in Chapter XIII for SMC and dementia/cognition in China 
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appears unlikely to be relevant here since higher numbers of competing causes of IMD 
accounting for a weak association with dementia in India would not explain the overall low 
prevalence. Similarly, a general lack of performance of IMD as a construct in India might 
account for a low prevalence but not for a specific lack of association with cognitive 
impairment. Instead, the picture is more consistent with a combination of reluctance to 
report the symptom in general and more marked reluctance in the case of someone with 
objective cognitive impairment – possibly because of stigma but equally possibly because 
of societal or familial compensatory mechanisms whereby someone with declining 
cognitive function may receive more support so that the impairment no longer becomes 
evident. However, these conclusions need to be viewed as speculative in the absence of 
more specific evidence. 
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XV.1 Introduction  
Functional disability in the elderly is defined as an acquired difficulty in performing basic 
everyday tasks or more complex tasks needed for independent living. According to this 
definition, functionality encompasses all body functions, tasks, or actions, and disability 
includes impairment, limited capacity, or restricted performance of activities (Pinheiro, 
2009). Impairment in functioning is core to the distinction between MCI and dementia. The 
aims of the analyses described in this chapter were to investigate the prevalence of 
activities of daily living impairment (ADLI) and factors associated with this in the 10/66 
samples, in particular investigating the relationship with cognitive function and 




The samples were as described in Chapter X.  
 
XV.2.1 Measurements 
The following measures were used in these analyses:  
 
1. For this analysis we considered the following participant characteristics: age, gender, 
education level (previously defined groups), number of assets, living alone status, 
depression (GMS) and dementia (as previously defined). For cognitive function, the 
same four measures were considered as previously described (CSI-D cog-score, 
verbal fluency (animal naming), immediate and delayed recall (CERAD word list)). 
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2. ADLI was ascertained using items of the informant interview from the Community 
Screening Instrument for Dementia (CSI-D) previously described. The decision to 
use this measure was guided by the following considerations: 1) Self-reported 
disability derived from participant interviews would be potentially problematic as 
an outcome analysed against cognitive function as an exposure, because of reporting 
bias; 2) A detailed analysis of the WHODAS outcome had already formed the basis 
for another PhD thesis (R Sousa, passed 2011) based on these samples. Six 
questions in the CSI-D informant interview concern the participant’s daily 
functioning, enquiring about loss of function within six domains: household tasks, 
previous skill/hobby, handling money, feeding, dressing and toileting. Four of these 
(household tasks, feeding, dressing and toileting), require the interviewer to 
ascertain whether the problem or difficulty is caused by physical limitation (if the 
answer is yes to this, then the primary question is scored as 0). The questions are 
listed in full below:  
 
1.  DOES SHE/HE HAVE DIFFICULTY PERFORMING HOUSEHOLD CHORES 
THAT SHE/HE USED TO DO, SUCH AS PREPARING FOOD OR BOILING A 
POT OF TEA?   IF YES - HOW OFTENDOESTHATHAPPEN? 
0 No 
1 Yes, Sometimes 
2 Yes, Regularly 
1a. - Does the INTERVIEWER think that the problem is primarily due to physical 
disability? (CHORE/DIS)  
0 No, not due to physical disability 
1 Yes, due to physical disability  
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2. HAS THERE BEEN A LOSS OF A SPECIAL SKILL OR HOBBY SHE/HE 
COULD MANAGE BEFORE?  
0  No 
1  Yes 
3. HAS THERE BEEN A CHANGE IN HER/HIS ABILITY TO HANDLE MONEY? 
0 No difficulty 
1 Some difficulty  
2 Cannot handle money  
4. DOES SHE/HE HAVE DIFFICULTY FEEDING HERSELF?  
0 Eats cleanly with proper utensils 
1 Eats messily with a spoon only  
2 Simple solids such as biscuits  
3 Has to be fed  
4a. – Does the INTERVIEWER think that the problem is primarily due to physical 
disability? 
0  No, not due to physical disability 
1  Yes, due to physical disability  
5. DOES SHE/HE HAVE DIFFICULTY DRESSING?  
0 Dresses self  
1 Occasionally misplaces buttons etc.  
2 Wrong sequences, commonly forgets items  
3 Unable to dress  
5a. - Does the INTERVIEWER think that the problem is primarily due to physical 
disability? 
0 No, not due to physical disability 
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1 Yes, due to physical disability  
6. DOES SHE/HE HAVE DIFFICULTY USING THE TOILET? DOES SHE/HE 
WET OR SOIL HER/HIMSELF? 
0 No problems  
1 Occasionally wets bed  
2 Frequently wets bed  
3 Double incontinence  
 6a. - Does the INTERVIEWER think that the problem is primarily due to physical 
disability? 
0 No, not due to physical disability 
1 Yes, due to physical disability  
 
The scoring for the ‘0/1/2’ items was 0, 0.5 and 1 respectively. For the analyses described 
here, a binary category was created a priori where any score of 0.5 or greater was classified 
as ADLI. 
 
Consideration was given as to whether or not to use measures of physical health as 
covariates. Following consultation, a decision was made not to do this for the following 
reasons: i) some physical disorders might have resulted as a consequence of cognitive 
decline, so that adjustment for these would have represented an ‘overadjustment’; ii) 
physical disorders most likely to be confounders for reasons of their being risk factors for 
cognitive impairment, such as hypertension and diabetes, are not prime causes of 
population-levels of disability in older people; iii) physical disorders most likely to cause 
disability in older people at a population-level (e.g. musculoskeletal disorders) are not 
candidate risk factors for cognitive decline; iv) an exception to (ii) and (iii) is stroke, 
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although its relationship to cognitive decline is complex (with prospective studies indicated 
bidirectional causation) and it was not felt to have sufficient prevalence in the samples to be 
a major confounder (since information on subclinical cerebrovascular disease was not 
available); v) the informant-rated ADL outcome was specifically designed to focus on 
disability not clearly caused by physical disorders.  
 
XV.2.3 Statistical Analysis 
Analyses were carried out on the 10/66 data archive release 2.6, using STATA version 10.1 
(Stata, 2000) and, broadly, followed the pattern adopted for SMC and IMD. Prevalence of 
ADLI was first calculated in the combined samples followed by stratification by age group, 
gender, educational level, assets, living alone, depression, dementia, and cognitive function 
(quartile groups) with odds ratios for group differences. The prevalence was next stratified 
by site and dementia status. Logistic regression analyses were used to further investigate 
site-specific associations between ADLI and the four tests of cognitive function in 
participants without dementia. The models used for these analyses were as follows:1) 
unadjusted; 2) adjusted  by socio-demographic variables (age, gender, education) and 3) 
adjusted for the same model 2 variables plus other  relevant variables (assets, living alone 
and depression). As described previously, the analysis outputs for the sites were combined 
using fixed effect meta-analyses estimating the degree of heterogeneity using Cochrane Q 
and Higgins’ I2 (95% CI) (Higgins JP, 2002) tests.  
 
XV.3 Results  
Associations between ADLI and participant characteristics in the combined samples are 
described in Table XV.1. Significant associations were found with older age, female gender, 
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and fewer assets, as well as with dementia, depression, and lower cognitive function on all 
four tests. No significant associations were found with education or living alone.  
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Table XV.1. Prevalence of activities of daily living impairment (ADLI) stratified by 
participant characteristics. 
Variable Categories Number ADLI (%) OR (95%CI) 
Age groups 
65-74 8,853 10.0 1 
75+ 6,152 22.8 2.66(2.42-2.92) 
Gender 
Female 9,248 15.6 1.12(1.02-1.22) 
Male 5,724 14.2 1 
Education 
None 3,197 16.8 1.44(1.19-1.75) 
Some 3,913 18.8 1.65(1.37-1.99) 
Primary 4,282 13.6 1.13(0.93-1.36) 
Secondary 2,263 10.2 0.81(0.65-1.00) 
Tertiary 1,280 12.3 1 
Number of assets 
3 or less 2,111 19.1 1.38(1.22-1.56) 
more than 3 12,893 14.6 1 
Living alone 
No 13,872 15.2 1 
Yes 1,150 16.4 1.09(0.93-1.29) 
Depression 
No 14,123 13.7 1 
Yes 899 39.6 4.13(3.59-4.76) 
Dementia 
No 13,643 9.8 1 
Yes 1,379 69.3 20.8(18.3-23.7) 
Global cognitive functioning 
Quartile 4 3,754 4.8 1 
Quartile 3 3,730 8.0 1.74(1.43-2.10) 
Quartile 2 3,763 13.3 3.04(2.54-3.64) 
Quartile 1 3,775 34.7 10.5(8.93-12.4) 
Verbal fluency 
Quartile 4 3,007 5.9 1 
Quartile 3 4,328 9.5 1.67(1.39-2.00) 
Quartile 2 3,547 16.4 3.11(2.60-3.71) 
Quartile 1 4,140 27.1 5.89(4.98-6.97) 
Immediate recall 
Quartile 4 3,272 5.5 1 
Quartile 3 3,255 8.1 1.50(1.24-1.83) 
Quartile 2 4,553 13.3 2.63(2.21-3.13) 
Quartile 1 3,937 31.5 7.91(6.69-9.34) 
Delayed Recall 
Quartile 4 2,569 5.8 1 
Quartile 3 4,700 8.7 1.54(1.26-1.87) 
Quartile 2 2,609 11.1 2.01(1.63-2.47) 
Quartile 1 5,144 28.0 6.28(5.25-7.50) 
ADLI= Activities of Daily Living, OR= Odds Ratio 
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The ADLI prevalence in the combined samples was 15.2% and varied considerably among 
the sites from 3.5% in urban India to 25.9% in Dominican Republic (Table XV.2). A 
particularly large difference in ADLI prevalence was observed between the rural and urban 
sites in India (24.4 vs. 3.5 respectively). Prevalence’s in participants with dementia ranged 
from 28.0% in urban India to 86.4% in Cuba while the prevalence in participants without 
dementia ranged from 1.1% in rural China to 19.4% in Dominican Republic.   
 























Cuba 323 86.4 2,621 7.8 2,944 16.4 
Dom. Rep. 242 73.6 1,769 19.4 2,011 25.9 
Peru (urban) 130 76.9 1,251 6.3 1,381 13.0 
Peru (rural) 36 36.1 516 5.8 552 7.8 
Venezuela 145 80.0 1,820 10.3 1,965 15.5 
Mex. (urban) 93 74.2 910 15.7 1,003 21.1 
Mex. (rural) 87 46.0 913 9.9 1000 13.0 
China (urban) 84 78.6 1,076 3.0 1,160 8.5 
China (rural) 56 51.8 946 1.1 1002 3.9 
India (urban) 75 28.0 930 1.5 1,005 3.5 
India (rural) 108 40.7 891 22.5 999 24.4 
Total 1,379 69.3 13,643 9.8 15,022 15.2 
ADLI= Activities of Daily Living 
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Logistic regression analyses for associations between ADLI and cognitive functioning in 
participants without dementia are summarized in Tables XV.3-6. Considering the combined 
estimates, adjustment for covariates had only modest effects on associations with ADLI and 
all remained significant after adjustment. However, the association of ADLI with global 
function (CSI-D cogscore) was over twice as strong as that with delayed recall, the other 
two tests occupying intermediate positions. Site-specific associations between worse global 
function and ADLI were statistically significant in five sites, whereas worse delayed recall 
was only significantly associated with ADLI in two sites.  
 
Between-site heterogeneity was strongest for verbal fluency and immediate recall. Across 
all four tests, the sample from the urban China site had substantially stronger associations 
between cognition and ADLI than the remainder, with the rural China sample occupying 
second position for all tests apart from verbal fluency. Otherwise, there was no clear 
consistency in site ranking across the four assessments although they tended to be relatively 
strong in Venezuela and were consistently significant in Cuba.  
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Table XV.3 – Site-specific associations between lower global cognitive function and 
activities of daily living impairment (ADLI) in participants without dementia 
 
 
Odds ratio (95% CI) for ADLI per descending quartile of 
CSI-D cog-score 
Site Model 1 Model 2 Model 3 
Cuba 1.38(1.20-1.59) 1.27(1.08-1.50) 1.26(1.06-1.49) 
Dominican Republic  1.57(1.39-1.77) 1.52(1.33-1.73) 1.45(1.27-1.66) 
Peru (urban) 1.27(1.02-1.58) 1.22(0.93-1.59) 1.11(0.85-1.44) 
Peru (rural) 1.48(0.98-2.25) 1.47(0.95-2.28) 1.39(0.86-2.24) 
Venezuela 1.88(1.58-2.23) 1.77(1.46-2.16) 1.63(1.34-1.99) 
Mexico (urban) 1.31(1.10-1.57) 1.27(1.04-1.56) 1.25(1.03-1.53) 
Mexico (rural) 1.26(1.01-1.57) 1.22(0.96-1.55) 1.22(0.96-1.55) 
China (urban) 3.69(2.52-5.41) 4.03(2.44-6.63) 3.70(2.22-6.18) 
China (rural) 2.39(1.29-4.44) 2.07(1.08-3.96) 1.80(0.81-3.97) 
India (urban) 1.51(1.03-2.20) 1.38(0.74-2.59) 1.44(0.69-3.00) 
India (rural) 0.89(0.73-1.10) 0.75(0.58-0.96) 0.94(0.71-1.25) 
Pooled meta analysis   
Combined estimate 
1.45(1.36-1.54) 1.37(1.28-1.47) 1.35(1.26-1.45) 
Test for overall effect 
I2 Higgins (95% CI) 84% (73-91) 81% (68-89) 67% (38-83) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression. 
ADLI= Activities of Daily Living, CI= Confidence Interval, CSI-D= Community 









Table XV.4 Site-specific associations between lower verbal fluency and activities of 
daily living impairment (ADLI) in participants without dementia. 
 
 Odds ratio (95% CI) for ADLI per descending quartile of 
verbal fluency score 
Site Model 1 Model 2 Model 3 
Cuba 1.48(1.28-1.70) 1.40(1.21-1.63) 1.39(1.20-1.62) 
Dominican Republic 1.20(1.07-1.36) 1.12(0.99-1.27) 1.10(0.97-1.24) 
Peru (urban) 1.30(1.03-1.64) 1.26(0.98-1.64) 1.22(0.95-1.58) 
Peru (rural) 1.31(0.86-1.99) 1.20(0.80-1.81) 1.10(0.74-1.64) 
Venezuela 1.60(1.39-1.84) 1.51(1.29-1.77) 1.52(1.30-1.78) 
Mexico (urban) 1.29(1.07-1.54) 1.21(0.99-1.47) 1.19(0.98-1.45) 
Mexico (rural) 1.05(0.84-1.31) 1.03(0.82-1.29) 1.02(0.81-1.29) 
China (urban) 2.55(1.85-3.52) 2.56(1.80-3.62) 2.48(1.73-3.56) 
China (rural) 0.91(0.53-1.58) 0.78(0.39-1.59) 0.74(0.33-1.65) 
India (urban) 0.48(0.26-0.90) 0.39(0.20-0.76) 0.39(0.19-0.80) 
India (rural) 0.85(0.69-1.07) 0.82(0.65-1.03) 0.75(0.58-0.97) 
Pooled meta analysis   
Combined estimate 
1.30(1.23-1.38) 1.23(1.15-1.31) 1.21(1.14-1.29) 
Test for overall effect 
I2 Higgins (95% CI) 83% (71-90) 81% (69-90) 82% (69-90) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression. 











Table XV.5 – Site-specific associations between lower immediate recall and activities 
of daily living impairment (ADLI) in participants without dementia 
 
Site 
Odds ratio (95% CI) for ADLI per descending quartile of 
CERAD word list immediate recall score 
 Model 1 Model 2 Model 3 
Cuba 1.48(1.28-1.70) 1.40(1.21-1.63) 1.36(1.17-1.59) 
Dominican 
Republic 
1.20(1.07-1.36) 1.12(0.99-1.27) 1.12(0.98-1.27) 
Peru (urban) 1.30(1.03-1.64) 1.26(0.98-1.64) 1.46(1.14-1.87) 
Peru (rural) 1.31(0.86-1.99) 1.20(0.80-1.81) 1.00(0.60-1.65) 
Venezuela 1.60(1.39-1.84) 1.51(1.29-1.77) 1.30(1.09-1.54) 
Mexico (urban) 1.29(1.07-1.54) 1.21(0.99-1.47) 1.03(0.85-1.24) 
Mexico (rural) 1.05(0.84-1.31) 1.03(0.82-1.29) 0.94(0.72-1.23) 
China (urban) 2.55(1.85-3.52) 2.56(1.80-3.62) 3.86(2.57-5.81) 
China (rural) 0.91(0.53-1.58) 0.78(0.39-1.59) 2.25(0.98-5.17) 
India (urban) 0.48(0.26-0.90) 0.39(0.20-0.76) 0.84(0.44-1.62) 
India (rural) 0.85(0.69-1.07) 0.82(0.65-1.03) 1.20(0.86-1.68) 
Pooled meta analysis   
Combined estimate 
1.40(1.31-1.49) 1.28(1.19-1.37) 1.23(1.15-1.34) Test for overall 
effect 
I2 Higgins (95% CI) 84% (73-91) 81% (68-89) 79% (63-88) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression. 
ADLI= Activities of Daily Living, CERAD= Consortium to establish a registry for 






Table XV.6 – Site-specific associations between lower delayed recall and activities of 
daily living impairment (ADLI) in participants without dementia 
 
Site 
Odds ratio (95% CI) for ADLI per descending quartile of 
CERAD word list delayed recall score 
 Model 1 Model 2 Model 3 
Cuba 1.33(1.16-1.53) 1.23(1.06-1.43) 1.20(1.03-1.40) 
Dominican Republic 1.26(1.11-1.42) 1.15(1.02-1.30) 1.11(0.98-1.26) 
Peru (urban) 1.40(1.14-1.71) 1.31(1.03-1.67) 1.27(0.99-1.62) 
Peru (rural) 1.14(0.77-1.67) 1.03(0.68-1.55) 1.01(0.66-1.54) 
Venezuela 1.22(1.05-1.41) 1.12(0.96-1.32) 1.11(0.95-1.30) 
Mexico (urban) 1.15(0.96-1.37) 1.05(0.88-1.27) 1.04(0.86-1.26) 
Mexico (rural) 1.06(0.86-1.30) 0.99(0.80-1.24) 0.99(0.80-1.24) 
China (urban) 3.17(2.29-4.39) 2.89(2.01-4.16) 2.69(1.84-3.93) 
China (rural) 2.32(0.95-5.65) 1.96(0.80-4.79) 1.70(0.71-4.07) 
India (urban) 1.27(0.79-2.05) 1.13(0.66-1.93) 1.18(0.66-2.13) 
India (rural) 1.25(1.01-1.55) 1.21(0.97-1.50) 1.21(0.94-1.56) 
Pooled meta analysis   
Combined estimate 
1.28(1.21-1.36) 1.18(1.11-1.25) 1.15(1.08-1.23) 
Test for overall effect 
I2 Higgins (95% CI) 74% (52-86) 67% (39-83) 60% (22-79) 
Model 1 = Unadjusted 
Model 2 = Adjusted for age, gender and education. 
Model 3 = Adjusted for age, gender, education, assets, living alone, depression. 
ADLI= Activities of Daily Living,  
CERAD= Consortium to establish a registry for Alzheimer Disease  




XV. 4. - Discussion 
The following were key findings from these analyses:  
Activities of daily living impairment (ADLI) in the participant, as reported by their 
informant, were present in 15% of the total sample and were associated with increased age, 
female gender and fewer assets, as well as with depression, dementia and lower cognitive 
function.  
 
ADLI prevalence varied substantially between sites from 4% in urban India to 26% in 
Dominican Republic. Prevalence in participants with dementia also varied with relatively 
high (>75%) frequencies in Cuba (86%), Venezuela (80%), urban China (79%), urban Peru 
(77%) and relatively low frequencies in urban India (28%) and rural Peru (36%).  
 
Associations between ADLI and worse cognitive function in participants without dementia 
were present in combined samples for all four tests although stronger for the test of global 
function compared to the other three. The most consistently strongest associations between 
cognitive function and ADLI were observed in urban China, Venezuela and Cuba.  
 
As described before, key strengths were the sample sizes, the community assessments, the 
high response rates, the heterogeneity and diversity of countries surveyed and the 
diagnostic assessments of depression and dementia. ADLI was derived from an informant 
interview and therefore had some objectivity and independence from the cognitive 
measures (e.g. removing the problem of people with cognitive impairment finding it 
difficult to report their daily function). Although defined a priori and drawn from a 
standard schedule with previous cross-cultural application, it should be borne in mind that 
the psychometric properties of the scale and cut-off have not been formally assessed. 
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However, as with the IMD definition, the questions are relatively straightforward and 
unlikely to be misunderstood. ADLI as defined here was strongly associated with a 
participant-reported WHODAS score above the 90th percentile with an odds ratio of 8.58 
(95% CI 7.63-9.66). Disability has been assessed with a wide variety of instruments in 
previous research but even when instruments contain the same items, they may differ in 
how they assess specific aspects of performing the task or the severity of limitation in 
performing the task. Finally, it is important to bear in mind that impaired activities of daily 
living is a core component of dementia diagnostic criteria so that associations with 
dementia (as with those between IMD and dementia) are inevitably circular – although 
ADLI is not an absolute requirement in the 10/66 dementia algorithm as is clear from the 
wide range of prevalences in the second column of Table XV.2.    
  
Functional impairment has significant implications for older adults because of the potential 
step of institutionalization as an outcome, higher mortality rates, poorer underlying health 
status, poorer health outcomes, poorer quality of life and caregiver burden (Angel & Fisco, 
2001; Winer et al 1990). However, most epidemiological evidence on disability comes 
from high income countries, despite the fact that around 10% of the world’s population 
(650 million people) suffer a disability (UN, 2006) and 80% of these live in LMIC settings 
(UN 2006; Lancet 2009). Relationships between cognition and disability are potentially 
complex to elicit when categories such as dementia or MCI are applied because the 
presence or not of a given level of disability is used to define such categories. Nevertheless, 
a considerable body of research has examined the relationship between cognitive abilities 
and ADL/ADLI functional performance, with particular reference to older adults. Cognitive 
ageing studies have addressed the relationship of functional performance to different and 
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specific cognitive functions, and performance on various standardized psychometric 
measures for several mental functions (Marson D, 2006).  
 
In our analyses of the combined samples, increased prevalence of ADLI was found in older 
participants, female participants and those with fewer assets. There are reasonably 
consistent findings of an increase in disability prevalence with increasing age (Grundy, 
1999; Paul, 2007; Berlau, 2009) and higher prevalence in women compared to men (Berlau, 
2009; Zhao, 2009; Gu, 2009). The complex inter-relationship between education and 
income and their strong associations with poor health and onset of disability has also been 
illustrated by several studies (Taylor, 2010; Herd, 2007; Zimmer, 2003; Meltzer, 2001). In 
our unadjusted analyses we only confirmed the association with lower income (if fewer 
assets can be considered as a proxy for this) with no clear linear trend across education 
groups.  
 
The principal objectives in these analyses were  to clarify relationships between cognitive 
function and ADLI in participants without dementia. In our study clear evidence was found 
of associations between ADLI and lower cognitive function for all four measures, strongest 
for global cognitive functioning. Several studies have examined the association between 
cognitive and functional decline in what is termed ‘normal’ ageing (Barberger-Gateu, 1999; 
Mortimer, 1992; Willis, 1992). These authors have concluded that changes in functional 
performance are not the direct result of advancing age per se but instead are linked to a 
concurrent decline in those cognitive abilities that underlie everyday task competence. 
Global mental status measures, particularly neuropsychological measures of executive 
function, have been found to account for a significant portion of the variance in ADL and 
IADL function. Taking a broader view, deficits in higher-order cognitive abilities have 
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been found to correspond with difficulty in performing complex tasks of everyday living 
even in the preclinical stages of dementia (Griffith, 2003). It is likely that the CSI-D cog-
score scale is measuring a broader range of functions, which in combination are likely to be 
more predictive of daily functioning than lower scores on a specific test such as verbal 
fluency or learning.  
 
It is important, however, to bear in mind that causality between cognitive function and 
ADLI is difficult to infer, even in prospective research, particularly because of the 
difficulties distinguishing the influence of cognition from wider individual and 
environmental contexts. Cerebrovascular disorders for example may cause cognitive 
impairment due to effects on higher brain function and general functional incapacity due to 
effects elsewhere in the brain – i.e. acting as a confounder with no direct link between the 
cognitive impairment and ADLI. Because of the limited scope for in-depth assessments in 
the 10/66 sites  (e.g. no neuroimaging available), these processes cannot be excluded 
entirely, despite specific features of the CSI-D ADLI assessment to allow impairments 
caused principally by physical ill health to be excluded from consideration.  
 
As well as individual factors, socio-cultural environments may also modify the relationship 
between cognition and ADLI. Substantial variations in strengths of association were found 
and it is interesting that the strongest associations were not in sites with the lowest ADLI 
prevalence (i.e. not, like SMC, representing a propensity to report the construct less often 
but more ‘accurately’). Instead, the strongest associations between ADLI and cognitive 
impairment in participants without dementia tended to be seen in the sites where ADLI had 
the highest prevalences in participants with dementia. This suggests that there may be 
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features of these environments, which render both pre-dementia cognitive impairment and 
























One of the main achievements of the work of the 10/66 DRG is to have the opportunity to 
compare data obtained with a consistent, systematic and validated methodology between 
large multicultural samples from different regions and countries in the low and middle 
income world, the focus of this thesis being to investigate data and associations relevant to 
the MCI construct. An objective for the 10/66 programme overall was to standardize 
assessments as much as possible in order to gain a clearer idea of international variation 
and this advantage was utilised for the analyses described here. The fact that substantial 
heterogeneity remained in many circumstances suggests important variation in constructs 
underlying the definition.     
 
We found clear differences in cognitive function and symptom distributions between the 
sites. Cognitive norms tended to be lowest in India and highest in China, which was 
confirmed in relation to aMCI prevalence where, within the range of prevalence’s from the 
different sites, China (0.8%) and India (4.3%) were at the extremes, with the Latin 
American countries occupying the central ground. This is interesting considering that the 
Latin American countries share many cultural similarities to each other and clear 
differences compared to China and India. 
 
However, considering SMCs, these were relatively low in China, consistent with the higher 
norms and lower aMCI prevalence, but Indian prevalences were similar to those in Latin 
America. IMD on the other hand was low in both China and India compared to Latin 
America. The likelihood is that aMCI prevalence is primarily determined by cognitive 
function distributions within a given population, although it remains important to be aware 
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that the other elements of the construct may have more pronounced cultural influences. 
Low SMC and IMD prevalence may therefore have accounted at least in part for low aMCI 
prevalence in the Chinese sites but do not account for the relatively high aMCI prevalence 
in India.   
 
Inconsistencies between sites in aMCI prevalence and in the constructs underlying the 
aMCI diagnosis support questions previously raised concerning its conceptual basis and/or 
operationalisation outside clinical settings. However, aMCI has been reported to be 
associated with increased mortality in prospective studies, and differences in aMCI 
associated to survival between country sites cannot be excluded as a factor influencing 
variation in prevalence. Longitudinal studies in these settings will contribute to clarify these 
questions. 
 
Considering correlates of cognitive function we did not find consistent differences in 
demographic factors associated with cognition between sites. In the other hand SMC was 
particularly strongly related to both cognition and dementia in China. In the Indian sites, 
samples showed weak SMC associations with cognition, although those with dementia 
were similar to the Latin American range. IMD was more strongly associated with 
cognition in China and weaker in India compared to Latin America. IMD and SMC 
themselves were most strongly associated in China, but in India these were similar to 




Taking the Chinese sites to begin with, and considering the relatively good cognitive 
function and low frequency of complaints or reported deficits (SMC/IMD) our findings 
suggest at least that 'accuracy' of these symptoms/reports may vary between settings, one 
possibility being that Chinese participants and informants were better able to identify 
genuine problems than those in other sites which could possibly be explained by them 
being less likely to report memory problems/deficits associated with other non-cognitive 
syndromes, therefore maximizing the specificity of the relationship with cognition. 
However, clearly this can only be a speculative conclusion and further more specific 
research is indicated. The impact of cognitive impairment may also be a factor and it is 
noteworthy that associations between cognitive test scores and ADLI in people without 
dementia were relatively high in urban China (to be discussed further below).  
 
Considering the Indian sites, the picture is a little different because the associations 
between SMC and cognition in people without dementia were relatively weak but the 
associations between SMC and dementia were similar to those in Latin America. Also, 
IMDs were relatively weakly associated both with cognition and with dementia (but 
associations between IMD and SMC were comparable in strength to those in Latin 
America). As previously argued, it is possible that subjective complaints might have a 
different threshold between sites (i.e. in India, only become apparent in dementia and not in 
milder cognitive impairment) and that IMDs may be less reported in dementia, either 
because of reluctance to report this (e.g. because of stigma or social acceptability) or 
because there have been compensatory processes for reducing the visibility/impact of 
dementia so that informants do not even notice any deficit, although associations between 
cognition and ADLI were not markedly different in strength from those in many other sites.  
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Considering further potential differences in the impact of cognitive impairment, there was a 
relatively negative association between aMCI and WHODAS score in China but inferences 
are limited because of the self-report nature of the instrument.  
 
Associations between aMCI in China and NPI symptoms seem to be particularly strong 
which again may reflect a rarer but more severe syndrome being identified; these findings 
are adding to others that are questioning us about the role of behavioural symptoms in early 
dementia stages, in some cases with evidence of earlier manifestations even than very 
subtle cognitive changes. Several recent studies have also reported that neuropsychiatric 
symptoms are present in 35-59% of individuals with MCI, with some of the more common 
symptoms being depression, anxiety, apathy, irritability, and problems with sleep (Feldman 
et al, 2004; Geda et al, 2004; Liketsos et al, 2002).   
 
Considering ADLI, an important potential determinant of aMCI prevalence may be the 
threshold of ‘impact’ at which it is re-labeled as dementia. It is possible that low aMCI 
prevalence in a given setting may reflect a higher level of disability arising from cognitive 
impairment (for example because of a more demanding lifestyle for older people or lower 
social support) so that the ‘window’ between normal cognition and disabling cognitive 
impairment (i.e. dementia, according to standard definitions) is narrower. Some evidence 
was found for this in urban China where prevalence of ADLI was relatively high in people 
with dementia and the association relatively strong between cognition and ADLI in people 
without dementia.  
 
Prevalence of ADLI on the other hand was relatively low in people from the urban Indian 
site, but strengths of association with cognitive function in the remainder were not 
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consistently weak relative to those in other sites. Although there are inconsistencies, the 
high between site heterogeneity found in this study suggests overall that the impact of 
cognitive impairment and/or dementia on ADLI varies to a meaningful extent between 
settings, which may have at least some influence on the prevalence and nature of a-MCI as 
a construct. 
 
Further evaluation is needed of the associations with disability and neuropsychiatric 
symptoms since our findings do suggest higher than expected co morbidity and there are 
large absolute numbers of older people with aMCI in these rapidly ageing and populous 
world regions where the large number of those potentially affected has important 
implications in these rapidly ageing settings. However, little is known about the prevalence 
or impact of MCI in LAMIC settings; this is one of the first studies, to investigate the 
prevalence of a-MCI in LAMICs 
 
We believe that this work has generated important findings that will produce a substantial 
impetus for further research in these regions. Follow-up has recently been completed in 
most 10/66 sites, which will provide further data on predictive validity. As has been 
mentioned, there are several potential implications for further research. A key limitation of 
the findings is that they are cross-sectional, whereas MCI constructs are envisaged to be 
primarily of longitudinal value as predictors of future dementia. The predictive validity of 
the aMCI categories therefore needs evaluating and comparing between sites. This will help 
clarify some of the variability identified in this thesis. For example, if aMCI has lower 
prevalence in China because the SMC/IMD components are restricting it to a more rare but 
more ‘accurate’ syndrome then incidence of dementia in participants with aMCI should be 
highest in China and lowest in India.  
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Prospective research is also indicated to investigate the onset of SMC/IMD in relation to 
different trajectories of cognitive decline as well as the temporal relationship between these 
two factors themselves (e.g. whether SMC identifies earlier or more mild deficits compared 
to IMD). Finally, the prospective relationship between cognitive decline and ADLI 
incidence could be further investigated in terms of the threshold at which function becomes 
impaired, the extent to which this varies between sites, and the extent to which any 
variation is accounted for by factors such as level of social support. As we previously 
mentioned, follow-up studies have recently been completed in the Chinese and Latin 
American 10/66 sites and data, as these become available, will be analysed with these 
objectives in mind.   
 
For at least some assumed cultural variation, quantitative research is likely to provide only 
limited insights, and further exploration of underlying reasons for our observations is likely 
to require qualitative approaches. These could include in-depth studies into attitudes 
towards perceived memory deficits in older people (both by those reporting deficits and 
those concerned about deficits in a close other). The meaning of the symptoms/observations 
could be explored further, as could knowledge about dementia and attitudes towards help 
seeking from formal or informal sources. Of particular interest for the findings reported 
here would be research in China to clarify reasons for the relatively rare SMC and IMD 
categories including specific research in people reporting these symptoms/observations to 
understand further why these appear to be more accurate reflections of cognitive function 
than they are in other cultures, including Western settings.  
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In the meantime, while further research is awaited, there are certain implications which can 
be drawn for public health and clinical practice. First, it is important to bear in mind that 
MCI-related constructs applied in epidemiological research have differences to decisions 
made in clinical environments where there is more of a process of judgement regarding the 
presence and impact of cognitive impairment. Attempts to apply these in community 
studies have tended to lead to broader definitions with substantially lower predictive 
validity. Heterogeneity in prevalence has also been high and our study confirmed this, 
despite the standardisation of measurement and sampling across surveys.  
 
Furthermore, there were clear and substantial variations in SMC, IMD and ADLI as 
important components of the syndrome. Regardless of underlying reasons, these at very 
least suggest important cultural or other environmental influences, so that community 
prevalences should be viewed with caution. Although the samples analysed are from 
particular international settings, some of the conclusions may be more generalisable. In 
particular, if differences between sites exist then differences between individuals may also 
be substantial in the same respects (e.g. ability / willingness to detect cognitive impairment 
in oneself or a close other, propensity for functional impairment at a given level of 
cognitive decline).  
 
In clinical settings, the same issues apply where there is a focus on detection and 
management of MCI or early dementia. If some people in some settings or circumstances 
are more or less likely to notice/report memory deficits in themselves or others then 
services orientated around such reporting behaviour may have inevitable underlying 
inequalities in provision. The same may arise from differences in impacts of cognitive 
impairment if the impact itself is a component of a diagnosis and/or eligibility for 
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intervention. Clearly the findings from specific sites or countries need to be taken into 
account by local services (if only to seek replication and clarification through further 
research). However, the simple fact that context and environment have been found to be 
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